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DNA methylation is essential for mammalian development and transcriptional repression 
of genes and retrotransposons during embryo development and in somatic cells. The patterns 
of DNA methylation are established by de novo DNA methyltransferases, which are regulated 
by developmental signalling and require access to chromatin. Besides DNA 
methyltransferases, other proteins have recently been implicated in DNA methylation, such as 
the ATP-dependent chromatin remodeler LSH. The absence of LSH in mouse embryos leads 
to defects in DNA methylation and development. In relation to this, mutations in LSH have 
been found to cause Immunodeficiency–Centromeric instability–Facial anomalies (ICF) 
syndrome. This syndrome is characterized by centromeric instability and CpG 
hypomethylation of centromeric satellite repeats, and is most often caused by mutations in the 
catalytic domain of the DNA methyltransferase DNMT3B.  
LSH is essential for developmentally programmed de novo DNA methylation of large 
chromosomal domains including promoters of protein coding genes and repetitive sequences. 
Importantly, fibroblasts derived from chromatin remodeling ATPase LSH-null mouse embryos, 
which lack DNA methylation at transposons and specific gene promoters, are capable of re-
establishing normal patterns of DNA methylation and transcriptional silencing of misregulated 
genes upon re-expression of LSH. The ATP hydrolysis by LSH is essential for its function in 
gene silencing and de novo DNA methylation. However, the molecular mechanisms of LSH-
dependent gene silencing and de novo DNA methylation are yet unclear. Here we use an 
inducible system that enables controlled expression of LSH in Lsh-null mouse embryonic 
fibroblasts (MEFs) to follow chromatin dynamics, transcriptional silencing and establishment 
of de novo DNA methylation. This conditionally reversible Lsh knockout cellular system 
allowed us to study the order of events occurring immediately after LSH restoration in MEF 
cell lines in order to elucidate the molecular mechanism of LSH-dependent gene silencing. 
We have demonstrated that LSH upon its restoration localises to the promoters of LSH-
dependent loci leading to a mild decrease in the occupancy of H3, which reinforces the 
previously shown role of LSH as a chromatin remodeler. Simultaneously, there is removal of 
acetyl groups from H3 tails when LSH is bound to these target regions, which might be 
facilitated by the interaction of HDACs with LSH. The removal of H3Ac marks is followed by 
deposition of H3K9me2 by G9a/GLP histone methylases at the same time point when 
misregulated genes are silenced. This suggests that LSH creates a suitable substrate for 
G9a/GLP promoting gene silencing. Surprisingly, transcriptional repression occurs without 
acquisition of DNA methylation at the promoters of these loci. This order of events implies that 
LSH plays a role as a chromatin remodeler leading to changes in chromatin structure and 
modifications that facilitate epigenetic gene silencing without DNA methylation in the initial 
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period when LSH is restored in MEF cell lines. Furthermore, deposition of H3K9me2 by the 
G9a/GLP complex is critical for silencing of specific genes, but not for repetitive elements such 
as IAPs. The histone modification H3K27me3 seems to play a transitory role in the silencing 
of IAP retrotransposons in the absence of G9a/GLP activity.  
In conclusion, this work has demonstrated that changes in chromatin modifications 
leading to a transcriptionally repressive chromatin state can be established in somatic cells by 
the chromatin remodeler LSH without acquisition of DNA methylation. This suggests that the 
primary role of LSH is to promote changes in chromatin structure and modifications that lead 






Chapter 1 - Introduction  
 
1.1 DNA packaging into chromatin 
Mammalian diploid cells contain approximately 6 billion base pairs of DNA, corresponding 
to about 2 meters that need to be packaged to fit into the nucleus. The basic level of DNA 
compaction consists of 147 bp of DNA double helix wrapped around a histone protein octamer 
in 1.65 left-handed turns to form a nucleosome unit with DNA compacted into a superhelix. 
The nucleosome unit represents the basic structure of chromatin (Kornberg, 1974; Luger, 
Mäder, Richmond, Sargent, & Richmond, 1997; C. L. F. Woodcock, Safer, & Stanchfield, 
1976). The histone octamer consists of one H3/H4 tetramer and two H2A/H2B dimers. Histone 
N-terminal and C-terminal tails extend from the nucleosome core particle and this facilitates 
their modification by a series of chromatin regulators (Luger et al., 1997; Luger & Richmond, 
1998). All histone can be post-translationally modified (PTM) in a dynamic and reversible 
manner and this contributes to the regulation of chromatin function (Bannister & Kouzarides, 
2011). The nucleosome core particles are interconnected by linker DNA, which varies in length 
depending on species and tissue. This linker DNA is associated with the linker histone H1 
(Bednar et al., 1998). The 10nm chromatin fibre consists of nucleosomal arrays which are 
regularly spaced nucleosomes bound by linker histone H1 and other nucleosome binding 
proteins (Luger & Hansen, 2005). Interactions of linker DNA and linker histone H1 were found 
to result in a unique structural motif that directs chromatin folding and compaction facilitating 
the folding of chromatin into a 30 nm fibre (Bednar et al., 1998; C. L. Woodcock, 1994). 
Depletion of histone H1 in embryonic stem cells has been shown to cause a decrease in the 
spacing of nucleosomes and a reduction in the compaction of chromatin. Therefore H1 seems 
to be essential for higher order chromatin folding and chromosome structure (Y. Fan et al., 
2005). Some proteins which are members from the high-mobility group protein superfamily, 
weaken the binding of H1 to nucleosomes and cause a decrease in the degree of compaction 
of the chromatin fibre. Therefore these proteins tend to facilitate the access of regulatory 
factors to their chromatin targets (Catez et al., 2004), which suggests that a network of 
structural proteins that interact constantly, modulates the nucleosome accessibility and the 
local structure of the chromatin fibre. However, it is not clear whether the 30 nm fibre exists in 
higher eukaryotes since there is no strong in vivo evidence for it, although it can be assembled 
in vitro (only on repetitive and very regular DNA sequences) and extracted from nuclei. This 
suggests that the 30 nm fibre could be a distinct secondary higher-order chromatin structure, 
while an unfolded 30 nm fibre intermediate might be the preferred conformation of chromatin 
in vivo (Tremethick, 2007). It has been shown that the nucleosomal arrays, the 10 nm fibre, 
can be condensed into multiple higher order structures, which are defined as secondary and 
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tertiary chromatin structures (Luger & Hansen, 2005). The secondary structures refer to the 
30 nm chromatin fibre, which is formed by interactions of nucleosomes and regulatory 
proteins. The interaction between the N-terminal tail domain of histone H4 and the surface of 
histone H2A from a neighbouring nucleosome is needed to form this secondary chromatin 
structures (Dorigo, Schalch, Bystricky, & Richmond, 2003; J. Y. Fan, Rangasamy, Luger, & 
Tremethick, 2004). The tertiary structures, which are formed by interactions between 
secondary structures, include long distance contacts involving enhancers and promoters or 
looped chromatin domains (Woodcock and Dimitrov 2001). Many nucleosome-binding 
proteins have the capacity to assemble specific secondary and tertiary chromatin structures. 
These chromatin structures, formed by interactions with non-histone proteins, differ from the 
structures formed during intrinsic fibre folding (Luger & Hansen, 2005). For example, 
heterochromatin protein 1 α (HP1α) has been shown to bind to folded nucleosomal arrays 
inducing local rearrangement of secondary chromatin structures (J. Y. Fan et al., 2004). 
Besides the canonical histones H2A, H2B, H3, and H4 deposited immediately after DNA 
replication to package the newly generated genome, there are histones variants that can 
influence the properties and dynamics of the nucleosome. These histone variants play an 
important role during transcription influencing gene regulation  (Weber & Henikoff, 2014). 
Furthermore, it has been shown that HP1α binds preferentially to condensed higher order 
chromatin structures and cooperates with the histone variant H2A.Z to generate highly 
compacted secondary structures of chromatin (J. Y. Fan et al., 2004).  
Compaction of chromatin into higher order structures is thought to impair the access of 
regulatory factors to DNA, but not all the genome is condensed to the same level. This allows 
different regions of the genome to be regulated in different cells and at different stages during 
development (Trojer & Reinberg, 2007). Based on a classic definition there are two distinct 
states of chromatin configuration, active chromatin or euchromatin and silent chromatin or 
heterochromatin. Euchromatin usually contains single copy genes and genome regions that 
are transcribed, while heterochromatin contains repetitive sequences and regulates various 
functions including gene silencing, normal centromere function and nuclear organization (Bird 
2002). Heterochromatin can be divided into two different types - constitutive and facultative 
heterochromatin. Constitutive heterochromatin includes repetitive and non-coding sequences 
such as centromeric and telomeric DNA.  On the other hand, facultative heterochromatin 
includes condensed and transcriptionally silent chromatin regions that retain the capacity to 
interconvert with euchromatin depending on the specific circumstances, such as 
developmental stage or nuclear localization (Trojer & Reinberg, 2007). Besides euchromatin 
and heterochromatin, there is now evidence for diversity of genome segmentations into 
different chromatin states (Filion, Bemmel, Braunschweig, & Talhout, 2010). Also, targeting of 
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DNA-binding factors to specific regions is influenced by the different structures of chromatin 
(Filion, van Bemmel et al. 2010).  
In summary, the dynamics of nucleosomal compaction allow to access the DNA when 
needed while DNA is simultaneously packaged into highly condensed chromosomal 
structures. The different structures of chromatin are dynamic and allow transitions between 
different compaction states. Numerous proteins and protein complexes target nucleosomes in 
chromatin fibres to disassemble, reassemble and remodel nucleosome structures (Luger & 
Hansen, 2005). The effects of proteins, protein complexes and modifications on chromatin 
structure are not independent processes. There is an interplay between them. One example 
is the linker histone H1 the binding of which has been shown not only to reduce the mobility 
of H3 tails but also inhibit modifications of H3. Likewise, modifications of histones such as 
phosphorylation and acetylation, which weaken the contact between H3 tail and linker DNA, 
facilitate H3 tail dynamics and modifications (Stützer et al., 2016). Finally, the chromatin 
dynamics are also regulated by DNA methylation and ATP-dependent enzymes which 
remodel chromatin in addition to the post-translational modifications of histone proteins 
mentioned earlier (Ho & Crabtree, 2010). These have implications in different processes such 
as gene regulation, transcription and DNA repair (Luger, 2003; Luger & Hansen, 2005). 
 
1.2 Epigenetic modifications and gene regulation 
Waddington referred to epigenetics as the study of how genotypes give rise to different 
phenotypes during development (Waddington, 1957). This was followed by the definition of 
epigenetics as the study of heritable changes in the gene function, which cannot be explained 
by the changes of the genetic sequences (Russo V.E.A., Martienssen R.A., & Riggs A.D., 
1996). There are different layers of epigenetic regulation including DNA methylation, post-
translational modifications of amino terminal tails of histone proteins and exchange of 
canonical histones by histone variants (A. Bird, 2007). The inheritance of epigenetic profiles 
is necessary to maintain the gene expression characteristic of different cell types during cell 
division (M. Xu & Zhu, 2010), however not all epigenetic marks are transmissible between 
generations. Examples of this are transient phosphorylation of the histone variant H2A.X after 
a double-strand break and histone modifications associated with transcription (A. Bird, 2007). 
Adrian Bird refined the classical definition, referring to epigenetics as “the structural adaptation 
of chromosomal regions so as to register, signal or perpetuate altered activity states”.  
Gene activation is regulated by transcription factors and gradients of signalling molecules 
and epigenetic modifications can contribute to stabilise the expression patterns. In addition, 
gene silencing is also controlled by epigenetic mechanisms involving post-synthetic 
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modifications of DNA, such as DNA methylation, and modifications of amino-terminal tails of 
histone proteins (Klose & Bird, 2006; Leeb & Wutz, 2012). Some proteins bind specifically to 
methylated DNA and promote changes in chromatin acting as a link between DNA methylation 
and chromatin remodeling and modification (Klose and Bird 2006). DNA methylation, histone 
modification and chromatin remodelling are not independent processes, they are linked 
through different molecular mechanisms. This has important consequences for developmental 
and differentiation processes causing alterations in appropriate gene expression patterns that 
can lead to diseases and cancer through silencing of cancer-relevant genes (P. a Jones & 
Baylin, 2007). An example of the interaction between DNA methylation and histone 
modifications are proteins that contain a methyl CpG binding domain (MBD), which can recruit 
chromatin modifiers, such as histone deacetylases, that condense chromatin and repress 
transcription (Wade & Wolffe, 2001). Another layer of epigenetic regulation is provided by the 
exchange of histone variants that can occur independently of DNA replication. Non-canonical 
histone variants play an important role during transcription and might have a role perpetuating 
active chromatin states (Weber & Henikoff, 2014). The inheritance of all epigenetic marks has 
been questioned, but some epigenetic profiles, particularly the repressive ones, are 
maintained through DNA replication. Histone post-translational modifications in constitutive 
pericentromeric heterochromatin are maintained during chromatin replication (Cedar & 
Almouzni, 2016). These epigenetic marks not only help maintaining gene expression profiles 
but also maintaining chromatin structure such as centromere and telomere through 
interactions between specific histone modifications and chromatin binding proteins (M. Xu & 
Zhu, 2010). The next sections will describe in detail the main epigenetic marks that will be 




                 
 
 
1.3 DNA methylation 
Multiple epigenetic mechanisms affect the structure of chromatin and lead to activation or 
repression of some genes. DNA methylation is one of the mechanisms that play a role in 
chromatin structure (Theresa M Geiman & Muegge, 2010; Hansen, Ghosh, & Woodcock, 
2010). In animals, DNA methylation refers to the addition of a methyl group to the 5-position 
carbon within the cytosine pyrimidine ring. During the methylation process, DNA 
methyltransferases (DNMTs) use S-adenosylmethionine (SAM) as a methyl group donor to 
transfer the methyl group from SAM to the cytosine residue which becomes a 5-methyl 
cytosine (5meC). This process occurs mostly in the context of a cytosine-guanine dinucleotide 
(CpG) in the mammalian genome (Yoder, Soman, Verdine, & Bestor, 1997). Methylation can 
also occur in non-CpG dinucleotide context at cytosines in the context of CH, CHG and CHH, 
where H is a non-guanine nucleotide. Methylation of cytosine at these other contexts is 
widespread in plants (Cokus et al., 2008), and has recently been observed in mammals (Lister 
Figure 1.1. Epigenetic modifications on DNA compacted into chromatin.  
DNA double helix wrapped around core histones into nucleosome units, that are further compacted into higher 
order chromatin structures. DNA methylation at CpG dinucleotides (5meC) indicated as black circles on the 




et al., 2009). However, the function of non-CpG methylation is currently unknown in mammals 
(P. A. Jones, 2012) although, like CpG methylation, non-CpG methylation has been suggested 
to have a function in gene silencing (Malone et al., 2001). During DNA replication, the 
methylation mark is passed to the newly synthesised DNA strands due to the symmetric nature 
of the CpG methylation in the genome (A. Bird, 2002). In somatic cells, only 1% of all DNA 
bases is a methyl-cytosine but about 70-80% of the CpGs in the genome are methylated 
(Ehrlich et al., 1982). An exception to this highly methylated CpGs in the genome are the CpG 
islands (CGI). CpG islands are regions high in CpG dinucleotide content which are usually 
unmethylated (A. P. Bird, 1986). The length of CpG islands varies between hundreds of base 
pairs and four kilo-base pairs. Most CpG islands are positioned in the proximal, 5’ end, 
promoter region of the genes in the mammalian genome and are normally unmethylated (A. 
Bird, 2002; A. Bird, Taggart, Frommer, Miller, & Macleod, 1985). Approximately 60% of 
annotated mammalian genes have CpG islands found near the transcription start sites (TSS). 
Most of them are unmethylated during all stages of development in different tissues types 
(Antequera & Bird, 1993; A. Bird et al., 1985). The high content of CpG dinucleotides in CpG 
islands compared to the rest of the genome is due to the conversion of methylated cytosines 
to thymidines through spontaneous deamination. This explains the low frequency of CpGs 
found in the genome, in opposition to CpG islands which are normally unmethylated 
(Antequera & Bird, 1999; Smallwood et al., 2012).  
 
1.3.1 Distribution of DNA methylation and function in gene regulation 
The distribution of DNA methylation is related to the different functions associated with 
this epigenetic mark (Figure 1.2). The association of CpG islands with gene promoters 
suggests that their methylation state has a role in the regulation of gene transcription (A. Bird, 
2002). As mentioned earlier, most CpG islands are unmethylated, but a small proportion 
become methylated during early mammalian development and in disease such as cancer, 
which leads to long term stable gene silencing in somatic cells (Antequera & Bird, 1999). This 
long term stability of gene silencing due to methylated CpG islands is also associated with 
imprinted genes and genes located on the inactive X chromosome. On the other hand, 
transcriptionally active genes that contain unmethylated CGIs at their promoters are 
characterized by nucleosome-depleted regions (NDRs) at the TSS. The nucleosomes flanking 
NDRs often contain the histone variant H2A.Z and are marked with active histone 
modifications such as the trimethylation of lysine 4 from histone H3 (H3K4me3) and 
acetylation of histones H3 and H4 (Kelly et al., 2010). The histone modification H3K4me3 
impairs the establishment of DNA methylation since DNMTs cannot interact via their ADD 
domain with methylated H3K4, showing again a link between methylation and histone 
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modifications (Otani et al., 2009; Sormani, Haerter, Lövkvist, & Sneppen, 2016). The idea of 
the establishment of DNA methylation at gene promoters that precedes and directs gene 
silencing has been controversial, but this timing of events might not be the most general 
mechanism. It seems that generally gene silencing precedes de novo DNA methylation at 
promoters (P. A. Jones, 2012). One example of this timing is the silencing of the Oct-3/4 gene 
by the repressive histone modification H3K9me2 and subsequent establishment of DNA 
methylation during early embryogenesis (Athanasiadou et al., 2010; Feldman et al., 2006). 
During development, genes containing CpG island promoters can be repressed by Polycomb 
proteins, such as the PRC2 complex that deposits H3K27me3, a histone modification 
associated with repressed genes (Curie & Paris, 2011). There is now evidence demonstrating 
that approximately half of the CpG islands in mammalian genomes are not associated with 
annotated promoters and they are found in intragenic or intergenic regions. These CpG islands 
are referred to as orphan CGIs. Orphan CGIs show transcriptional activity although they are 
more likely to become methylated during development than CGIs at promoters. This suggests 
a possible functional role of orphan CGIs during development (Illingworth et al., 2010). 
 
 
     
 
 
Two models have been proposed to explain how DNA methylation is associated with gene 
silencing. DNA methylation can repress transcription by blocking transcriptional activators 
from binding to methylated CpGs and also promoting the binding of proteins with a methyl-
CpG binding domain (MBD) that can recruit corepressors to silence gene expression. MBD1 
can interact with the histone methyltransferase enzyme SETDB1, creating a link between 
Figure 1.2. Distribution of DNA methylation at CpG dinucleotides.  
Methylated and unmethylated CpG dinucleotides are indicated as black and white lollipops, respectively. Most 
of the genome is methylated at CpG dinucleotides (intergenic and intragenic CpG dinucleotides). Exception to 
this are CpG islands (CpG rich regions) which are usually located at promoter regions. CpG islands are usually 
unmethylated, unless they are involved in developmental regulation of gene activity. Orphan CpG islands are 
not associated with annotated promoters and they are found in intragenic or intergenic regions.  
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recognition of DNA methylation and modification of the chromatin state by methylation of 
histone H3 lysine 9 (Sarraf & Stancheva, 2004). DNA methyltransferases show another layer 
of regulation, since they interfere with gene expression through interaction with proteins such 
as histone deacetylases that create a repressive chromatin state (Klose & Bird, 2006). It 
seems that gene silencing is not caused by a single mechanism such as DNA methylation, 
but requires multiple different processes for efficient repression including: interference with 
binding of transcription factors, recruitment of histone deacetylases via repressor proteins, 
methyl-CpG binding proteins or DNA methyltransferases, and non-coding RNAs (Klose and 
Bird 2006). These mechanism indicate a crosstalk between different epigenetic marks to 
stabilise expression states (Sormani et al., 2016).          
Most gene bodies are poor in CpG dinucleotide content but CpGs found in gene bodies 
are methylated. Methylation of gene bodies is associated with silencing of repetitive and 
transposable elements, such as intracisternal A particle (IAP) elements (Yoder, Walsh, & 
Bestor, 1997). It has also been shown that intragenic DNA methylation can prevent spurious 
transcription through a crosstalk between the histone modification H3K36me3 and DNA 
methyltransferase DNMT3B. Transcribed genes contained H3K36me3 at their gene bodies, 
which is associated with transcription elongation and can also recruit DNMT3B (Neri et al., 
2017). When DNA methylation is established in the gene body, it does not block transcription 
and it might even stimulate transcription elongation (Wen et al., 2014). Another characteristic 
of methylation at gene bodies is that exons are highly methylated compared to introns, which 
correlates with higher nucleosome occupancy at exons (Chodavarapu et al., 2010). The 
change in the level of DNA methylation between exons and introns occurs at the boundary 
suggesting a role of DNA methylation in the regulation of splicing (L. Laurent et al., 2010).  
Enhancers are CpG poor regions that control gene expression and have variable levels 
of DNA methylation with an average of 30% 5meC. These regions are referred to as low-
methylated regions and this suggests that enhancers might be in a dynamic state since they 
can be methylated or unmethylated at different times. Transcription factors and proteins that 
affect DNA methylation levels, such as TET enzymes, have been found at enhancers, but the 
relation between methylation of enhancers and the regulation of their function is not clear yet 
(Stadler et al., 2011; Yin et al., 2017). The TET enzymes could be recruited through its CXXC 
domain to unmethylated CpGs and thus reinforce the unmethylated state (Sormani et al., 
2016).   
In summary, promoter hypomethylation is associated with potential for active transcription 
and higher levels of gene body methylation are correlated with active transcription (L. Laurent 
et al., 2010). DNA methylation is critical in different processes, for example genomic imprinting 
causing allele-specific expression of some genes (Reik & Walter, 2001), X inactivation 
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ensuring expression of genes from only one X chromosome in female mammals (Senner and 
Brockdorff 2009) and silencing of retrotransposons in the genome contributing to genome 
stability (Huang et al., 2004). Aberrant hypermethylation of CpG islands at gene promoters is 
important in cancer initiation and progression, since it leads to inappropriate silencing of 
genes, such as  tumour suppressor genes or BRCA1 gene in breast cancer (P. A. Jones & 
Baylin, 2002; P. a Jones & Baylin, 2007). Early differentiation is marked by important changes 
in DNA methylation and genome structure. However, it is still unclear how DNA methylation is 
stablished at specific sites in the genome and how DNA methylation contributes beyond 
silencing gene expression to affect chromatin structure, modifications and nuclear architecture 
(Geiman and Muegge 2010).  
 
1.3.2 DNA methyltransferases  
DNA methylation patterns are established during gametogenesis, embryo development, 
and cell differentiation by enzymes of the DNA cytosine methyltransferase family, which 
includes five DNA methyltransferases (DNMTs) in mammals. The maintenance DNA 
methyltransferase DNMT1 and the de novo methyltransferases DNMT3A and DNMT3B are 
referred to as the canonical DNMT enzymes since they catalyse the addition of methylation 
marks to CpGs in the genomic DNA (Okano, Bell et al. 1999, Bird 2002). The functions of 
these enzymes are not limited to the establishment and maintenance of DNA methylation 
patterns, they also have an important role in epigenetic gene regulation (Lyko, 2017). The 
non-canonical DNMT enzymes, DNMT2 and DNMT3L (DNMT3-like), have sequence 
conservation with the canonical DNMT3 enzymes. 
 
Domain architecture of DNMT enzymes  
DNMT enzymes share a similar domain structure with an N-terminal regulatory domain 
and a C-terminal catalytic domain, except for DNMT2 that only contains the catalytic domain 
and DNMT3L that is catalytically inactive (Figure 1.3). The catalytic domain contains six 
conserved motifs involved in SAM cofactor binding and catalytic activity (Bestor, 2000). The 
N-terminal regulatory domains are different between DNMT1 and DNMT3 enzymes and this 
differences could play an important role in their specific activity in the genome since the N-
terminal region is responsible for protein-protein interactions and targeting of these enzymes 







The N-terminal domain of DNMT1 contains several conserved subdomains that are 
important for molecular interactions, such as the protein binding domain (PBD) that is able to 
interact with different proteins, RFTS domain, CXXC domain and BAH domains. The PBD 
domain contains a DMAP1 binding domain that is required for DNMT1 to establish a 
repressive transcription complex during DNA replication in addition to its role maintaining DNA 
methylation. DNMT1 interacts through this domain with the transcriptional repressor DMAP1 
(DNMT1-associated protein 1) and with the histone deacetylase HDAC2 (Rountree, Bachman, 
& Baylin, 2000). The PBD domain also contains a PCNA binding domain. The RFTS domain, 
replication foci targeting sequence, is necessary for targeting DNMT1 to the replication foci. 
This allows the methylation of newly synthesized DNA in a replication-dependent manner and 
Figure 1.3. Domain architecture of murine DNMT enzymes. 
Domain annotation of maintenance DNA methyltransferase DNMT1, de novo DNA methyltransferases 
DNMT3A and DNMT3B, and the non-canonical enzymes DNMT3L and DNMT2. PBD: includes the DMAP1 
and PCNA binding domains, RFST: replication foci targeting sequence, CXXC: DNA binding domain, BAH: 
bromo-adjacent homology domains, PWWP: required for chromatin targeting, ADD (ATRX-DNMT3-DNMT3L): 
important for protein interactions.  
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maintains the specific pattern of methylation (Hervouet, Peixoto, Delage-mourroux, Boyer-
guittaut, & Cartron, 2018; Leonhardt, Page, Weier, & Bestor, 1992). The CXXC is a conserved 
zinc-finger domain that binds unmethylated CpG and the function of the BAH domains, bromo-
adjacent homology domains, still needs to be elucidated (Lyko, 2017).  
The N-terminal region of DNMT3A and DNMT3B enzymes also contains conserved 
domains, including a PWWP domain and an ADD domain. Both PWWP and ADD domains, 
are important for chromatin interactions. The PWWP domain, Pro-Trp-Trp-Pro, is important 
for DNA binding and it recognizes the H3K9me3 and H3K36me3 marks (Dhayalan et al., 2010; 
Neri et al., 2017) and it is also required for the localisation to pericentromeric repeats (Ambrosi 
et al., 2017). The ADD domain, ATRX–DNMT3–DNMT3L, is also important for interactions 
with chromatin. This domain recognizes unmodified histone H3 and is inhibited by methylation 
of H3 lysine 4 (Ooi et al., 2009; Otani et al., 2009).  
DNMT2 lacks the N-terminal regulatory domain and its catalytic target is not the cytosine 
nucleotide but it contains all the conserved catalytic motifs of cytosine-5 DNMTs. There is now 
evidence showing that DNMT2 methylates transfer RNA (tRNA) by employing a DNA 
methyltransferase-like catalytic mechanism, which suggests that this enzyme changed its 
substrate specificity from DNA to RNA during its evolution. The tRNA binding site of DNMT2 
has been mapped within its catalytic domain (Jurkowski, Shanmugam, Helm, & Jeltsch, 
2012).   
DNMT3L is a catalytically inactive variant of DNMT3 that lacks the N-terminal part of the 
regulatory domain which includes the PWWP domain, and the C-terminal part of the catalytic 
domain, but it maintains the ADD domain (Lyko, 2017).  
 
Function of DNMT enzymes  
DNMT1 is the most abundant DNMT in somatic cells and its main function is to maintain 
DNA methylation levels during DNA replication by copying an already established methylation 
pattern (Yoder, Soman et al. 1997). DNMT1 binds to hemi-methylated DNA at CpG sites after 
DNA replication. The parental strand remains methylated and DNMT1 catalyses the 
methylation of the cytosine on the newly synthesized stand. This maintains established CpG 
methylation patterns through mitosis (Robertson et al., 1999). DNMT1 requires accessory 
proteins, such as the protein UHRF1, which also plays a role in the maintenance of DNA 
methylation. UHRF1 preferentially binds to hemi-methylated DNA and is recruited to 




DNMT3A and DNMT3B establish de novo DNA methylation in unmethylated CpGs and 
do not require hemi-methylated DNA to bind, they show equal affinity for hemi-methylated and 
non-methylated DNA (Okano, Bell, Haber, & Li, 1999). Both DNMT3A and DNMT3B are 
required for the genome-wide de novo methylation of DNA that occurs during gametogenesis 
and after embryo implantation in mammalian development. Their activity is facilitated by the 
ADD domains that enable DNMT3 enzymes to recognise histone H3 N-terminal tail lacking 
methylation at lysine 4. Regulatory regions in the genome, including CpG islands at gene 
promoters and enhancers, are protected from methylation by different mechanisms such as 
bound transcription factors and methylation of histone H3 lysine 4 (Lyko, 2017; Otani et al., 
2009).  DNMT3A and DNMT3B are highly expressed in undifferentiated embryonic stem cells, 
but they are downregulated after differentiation with low expression levels in somatic cells 
(Okano et al., 1999). However, this model where DNMT3 enzymes establish DNA methylation 
and DNMT1 enzyme maintains the already established patterns of methylation might be 
oversimplified. There is now evidence showing that there is a crosstalk between de novo and 
maintaining DNA methylation machineries. There are several studies showing that DNMT3A 
and DNMT3B are also essential for the maintenance of DNA methylation patterns in 
embryonic stem cells (Chen, Ueda, Dodge, Wang, & Li, 2003) and that the de novo DNA 
methylation is partially catalysed by DNMT1. There are also DNMT-including complexes for 
de novo establishment or maintenance of DNA methylation that can be targeted to particular 
DNA sequences in a specific or non-specific manner. Specific complexes include the 
Polycomb proteins and transcriptional factors; while non-specific complexes include 
heterochromatin readers and replication associated proteins, such as HP1 and UHRF1, 
respectively (Hervouet et al., 2018). DNMT3B has different isoforms that stimulate gene body 
methylation independently of their catalytic activity. This suggests a similar functional role to 
DNMT3L enzyme which recruits DNMT3A to initiate DNA methylation. DNMT3L is only 
expressed in undifferentiated cells, therefore DNMT3B isoforms might be playing the same 
role in somatic cells (Duymich, Charlet, Yang, Jones, & Liang, 2016). DNMT3A and DNMT3B 
have overlapping functions in development but they also exhibit non overlapping functions, 
since DNMT3B is specifically required for methylation of centromeric minor satellite repeats 
(Okano et al., 1999) and gene body methylation (Baubec et al., 2015). DNMT3A shows higher 
DNA methylation activity towards naked DNA and the naked part of nucleosomal DNA while 
DNMT3B shows activity towards the nucleosome core region, although the activity is low 
compared to naked DNA. This difference in their activity could contribute to their distinct 
methylation of genomic DNA regions in vivo, which could also be influenced by the difference 
in timing of expression of DNMT3A and DNMT3B (Takeshima et al., 2006).  
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DNMT2 is a tRNA methyltransferase that methylates a small set of transfer RNAs at a 
single specific site (cytosine 38) close to the anticodon loop (Jurkowski et al., 2012). DNMT2 
has a post-transcriptional function since methylation of tRNAs protects them against 
fragmentation having an impact on their stability. The activity of DNMT2 also influences 
different aspects of protein translation (Lyko, 2017). DNMT3L is an important cofactor for 
DNMT3 enzymatic activity and increases the affinity of DNMT3A to DNA in undifferentiated 
cells (Lyko, 2017). Moreover, DNMT3L plays an essential role in the regulation of DNA 
methylation in gametes, where it guides DNMT3A to establish genomic imprints and facilitates 
genome stability through the methylation of transposable elements (Ambrosi et al., 2017).  
Besides DNMT enzymes, there are other proteins that also affect DNA methylation 
patterns, such as UHRF1 mentioned earlier and the chromatin remodelling enzymes LSH and 
ATRX (Dennis, Fan, Geiman, Yan, & Muegge, 2001; Garrick et al., 2000). The role of ATP-
dependent chromatin remodelers in DNA methylation remains unclear, but targeting of 
DNMT3B is impaired and nucleosome occupancy is reduced in the absence of LSH (Ren et 
al., 2015). The link between DNMTs and human diseases is often discussed in the context of 
cancer, since aberrant DNA methylation patterns has been shown to affect tumorigenesis. 
Mutations in DNMTs are rare in human diseases due to the requirement of their activity for 
appropriate mammalian development. However, ICF syndrome is a developmental genetic 
disorder characterized by hypomethylation of pericentromeric repeats and is mainly caused 
by DNMT3B mutations (Jiang et al., 2005), although some patients show mutations in genes 
that are linked or required for DNA methylation by DNMT3B such as the chromatin remodeler 
LSH (Thijssen et al., 2015). Another disorder, the Rett syndrome, has been found to result 
from mutations in the MECP2 gene, which encodes a protein that binds to methylated DNA 
(Amir et al., 1999).  
DNMTs are essential for normal development, but it remains unclear how genome-wide 
cytosine methylation patterns are established and maintained. Deletion of DNMT3A results in 
impaired postnatal development while deletion of either DNMT1 or DNMT3B is embryonic 
lethal in mice indicating a critical role of DNMTs in development (Li, Bestor, & Jaenisch, 1992; 
Okano et al., 1999). 
 
1.3.3 DNA methylation reprogramming during embryonic mammalian development 
The patterns of DNA methylation undergo reprogramming during early development 
(Figure 1.4) which is implicated in early cell lineage specification, genomic imprinting and X 
chromosome inactivation (Leeb & Wutz, 2012). During early embryonic development, the DNA 
methylation patterns inherited from the parental gametes are largely erased after fertilization 
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(P. Zhang et al., 2012). The removal of DNA methylation occurs similarly over the entire 
genome independently of CpG density, with the exception of imprinted loci and some repetitive 
elements such as intracisternal A-particle (IAP) elements that maintain high levels of 
methylation (Reik & Walter, 2001; Smith et al., 2012). The maintenance of DNA methylation 
at these specific regions requires DNMT1, which is expressed in early embryos from the 
zygote to the blastocyst stage (Uysal, Akkoyunlu, & Ozturk, 2015). Both parental genomes 
undergo the same wave of demethylation, but the rate of demethylation is different between 
the oocyte and sperm. Also, oocytes are already globally hypomethylated compared to sperm 
(Smith et al., 2012). The paternal genome is subjected to an active and almost complete 
demethylation after fertilisation and prior to replication (Oswald et al., 2000). However, the 
maternal genome becomes demethylated passively during cell divisions and it reaches the 
minimum level of methylation around the blastocyst stage. The majority of the genome at 
blastocysts stage, before implantation, shows the lowest level of CpG methylation during 
embryogenesis (Bird 2002, Li 2002). Following this wave of demethylation, DNA methylation 
is re-established after implantation of the embryo in a wave of de novo DNA methylation 
carried out by DNMT3A and DNMT3B (Okano et al., 1999). However, the level of DNA 
methylation acquired is different at the embryonic and the extraembryonic lineages. Both 
lineages gradually gain DNA methylation but the extraembryonic layer contains much less 
methylation than the embryonic lineages (Chapman, Forrester, Sanford, Hastie, & Rossant, 
1984; Monk, Boubelik, & Lehnert, 1987). The de novo DNMTs are upregulated at this stage 
to allow DNA methylation to be re-established genome-wide during the transition to the 
epiblast stage. The expression patterns and targets of de novo DNMTs are different during 
post-implantation development. DNMT3B might be more important during early development 
after implantation and methylates a broad spectrum of target sequences, while DNMT3A could 
methylate specific genes that are critical during late development or after birth (Borgel et al., 
2010; Okano et al., 1999). This de novo methylation occurs at many types of gene sequences 
with the exception of CpG islands. There is a correlation between de novo methylation and 
low CpG density regions (Smith et al., 2012). Several promoters become methylated, including 
pluripotency gene promoters, promoters of gamete specific genes, and numerous promoters 
associated with tissue specific genes that will be activated later during development (Borgel 
et al., 2010). Pluripotency genes, such as Oct4 and Nanog, become de novo methylated in a 
specific stage of the development which suggests a role for DNA methylation in the exit from 




    
 
 
The dynamic changes of DNA methylation during development are also accompanied by 
changes in histone modifications, such as methylation of H3 lysine 4 and lysine 27, that are 
also essential for development (L. Laurent et al., 2010; Reik, 2007). The importance of post-
translational histone modifications will be the focus of the next section.  
 
1.4 Chromatin modifications: chemical modification of histone tails  
N-terminal tails of histone proteins can be post-translationally modified by different 
chemical groups such as acetylation, methylation, phosphorylation and ubiquitination. These 
modifications, which are dynamic and reversible, play an important role as epigenetic factors 
that in addition to DNA methylation contribute to transcriptional regulation. The histone marks 
can attract a variety of binding proteins and complexes that can further modify the chromatin 
architecture and gene expression (Bannister & Kouzarides, 2011; Smith & Meissner, 2013).  
Figure 1.4. Dynamics of DNA methylation in early mouse development. 
Schematic view of different time points from fertilization in early mammalian development and levels of DNA 
methylation (5meC) during the different stages of development. Male and female DNA methylation levels are 
indicated in blue and pink, respectively. During pre-implantation development DNA methylation is lost from 
both the maternal and the paternal genome. DNA methylation reaches its lowest level at blastocyst stage, 
before implantation. DNA methylation is re-established after implantation of the embryo in a wave of de novo 
DNA methylation carried out by DNMT3A and DNMT3B enzymes. DNMT1 is responsible for the maintenance 
of DNA methylation levels. Repetitive IAP elements and imprinted loci maintain high levels of DNA methylation 
during this process.    
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The acetylation of lysines in histone tails is regulated by two families of enzymes, histone 
acetyltransferases (HATs) and histone deacetylases (HDACs). The HAT enzymes catalyse 
the transfer of an acetyl group, which neutralizes the positive charge of the lysine and weakens 
the interaction between histones and DNA. Acetylation occurs on numerous lysines in histone 
tails, including H3K9, H3K14, H3K18, H3K27, H4K5, H4K8 and H4K12. Histone acetylation is 
enriched at enhancers and gene promoters, where they facilitate the access to transcription 
factors (Z. Wang et al., 2009). HDAC enzymes remove the acetylation mark, restoring the 
positive charge of the lysine and therefore stabilizing the local chromatin architecture, which 
is consistent with HDACs being predominantly involved in transcriptional repression 
(Bannister & Kouzarides, 2011). 
Histone methylation occurs mainly on lysines but also on arginines in histone tails and it 
does not alter the charge of the histone protein. Lysines can be mono-, di- or tri-methylated 
and these marks are deposited by different histone lysine methyltransferases (HKMTs). 
Histone demethylases remove this mark and they are specific to the degree of lysine 
methylation (Du, Johnson, Jacobsen, & Patel, 2015). The HKMTs usually contain a SET 
domain that harbours the enzymatic activity. There are different HKMTs, such as the G9a/GLP 
complex that catalyse mono and di-methylation of H3K9 which is associated with silent genes 
in euchromatin, and SUV39H1 and SUV39H2 that catalyse the trimethylation of H3K9 a 
modification mainly associated with centromeric and pericentromeric heterochromatin. 
SETDB1 is a methyltransferase responsible for the deposition of H3K9me3 mark at 
endogenous retrovirus and the inactive X chromosome in ES cells and differentiating ES cells, 
respectively (Du et al., 2015). During embryonic development, the Polycomb group proteins 
repress gene expression via the formation of complexes containing different subunits referred 
to as Polycomb repressive complex 1 (PRC1) and 2 (PRC2). PRC2 has histone 
methyltransferase activity and trimethylates H3K27, a mark of transcriptionally 
silent chromatin. PRC1 is required for stabilising this silencing through ubiquitylation of histone 
H2A (A. Bird, 2007; Boyer et al., 2006).  
There are other histone modifications such as phosphorylation that reduces the positive 
charge of histones and ubiquitylation in tails of H2A associated with gene silencing as 
mentioned earlier (Bannister & Kouzarides, 2011), or ubiquitylation of H3 shown to direct 







1.4.1 Distribution and function of histone modifications  
The genome is segmented into different chromatin states with specific chromatin 
modifications that vary between chromatin types (Filion, van Bemmel et al. 2010). Histone 
modifications including acetylation or methylation of histone tails reflect either the presence or 
absence of gene activity in chromatin. While active promoters are characterized by 
hypomethylated DNA and chromatin methylated at H3K4 residues, silenced chromatin is 
characterised by low methylation at H3K4 and high methylation levels at H3K9 residue 
(Bannister & Kouzarides, 2011). However, it is not clear yet whether histone modifications are 
the cause or consequence of the specific transcriptional state. Induction of H3K4me3 has 
been shown to induce gene re-expression although this outcome depends on the DNA 
methylation status of the genomic region (Cano-rodriguez, Gjaltema, Jilderda, Jellema, & 
Dokter-, 2016). 
Transcriptionally active genes are marked by acetylation of histones H3 and H4 in their 
promoter regions. Histone acetylated lysines are bound by proteins with bromodomain, which 
are often found in HATs and chromatin remodelling complexes (Bannister & Kouzarides, 
2011). In addition to acetylated histones, H3K4me2/3 are also present at active gene 
promoters, as mentioned earlier. H3K4me3 promotes transcription initiation and H3K9ac could 
stimulates the release of paused RNA Polymerase II needed for transcription elongation 
(Gates et al., 2017). Another study showed that Cfp1, the conserved subunit of the Set1 
complex that is responsible for H3K4me3, establishes H3K4me3 at promoters upon 
transcriptional induction and this contributes to H3K9 acetylation, enabling an active chromatin 
state (Clouaire, Webb, & Bird, 2014). The histone modification H3K4me2 has also been 
observed in coding regions and correlates with transcriptional activity (Bernstein, Humphrey 
et al. 2002). Histone modifications not only act as binding sites for protein complexes, they 
can also inhibit protein interactions such as H3K4me3 that impairs binding of DNMT3 enzymes 
(Otani et al. 2009).   
H3K9 methylation is generally associated with transcriptional silencing and 
heterochromatin formation, which ensures stable repression and genomic integrity. Gene 
repression usually correlates with increased H3K9 methylation at promoters and across large 
genomic regions. The lysine methyltransferases SUV39H1 and SUV39H2 have their main 
function at constitutive heterochromatin, while SETDB1 and G9a/GLP are responsible for 
H3K9 methylation at euchromatin and facultative heterochromatin, and are involved in 
dynamic transcriptional repression (Bannister & Kouzarides, 2011). Repression of 
transposons and repetitive elements in mouse embryonic stem cells depends on the 
methylation of histone lysines (Mozzetta, Boyarchuk, Pontis, & Ait-Si-Ali, 2015). The 
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repression of transcription through H3K9 methylation occurs via the interplay of different 
enzymes, including DNA methyltransferases, histone deacetylases and H3K4 demethylases 
(Bannister & Kouzarides, 2011). 
Methylation of H3K27 by the PRC2 complex correlates with gene silencing. PRC2 is 
mainly responsible for the maintenance rather than the establishment of transcriptional 
silencing and it interacts with other protein complexes, including H3K4 and H3K36 
demethylases, to repress transcription through chromatin compaction. This indicates that 
gene silencing involves removal of activating marks and deposition of repressive H3K27 
methylation marks (Mozzetta et al., 2015), which also occurs for other forms of silencing such 
as methylation of H3K9 that requires removal of active marks. PRC2 is recruited to regions 
with high CpG content via the zinc finger-CXXC domain of KDM2B that can recognise non-
methylated CpGs and favours PRC2 recruitment (Blackledge et al., 2014; Long, Blackledge, 
& Klose, 2013). However, this recruitment is impaired by transcriptional activity or DNA 
methylation (Jermann, Hoerner, Burger, & Schübeler, 2014). Developmentally regulated 
genes in murine embryonic stem cells have been reported to be enriched for bivalent marks 
that include both active H3K4me3 and repressive H3K27me3 histone modifications. The 
promoters that contain these bivalent marks in their CpG islands are in an inactive 
transcriptional state while keeping the genes poised and ready to be activated. Bivalent 
domains have also been found in intragenic CpG islands that undergo DNA methylation during 
differentiation. The loss of the bivalent marks results in the activation of their associated genes 
(S.-M. Lee et al., 2017). The H3K27me3 mark has also been shown to recruit the PRC1 
complex that leads to the displacement of PRC2, ubiquitylation of H2A and subsequent gene 
silencing (Boyer et al., 2006).  
 
1.4.2 Histone methylation crosstalk with DNA methylation  
Numerous chromatin-associated factors and proteins such as DNMT enzymes interact 
with modified histones through different domains and produce further changes in chromatin. 
DNMT enzymes, in addition to their DNA methyltransferase activity, also interact with histone 
deacetylases and histone methyltransferases. Therefore, DNA methylation is also coupled to 
transcriptional repression by chromatin modifications (Klose & Bird, 2006). Some interactions 
between histone methylation and both de novo and maintenance DNA methylation have been 
mentioned earlier, but this section will recapitulate relevant crosstalk mechanisms.  
As mentioned earlier, H3K36me3 modification is established in the gene bodies of 
transcribed genes and associated with transcription elongation. H3K36me3 mark can be 
recognised by the PWWP domains of the de novo DNA methyltransferases and target DNA 
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methylation to the intragenic region to avoid spurious transcription (Neri et al., 2017; Rondelet, 
Dal Maso, Willems, & Wouters, 2016). The DNMTs enzymes also contain the ADD domain, 
which facilitates their interaction with unmethylated H3K4, but this protein interaction is 
inhibited by the H3K4me3 modification associated with active chromatin at promoters, 
including unmethylated CpG islands (Otani et al. 2009).   
It has been suggested that DNA methylation is linked to the Polycomb protein complexes 
to stabilize silencing at Polycomb target genes. The H3K27me3 modification mediated by 
EZH2, component of the PRC2 complex, can lead to recruitment of DNMTs. The link between 
histone methylation by Polycomb proteins and DNA methylation influences transcriptional 
repression (Gopalakrishnan, Emburgh, & Robertson, 2008). However, this link is not clear 
since H3K27me3 and CpG methylation are largely mutually exclusive and DNA methylation 
has been shown to prevent binding of PRC2 (van Kruijsbergen, Hontelez, & Veenstra, 2015). 
Methylation of histone tails and DNA methylation are involved in the formation of 
heterochromatin, but the relationship between both is still not clear in mammals. The 
H3K9me3 mark is associated with repressive heterochromatin and there is a specific 
interaction between this mark and the protein HP1 that recognises the H3K9me3 modification 
via its N-terminal chromodomain and promotes chromatin condensation (Bannister & 
Kouzarides, 2011). Also, H3K9me3 has been shown to direct DNA methylation at 
pericentromeric repeats via the interaction of DNMT3B with HP1 (Lehnertz et al., 2003). 
Another study shows that transcriptional repression of Oct-4 gene is followed by an increase 
in H3K9 methylation that is mediated by the G9a/GLP complex. This leads to local 
heterochromatinization via the binding of HP1 and is required for subsequent de novo 
methylation at the promoter by DNMT3A/B (Feldman et al., 2006). Another study has shown 
that G9a recruits DNMT3A/B through its ANK domain, which also interacts with H3 mono- or 
di-methyl K9 (Epsztejn-Litman et al., 2008). The G9a/GLP complex has also been shown to 
stabilize imprinted DNA methylation in ES cells by recruitment of de novo DNA 
methyltransferases that antagonize TET-dependent loss of DNA methylation (T. Zhang et al., 
2016). These examples indicate the crosstalk between different epigenetic marks and 
chromatin modifying enzymes.   
There are also other proteins involved in the crosstalk between histone modifications and 
DNA methylation, such as the protein UHRF1 and the ATP-dependent chromatin remodeling 
protein LSH. It has been shown that UHRF1 plays an important role as a link between histone 
methylation and maintenance of DNA methylation by DNMT1 at the replication foci. UHRF1 
binds to hemi-methylated DNA and methylated DNA ligase 1, which contains a similar motif 
to H3K9 that is methylated by G9a/GLP (Ferry et al., 2017). Methylated ligase 1 recruits 
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UHRF1 to replication foci and UHRF1 ubiquitinates H3K23. The ubiquitylation mark recruits 
DNMT1 via its RFTS domain and stimulates the activity of DNMT1 at the replication foci 
(Nishiyama et al., 2013). The chromatin remodeler LSH has been associated with 
pericentromeric heterochromatin and normal CpG methylation at pericentromeric sequences 
(Dennis, Fan et al. 2001). Loss of LSH results in accumulation of H3K4me2 and H3K4me3 in 
pericentromeric DNA and other repetitive sequences. This gain of H3K4 methylation follows 
the loss of CpG methylation caused by LSH deficiency, indicating how LSH is crucial for the 
formation of normal heterochromatin (Yan, Huang et al. 2003). LSH is also required during 
embryo development for establishment of normal patterns of DNA methylation genome wide. 
The loss of methylation observed in the absence of LSH is accompanied by an increase of 
H3K27me3 at LSH-dependent loci, indicating redundancy of epigenetic silencing mechanisms 
(Yu et al., 2014). This demonstrates that there is a clear link between DNA methylation, 
histone modifications, and chromatin remodeling proteins; that contribute collectively to 
establishment and maintenance of transcriptionally inactive chromatin state.  
                                   
1.5 ATP-dependent chromatin remodelers  
Chromatin compaction into higher order structures inhibits the access of many regulatory 
proteins to DNA, but it also creates an additional layer of organization. Chromatin dynamics 
change to allow different biological processes to occur and these changes in chromatin 
organization are predominantly caused by ATP-dependent chromatin remodelers. These 
proteins are recruited to chromatin through direct binding to epigenetic marks or through 
proteins that bind epigenetic modifications (Clapier & Cairns, 2009). ATP-dependent 
chromatin remodelers hydrolyse ATP to obtain the energy required for altering the structure 
of chromatin (Cairns, 2007). Chromatin remodelers can often be found as part of large 
remodelling complexes and they lead to different changes in chromatin structure to expose 
DNA and make it accessible for DNA binding proteins. The different remodeling activities lead 
to nucleosome sliding through individual nucleosome repositioning, histone octamer eviction 
that exposes DNA previously wrapped around the histone octamer or nucleosome unwrapping 
by destabilisation of certain histone-DNA contacts (Figure 1.5). Some chromatin remodelers 
can alter the histone octamer through either histone dimer eviction or histone dimer exchange, 








1.5.1 Classification of ATP-dependent chromatin remodelers 
Chromatin remodeling complexes are divided into four different families based on the 
similarity of the domains flanking the conserved ATPase region: SWI/SNF, ISWI, CHD and 
INO80 (Clapier & Cairns, 2009).  The four families share a similar ATPase domain allowing 
them to use ATP hydrolysis to alter the histone-DNA contacts. However, they contain unique 
additional domains and associated subunits that specialise them for specific functions in 
Figure 1.5. Changes in chromatin structure by ATP-dependent chromatin remodelers or remodeling 
complexes. 
Three different remodeling activities expose DNA and make it accessible for DNA binding proteins: nucleosome 
sliding through individual nucleosome repositioning, histone octamer eviction and nucleosome unwrapping by 
destabilisation of certain histone-DNA contacts. ATP-dependent chromatin remodeling can also alter the 
histone octamer composition by histone dimer exchange, such as H2A-H2B dimer exchange for the histone 
variant H2A.X-H2B.    
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different biological processes. The general domains of chromatin remodelers are the following: 
a conserved Sucrose Non Fermentable 2 (SNF2) family ATPase domain which couples DNA 
binding to ATP hydrolysis for DNA translocation, domains that provide affinity to nucleosomes 
and recognise histone modifications, domains that regulate the ATPase domain and domains 
that interact with other chromatin regulatory proteins (Clapier & Cairns, 2009). The unique 
domains are located at flanking regions or between the SNF2 family ATPase regions. These 
domains provide specialised functions, such as recognition of PTMs, specific transcription 
factors or chromatin modifiers; that help target remodelers and regulate their function (Clapier 
& Cairns, 2009; Flaus & Owen-Hughes, 2011). Chromatin remodelers from the SWI/SNF 
family are characterised by the presence of a bromodomain in the C-terminal region of the 
ATPase. The bromodomain is a common domain in chromatin remodelers that recognises 
acetylated lysines in histones and other proteins. The CHD family of remodelers is 
characterized by the presence of two tandem chromodomains in the N terminal region and 
PHD finger domains. Chromodomains bind H3K4me2 or H3K4me3 and the PHD finger 
domain interacts with H3K4me3 and can also recognise core histones rather than the histone 
tails. The HAND-SANT-SLIDE is a combination of three domains that are found in the C 
terminal region of the ISWI subfamily and provide nucleosome recognition and stimulation of 
the ATPase activity. The INO80 subfamily is characterised by an extended linker region that 
splits the ATPase domain (Clapier & Cairns, 2009).    
The empirical classification of ATP-dependent chromatin remodelers into the four families 
mentioned earlier does not include all the previous subfamilies recognised from a phylogenetic 
comparison of the SNF2 family ATPase region, such as the subfamilies containing LSH and 
ATRX. These subfamilies are not included in the previous classification due to their unique 
flanking regions that cannot be categorised using domain finding tools. A new phylogenetic 
classification has been made including all known ATP-dependent chromatin remodelers 
(Figure 1.6). This new classification divides the Snf2 family of chromatin remodelers into 5 
groupings and subfamilies that also reflect differences in function (Flaus & Owen-Hughes, 
2011). The Snf2 family is named after the first protein of the group to be identified, a member 









1.5.2 Domain architecture and mechanism of action of ATP-dependent chromatin 
remodelers  
Members of the Snf2 family of proteins alter the chromatin state affecting the accessibility 
of DNA. Several Snf2 factors have been shown to shift nucleosomes along the DNA in vitro 
by disruption of histone-DNA interactions and sliding of nucleosomes along the DNA (Becker 
& Hörz, 2002; Dennis et al., 2001; Eisen, Sweder, & Hanawalt, 1995; J. Jeddeloh & Bender, 
1998), therefore allowing the access of transcription factors and other DNA binding factors to 
chromatin. ATP hydrolysis is required for the chromatin remodeling function and the ATP 
binding domain is highly conserved among the Snf2 proteins (Corona et al., 1999).  
Figure 1.6. Groupings and subfamilies of ATP-dependent chromatin remodelers defined by 
phylogenetic comparison of the SNF2 family ATPase region.  
Schematic of the phylogenetic classification of chromatin remodelers into subfamilies. Remodelers shown 
closer together without gaps are phylogenetically closer than others in the same grouping. Adapted from Flaus 
& Owen-Hughes 2011.        
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The ATPase region contains two domains, the SNF2_N and Helicase_C, which contain 
RecA-like domain lobes 1 and 2, respectively, and are defined by seven conserved helicase 
motifs (Figure 1.7). The helicase motifs are only required for DNA binding and translocation, 
they do not unwind double-stranded DNA. The RecA domains are responsible for the ATP 
hydrolysis, producing the energy necessary for DNA translocation. The ATPase region of Snf2 
proteins is characterised by the presence of a structured linker and two antiparallel alpha 
helical protrusions between the two RecA-like lobes (Flaus, Martin, Barton, & Owen-Hughes, 
2006). 
 
          
 
Different remodeling mechanisms have been suggested to explain the changes in 
nucleosome architecture induced by different remodelers, although the different remodeling 
outcomes might not involve different mechanisms, but modifications in certain kinetic or 
geometric parameters of the same DNA translocation mechanism (Längst & Becker, 2004). 
Two main mechanisms have been proposed: twist diffusion and loop propagation. Both 
models share the idea that a DNA distortion propagates over the surface of the nucleosome. 
The twist diffusion model suggests that energy fluctuations could be sufficient to twist the 
DNA helix at the edge of the nucleosomes, promoting replacement of DNA-histone 
interactions by 1bp of linker DNA that is pulled into a region between two histone-DNA 
contacts. This induces increased twist into the double helix, which is subsequently propagated 
around the nucleosome. This twist diffusion would shift the histone octamer along the DNA by 
the size of the distortion. The propagation of this twist around the histone octamer surface 
Figure 1.7. SNF2 family ATPase region architecture and structural features.  
The seven conserved helicase motifs and structural features are shown relative to RecA domain lobes 1 and 2. 
The figure is not to scale. Adapted from Flaus & Owen-Hughes 2011. 
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would change the rotational and the translational position of the nucleosome (Bowman, 2010; 
Längst & Becker, 2004).  
The loop propagation model suggests that after DNA binds between the RecA domains, 
structural changes through ATP hydrolysis could result in translocation activity with a segment 
of DNA being detached at the entry/exit into the nucleosome. The detached DNA fragment 
may either rebind to form the original nucleosome or interact with a different position on the 
histone octamer, creating a DNA loop on the nucleosome surface. The loop propagates 
breaking contacts between histones and DNA at the leading edge of the loop. The propagation 
of the loop involves the distal linker DNA, resulting in nucleosome repositioning. Depending 
on the length of the DNA segment detached and the subsequent extent of inclusion of 
nucleosomal linker DNA into a loop, different size DNA loops may be generated on the 
nucleosome surface (Cairns, 2007; Clapier & Cairns, 2009; Längst & Becker, 2004).   
In addition to the previous models, an alternative histone core swivel model has been 
proposed. This model involves rotation of the histone core with respect to the wrapping DNA 
and subsequent realignment of the DNA around it. The remodeler binds two helical turns away 
from the DNA entry site of the nucleosome. ATP hydrolysis by the remodeler is accompanied 
by a DNA conformational change, which facilitates the histone core to move one helical turn 
towards the remodeler and then DNA rewraps around (Bowman, 2010).  
 
1.5.3 Functional diversity of ATP-dependent chromatin remodelers  
The Snf2 family of chromatin remodelers, contains proteins which play important 
biological functions including DNA repair (ERCC6/CSB, INO80); genomic recombination 
(RAD54); transcriptional control (SNF2); chromosome segregation and checkpoint control in 
DNA replication (INO80); and chromatin assembly to maintain higher order structures (ISWI) 
(Eisen et al., 1995; Ho & Crabtree, 2010). The members of this family can be found as a 
subunit of chromatin remodeling complexes, which explains the functional diversity of these 
enzymes (Clapier & Cairns, 2009). The Isw2 complex has been shown to increase 
nucleosome occupancy of the intergenic region to prevent antisense transcription in S. 
cerevisiae (Whitehouse, Rando, Delrow, & Tsukiyama, 2007). Most ISWI complexes promote 
the equal spacing of DNA between nucleosomes to form periodic nucleosome arrays (Cairns, 
2007). CHD3 and CHD4 are subunits of the NURD (nucleosome-remodelling and histone 
deacetylase) complex, which contains histone deacetylases and functions as a transcriptional 
repressor. Mutations in CHD7, a chromatin remodeler involved in transcriptional activation of 
tissue-specific genes during differentiation, result in CHARGE syndrome which is a 
developmental syndrome in humans  (Ho & Crabtree, 2010). The function of the Snf2 family 
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proteins can be quite complex. Human patients null for the Snf2 member ATRX (α-
thalassemia/mental retardation syndrome X-linked homolog) have methylation alterations in 
DNA sequences at highly repeated sequences including a Y-specific satellite and 
subtelomeric repeats. These patients also exhibit a variety of developmental defects, including 
mental retardation and facial dysmorphology (Garrick et al., 2000). The homologs LSH (Mus 
musculus) and DDM1 (Arabidopsis thaliana) form their own subclass within the Snf2 family 
and are known to regulate DNA methylation during development (Dennis et al., 2001). These 
findings demonstrate that chromatin remodelers are essential during development and some 
Snf2 members also play a role in DNA methylation (Ho & Crabtree, 2010; Raabe, 
Abdurrahman, Behbehani, & Arceci, 2001). 
 
1.6 LSH, an ATP dependent chromatin remodeler 
LSH (lymphoid-specific helicase), also known as HELLS (helicase lymphoid-specific) or 
PASG (proliferation associated SNF2-like gene), belongs to the Snf2 family of proteins (Jarvis, 
Geiman et al. 1996), whose members participate in ATP-dependent chromatin remodeling 
(Längst and Becker 2004). Previous studies identified LSH as a transcript highly expressed in 
lymphocytes, leading to the proposed name of Lymphocyte Specific Helicase (LSH) (Jarvis et 
al., 1996). LSH was found to be expressed only in thymus, early lymphocytes and activated 
lymphocytes, but it has been shown early on that LSH is highly expressed throughout the 
embryo in early development (Raabe et al., 2001). LSH is expressed ubiquitously, but its 
expression is most prominent in proliferating tissues (D. W. Lee et al., 2000; Raabe et al., 
2001). A recent publication has shown that LSH forms part of a bipartite nucleosome 
remodeling complex, which includes a relatively understudied Myc-regulated zinc finger 
protein CDCA7. LSH alone fails to remodel nucleosomes, but CDCA7 stimulates the 
nucleosome remodeling activity of LSH. CDCA7 also facilitates binding of LSH to chromatin, 
although CDCA7 mutants defective in recruiting LSH can still support its remodeling activity. 
This suggests that CDCA7 can activate LSH by an allosteric mechanism in addition to its role 
in chromatin recruitment (Jenness et al., 2018). 
 
1.6.1 Domain architecture of LSH  
Murine Lsh gene is localized on chromosome 19 (the human homologue on chromosome 
10) and is composed of 24 exons. The seven helicase motifs that define the ATPase domain 
are distributed on seven exons (T M Geiman, Durum, & Muegge, 1998) and there is 99% 
homology of the helicase motifs between mouse and human LSH. The difference between 
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human and mouse LSH is the presence of 16 additional amino acids in the N-terminal region 
of the human protein (Briones & Muegge, 2012). Members of the Snf2 family, which are 
involved in transcriptional control and DNA repair, usually contain a chromodomain, 
bromodomain or a ring finger motif, but none of these are present in LSH (Eisen et al., 1995). 
The functional domains of murine LSH protein are shown in a schematic diagram in Figure 
1.8.  
 
        
 
 
The N-terminal region of LSH (amino acids 1-226) contains a coiled-coil (CC) region and 
a nuclear localisation signal (NLS) (D. W. Lee et al., 2000). The N-terminal region of LSH 
seems to be necessary for protein binding since co-immunoprecipitation experiments have 
shown that the CC domain of LSH binds to E2F3 (von Eyss et al., 2012) and the N-terminal 
region of LSH interacts with DNMT3B, that indirectly recruits HDAC1/HDAC2 (Myant and 
Stancheva 2008). The Snf2 ATPase region (from amino acid 226 to amino acid 722) contains 
the SNF2_N and Helicase_C domains with the seven helicase motifs. This ATPase region is 




Figure 1.8. Schematic view of murine LSH protein domains.  
CC (Coiled Coil) motif and NLS (Nuclear localization signal) map to the N-terminal region (amino acids 1-226) 
of the protein. The N-terminal region is required for interaction with DNMT3B and recruitment of HDAC1/2. The 
catalytic ATPase region includes the SNF2_N and Helicase_C domains with seven helicase motifs (from amino 
acid 226 to amino acid 722), and belongs to the conserved motif in the Snf2 family.  
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1.6.2 Role of LSH in DNA methylation  
Screening in Arabidopsis thaliana for DNA methylation mutants, that show genome 
hypomethylation, identified the protein Decrease in DNA methylation 1 (DDM1) (Vongs, 
Kakutani, Martienssen, & Richards, 1993). There is a 70% reduction in DNA methylation levels 
in DDM1-deficient plants, with repetitive elements and single copy genes showing 
hypomethylation. Moreover, DDM1-dependent methylation is required for gene silencing in 
Arabidopsis (J. Jeddeloh & Bender, 1998; Vongs et al., 1993). DDM1 was found to be a SNF2-
like protein by sequence similarity (J. A. Jeddeloh, Stokes, & Richards, 1999) and the ATP-
dependent nucleosome repositioning activity of DDM1 was also confirmed (Brzeski & 
Jerzmanowski, 2003). Therefore, DDM1 was the first Snf2 family chromatin remodeling 
protein found to be involved in DNA methylation (J. A. Jeddeloh et al., 1999). LSH, the 
mammalian homolog of DDM1, was identified in early developing lymphocytes in a study 
attempting to find helicases involved in VDJ recombination (Jarvis et al., 1996). Later on the 
role of LSH in DNA methylation was studied due to its sequence conservation with DDM1 (J. 
A. Jeddeloh et al., 1999) and it was found that, similarly to DDM1, LSH is required for genome-
wide DNA methylation (Dennis et al., 2001).   
Two different design strategies have been used to generate mice deficient in LSH in order 
to study the biological functions of LSH. Kathrin Muegge laboratory generated knockout mice 
through a targeted deletion of some exons in the Lsh gene using homologous recombination. 
The exons 6 and 7 with helicase domains I, Ia (ATPase domain) and part of domain II were 
removed; and the protein translation prematurely interrupted at the deletion. No wild-type or 
truncated forms of LSH protein were found in knockout mice (T M Geiman et al., 2001). The 
second strategy consisted on the disruption of Lsh gene through homologous recombination 
by deletion of the conserved helicase domains II, III, IV (exons 10-12). The deletion of these 
exons was shown to truncate the catalytic SNF2 domain generating a hypomorph Lsh allele. 
A truncated form of mRNA with predicted length was observed in the mice carrying this 
deletion. However, a short form of LSH protein with the deletion of 152 amino acids was 
detected in immunoprecipitation experiments, but not by Western blots, indicating that the 
expression of the truncated protein was very low (Sun et al., 2004).  
 These two knockouts have enabled to study the role of LSH in different biological 
processes. LSH is crucial for cell proliferation and normal development, and targeted deletion 
of LSH in mice leads to early postnatal lethality (T M Geiman et al., 2001; Sun et al., 2004). 
LSH has also been implicated in the control of CpG methylation (Dennis et al., 2001). It has 
been reported that the acquisition of DNA methylation at some loci in the genome depends on 
the presence of LSH, while the maintenance of previously methylated DNA does not require 
LSH (Zhu et al., 2006). However, our observation using mouse embryos (unpublished data) 
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suggests that LSH might support maintenance as well as de novo DNA methylation. LSH 
deficient cells and embryos show reduced DNA methylation by ~50% in cells and by ~40% in 
embryos (Myant & Stancheva, 2008; Tao et al., 2011), local increased levels of H3K4me3 
(Tao et al., 2011; Termanis et al., 2016), and local increased acetylation levels for histone H3 
and H4 (Dennis et al., 2001; Termanis et al., 2016). LSH is highly expressed in pluripotent 
embryonic stem cells and shows reduced expression in somatic cells and adult tissues. The 
effect of LSH on stem cell gene expression was shown to involve differentiation-dependent 
DNA methylation (Dennis et al., 2001). Furthermore, LSH is crucial for the control of 
heterochromatin at pericentromeric regions consisting of satellite repeats. The absence of 
LSH causes an increased association of acetylated histones with repeat sequences and de-
repression of retrotransposons, indicating an important function of LSH protecting against 
deregulation of retroviral elements in the genome (De La Fuente et al., 2006; T. Fan, Hagan, 
Kozlov, Stewart, & Muegge, 2005; Huang et al., 2004). LSH is required for DNA methylation 
and appropriate gene expression not only at repetitive elements, such as centromeric and 
pericentric satellite repeats, IAP retrotransposons, and LINE elements, but also at protein 
coding genes (Myant et al., 2011). More recent studies have also shown that specific protein 
coding genes are affected by lack of LSH as well as repetitive sequences and large 
chromosomal domains associated with the nuclear lamina (Myant et al., 2011; Yu et al., 2014). 
LSH associates with DNMT3A or DNMT3B, but not with DNMT1, in embryonic cells (Zhu 
et al., 2006). Other study has also shown that LSH interacts with DNMT3B and indirectly 
recruits DNMT1 and HDAC1/HDAC2. The N-terminal region of LSH is required for these 
interactions and sufficient for HDAC-mediated silencing (Myant & Stancheva, 2008). LSH has 
been shown to be necessary, but not sufficient, to control DNMT3B activity at specific genomic 
sites in ES cells (Xi et al., 2009). In relation to this, LSH plays a role in transcriptional silencing 
of the developmentally regulated Hox genes (Xi et al., 2007). However, not all de novo DNA 
methylation events are LSH dependent. Many promoters that are methylated in wild-type 
mouse embryonic fibroblasts (MEFs) have normal levels of DNA methylation in Lsh knockout 
MEFs, while 20% of the promoters show loss of DNA methylation in the absence of LSH 
(Myant et al., 2011). Extensive DNA methylation and expression defects in Lsh knockout MEFs 
has been characterised genome-wide, showing that LSH is directly involved in regulating DNA 
methylation throughout the genome at single gene promoters as well as clusters of promoters 
and repetitive sequences (Myant et al., 2011). LSH can partly overcome these defects cell 
autonomously, when introduced into the Lsh knockout MEFs. However, the catalytic activity of 
LSH is necessary for re-establishment of DNA methylation and transcriptionally silent state 
(Termanis et al., 2016). Supporting these experiments, a recent publication has shown that 
the ATPase function of LSH is critical for de novo methylation at repeat sequences. It was also 
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suggested in this study that ATP-dependent nucleosome remodeling is the primary molecular 
function of LSH, which may promote de novo methylation in differentiating ES cells (Ren et 
al., 2015).  
In summary, LSH is essential for developmentally programmed de novo DNA methylation 
at the promoters of protein coding genes (Myant et al., 2011) and also controls genome-wide 
cytosine methylation at repetitive and unique sequences (Tao et al., 2011). How DNA 
methylation at LSH-dependent loci is established is currently unclear. One hypothesis is that 
part of the LSH effect may be due to the stabilization of DNMT3B association with specific 
genomic loci since LSH depletion reduces DNMT3B binding  to specific sites at Hox genes in 
ES cells (Xi et al., 2009). However, it still remains unclear whether LSH is acting directly or 
indirectly to control DNA methylation. Furthermore, it is not well understood whether or not 
chromatin remodeling is required for LSH function or if LSH plays a role as a scaffolding protein 
to promote the association of the DNA methylation machinery with chromatin-organised DNA. 
Finally, the dynamics and the order of events that lead to LSH-dependent DNA methylation 
are also unclear and have never been investigated in detail.   
 
1.6.3 Involvement of LSH in other biological processes and disease  
 
LSH in DNA repair 
Previous experiments in yeast (Alvaro, Lisby, & Rothstein, 2007), which carry an LSH 
homologue but entirely lack DNA methylation, and Arabidopsis thaliana (Shaked, Avivi-
Ragolsky, & Levy, 2006) suggested that LSH may have an additional function in DNA repair 
that is independent of its role in DNA methylation and regulation of gene expression. This 
inspired the study in mammalian cells and LSH was shown to be necessary for the repair of 
DNA double-strand breaks (DSBs), which is independent of its function in de novo DNA 
methylation. LSH-deficient mouse and human fibroblasts show reduced viability after 
exposure to ionizing radiation and reduced efficiency in repairing DSBs compared to wild-type 
cells (Burrage et al., 2012). LSH-deficient cells show normal activation of the DNA damage-
responsive kinase ATM, which initiates the DNA damage response signalling, but weaker and 
more transient phosphorylation of the ATM substrate H2A.X. Phosphorylated H2A.X facilitates 
the recruitment of DNA damage repair mediator proteins, which localise at ionizing radiation 
foci to initiate DNA repair, and coordinates cell cycle arrest during double-strand break repair. 
However, H2A.X is not efficiently phosphorylated in response to DNA damage in the absence 
of LSH and therefore there is reduced recruitment of DNA damage response proteins, which 
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leads to inefficient DNA repair and apoptosis of LSH-deficient cells. DSB repair defects in 
LSH-deficient cells are independent of changes in DNA methylation and the ability of LSH to 
hydrolyse ATP is necessary for efficient phosphorylation of H2A.X at DSBs and efficient repair 
of DNA damage (Burrage et al., 2012).  
In relation to this, MUS-30, the LSH homolog in the filamentous fungus Neurospora 
crassa, has been reported to be required for genome stability but not DNA methylation. MUS-
30 deficient cells have normal DNA methylation, but are hypersensitive to DNA damaging 
agents. MUS-30 was shown to prevent DNA damage that arises from toxic base excision 
repair intermediates, which indicates that the LSH homolog has a function in DNA repair that 
is independent of DNA methylation. The function in DNA repair is most likely the ancestral 
function of the protein as it is conserved from S. cerevisiae to plants (Shaked et al., 2006) and 
humans (Basenko, Kamei, Ji, Schmitz, & Lewis, 2016; Burrage et al., 2012). However, it is not 
clear whether deficient DNA repair can explain the meiotic defects observed in Lsh-/- germ 
cells (De La Fuente et al., 2006) and premature ageing phenotype in mice expressing 
hypomorph alleles of LSH (Sun et al., 2004). 
 
LSH in cancer  
LSH has been found to be involved in different cancers, such as leukaemia (D. W. Lee et 
al., 2000), head and neck squamous cell carcinoma (Waseem, Ali, Odell, Fortune, & Teh, 
2010), prostate cancer (von Eyss et al., 2012) and lung adenocarcinoma (R. Wang et al., 
2015). LSH overexpression significantly correlates with poor survival in patients with lung 
adenocarcinoma cancer (R. Wang et al., 2015) and LSH expression positively correlates with 
progression of head and neck squamous cell carcinoma (Waseem et al., 2010), most likely 
indicating the high proliferation capacity of these cancers.  
The predominant isoform of p63 transcription factor is a protein that enables cells to 
bypasses oncogene-induced senescence and promotes stem-like proliferation and carcinoma 
development. LSH is a direct target of this p63 isoform in primary keratinocytes and LSH 
knockdown in keratinocytes causes increased senescence (Keyes et al., 2011). This study 
shows that p63-mediated LSH expression is essential to bypass senescence and promote 
tumorigenesis in keratinocytes (Keyes et al., 2011). 
The function of the pRB (retinoblastoma) tumour suppressor protein was originally thought 
to be exclusively due to its capacity to arrest cells in G1 by inhibiting the activity of E2F 
transcription factors. In human patients, aberrant E2 factor transcription factor 3 (E2F3) 
expression is linked to different types of cancer (Burkhart & Sage, 2008). LSH has been 
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identified as an interacting partner of E2F3. LSH was shown to bind E2F3 and to promote 
induction of E2F target genes and re-entry into the cell cycle. Both, LSH and E2F3 are 
overexpressed in several human tumours and they act as markers of aggressive stage in 
prostate carcinomas (von Eyss et al., 2012). LSH binds 93% of the transcriptional start sites 
bound by E2F3 and 86% of these promoters contain H3K4me3, a mark associated with active 
gene transcription. This study shows that LSH positively co-regulates E2F3-dependent 
transcription and is critical for cell proliferation in cancer (von Eyss et al., 2012).  
 
LSH in ICF syndrome 
Mutations in LSH have been found in patients with Immunodeficiency–Centromeric 
instability–Facial anomalies (ICF) syndrome (Thijssen et al., 2015). This syndrome is 
characterized by centromeric instability and CpG hypomethylation of centromeric satellite 
repeats. ICF syndrome is normally caused by mutations in the catalytic domain of DNMT3B 
that explains 50% of cases and mutations in the zinc-finger and BTB domain containing 24 
(ZBTB24) gene that explains 30% of cases (De Greef et al., 2011; Jiang et al., 2005). A recent 
study has found mutations in LSH and cell division cycle associated 7 (CDCA7) genes in ten 
unexplained cases of ICF. Five point mutant variants of LSH were identified in patients with 
ICF syndrome (Thijssen et al., 2015). The role of LSH in the establishment of DNA methylation 
shown in previous studies (Zhu et al., 2006) can explain its involvement in ICF syndrome. 
However, it was not clear how ZBTB24 and CDCA7 are involved in ICF syndrome, but recent 
studies have found that ZBTB24 can function as a transcription factor directly controlling 
CDCA7 expression (Wu et al., 2016) and CDCA7 was recently shown to form a bipartite 
nucleosome remodeling complex with LSH (Jenness et al., 2018). CDCA7 helps recruit LSH 
to chromatin and stimulates its remodeling activity. Notably, CDCA7 mutants in ICF syndrome 
are defective in chromatin recruitment of the LSH-CDCA7 complex. Therefore, ZBTB24 and 
CDCA7 mutations in patients with ICF syndrome may cause defects in LSH recruitment to 
chromatin and stimulation of LSH remodeling activity, affecting DNA methylation (Jenness et 









My project focuses on the study of the role of LSH in the establishment of epigenetic gene 
silencing. I aimed to investigate how LSH-mediated changes in chromatin structure and 
modifications facilitate de novo DNA methylation and gene silencing. LSH-null mice carrying 
conditionally reversible Lsh alleles were used to obtain mouse embryonic fibroblast (MEF) cell 
lines for the study. I characterised MEFs containing conditionally reversible Lsh knockout 
alleles and optimised the conditional expression of LSH in this system. The specific aims of 
my project were to address the following questions:  
 
• What is the efficiency of LSH expression in the conditional knockout cellular system?  
 
• How much time is required for acquisition of gene silencing and DNA methylation at 
the promoters of misregulated loci after restoration of LSH expression? 
 
• What is the order of events leading to gene silencing and de novo DNA methylation? 
 











Western Blotting antibodies 
All antibodies used at the indicated working concentration in 4% milk + 0.1% Tween 20. 
- LSH: Mouse monoclonal Santa Cruz sc-46665, 1:1000 dilution. 
- HDAC1: Rabbit polyclonal Santa Cruz sc-7872, 1:500 dilution. 
- H3Ac: Anti-acetyl histone H3 rabbit polyclonal IgG Upstate Millipore 06-599, 1:3000 
dilution. Acetyl-histone H3 (Lys9, Lys 14) rabbit polyclonal Invitrogen PA5-16194, 1:1000 
dilution. 
- H3K9me2: Mouse monoclonal Abcam ab1220, 1:2000 dilution. 
- Histone H4: Pan rabbit monoclonal Millipore 04-858, 1:1500 dilution.  
- Secondary antibodies: Donkey anti-mouse IR 800 or donkey anti-rabbit IR 680LT and IR 
800, LI-COR Biosciences, 1:10000 dilution. 
 
ChIP antibodies 
4 micrograms of antibody used per IP reaction unless otherwise indicated.  
- Histone H3: Rabbit polyclonal. Abcam ab1791. 
- H3Ac:  Anti-acetyl histone H3 rabbit polyclonal IgG Upstate Millipore 06-599. 
      Acetyl-histone H3 (Lys9, Lys 14) rabbit polyclonal Invitrogen PA5-16194, 1:50 dilution. 
- H3K4me3: Rabbit polyclonal Active Motif 39915.   
- H3K9me2: Mouse monoclonal Abcam ab1220. 
- H3K9me3: Rabbit monoclonal to Histone H3 (try methyl K9) Abcam ab 176916. 
- H3K27me3: Tri-Methyl-Histone H3 (K27) (C36B11) Rabbit. Cell Signalling Technology.  
- LSH: Anti-lymphoid-specific helicase (HELLS) rabbit polyclonal. Millipore ABD41. 
- Control mouse IgG and control rabbit IgG (Sigma).  
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2.1.2 Cell lines 
- Wild-type immortalised MEFs. 
- Lsh-/- immortalised MEFs: Isolated from Lsh-/- mouse embryos derived from crosses of 
heterozygous animals (Kathrin Muegge).  
- Lsh-/- MSCV, Lsh-/- LSH and Lsh-/- K237Q: Lsh-/- MEFs were infected with packaged 
lentiviral particles carrying pMSCV, pMSCV-LSH and pMSCV-K237Q plasmids (Ausma 
Termanis). All are immortalised cell lines.  
- Lsh+/+ ER-Cre+, Lshoff/off ER-Cre+ and Lshon/on ER-Cre+ MEFs: primary cell lines isolated 
from E13.5 stage mouse embryos derived from crosses of heterozygous animals for the 
Lshoff and Lshon alleles. Some of these cell lines were immortalised.    
 
2.1.3 Primers 
Primers were designed using DNASTAR Lasergene software and were purchased from MWG 
Eurofins. Lyophilised primers were diluted in distilled H2O to 100 μM stock concentration and 
stored at -20°C. The working concentration of the primers is 5 μM. See following tables for 




eGFP-Neo (Lshoff) CGCCGACCACTACCAGCAGAACA 
GCCGGAGAACCTGCGTGCAATC 
Lsh WT  CCTCCCCAAATAAGCAAATAAAAACT 
CGAAGGTTGCCAGGTTTTGAGATC 
Lsh on/off  CGCCTTCTATCGCCTTCTTGAC 
CAAGTTCAGCGTGTCCGGCG 
GCCATAAGCCAACCAACAGAAAGAATAAG 




















Dppa2  GCA TTC ATT CAG CGG CTG CCT TT 
TGC GTA GCG TAG TCT GTG TTT GG 
Dppa4  CAA GGG CTT TCC CAG AAC AAA TGC 
GCA GGT ATC TGC TCC TCT GGC AC 








































































































2.1.4 Buffers and solutions  
General buffers 
Buffers and reagents were kept at room temperature unless otherwise stated. 
- Tris-EDTA (TE): 10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 8. 
- TAE (Tris-acetate EDTA): 40 mM Tris, 20 mM glacial acetic acid, 1 mM EDTA pH 8. 
- PCR buffer IV: 750 mM Tris-HCl pH 8.8, 250 mM (NH4)2SO4, 0.1% Tween 20, 25 mM 
MgCl2.  
- Special PCR buffer for Bisulfite Sequencing: 166 mM (NH4)2SO4, 670 mM Tris pH 8 and 
100 mM Beta-mercaptoethanol. 
- 2.5 X Sequencing buffer: 20 mM Tris-HCl pH 8, 5 mM MgCl2. 
- Bisulfite conversion solution: 3.8 g sodium bisulfite was dissolved in 5 ml water and 1.5 ml 
freshly made 3 M NaOH in the dark. 110 mg hydroquinone was dossilved in 1 ml water at 
55°C for 10 minutes and subsequently added to the sodium bisulfite solution.   
- SOC media: 20 g/L Difco Bacto tryptone, 5 g/L Difco Bacto yeast extract, 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose. 
- LB media: 10 g/L Difco Bacto tryptone, 5 g/L Difco Bacto yeast extract, 5 g/L NaCl, pH 7.2. 
- LB Agar: LB media + 2% Difco Bacto agar.  
 
ChIP buffers 
- Crosslinking solution (10x): 500 mM Hepes pH 7.6, 1.5 M NaCl, 10 mM EDTA, 5 mM 
EGTA.  
- Buffer L1 for ChIP: 50 mM Hepes pH 7.9, 140 mM NaCl, 1 mM EDTA, 10% Glycerol, 0.5% 
NP-40, 0.25% Triton X-100.  
- Buffer L2 for ChIP: 10 mM Tris pH 8, 200 mM NaCl, 1 mM EDTA, 0. 5mM EGTA. 
- Buffer L3 for ChIP: 10 mM Tris pH 8, 1 mM EDTA, 0.5 mM EGTA.  
- ChIP dilution buffer: 20 mM Tris pH 8, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100.  
- Wash buffer 1 for ChIP: 20 mM Tris pH 8, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 
0.1% SDS.  
48 
 
- Wash Buffer 2 for ChIP: 20 mM Tris pH 8, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, 
0.1% SDS.  
 
Protein extraction and western blotting buffers 
- NE1: 20 mM Hepes pH 7.0, 10 mM KCl, 1 mM MgCl2, 0.1% (v/v) Triton X-100, 20% (v/v) 
glycerol. 0.5 mM DTT and complete protease inhibitors (Sigma) were added at time of use. 
- NE2: 20 mM Hepes pH 7.0, 500 mM NaCl, 10 mM KCl, 1 mM MgCl2, 0.1% (v/v) Triton X-
100, 20% (v/v) glycerol. 0.5 mM DTT and complete protease inhibitors (Sigma) were added 
at time of use. 
- Ponceau S staining solution: 1% (v/v) glacial acetic acid, 0.5% (w/v) Ponceau S. 
- SDS PAGE loading buffer (4x): 225 mM Tris-HCl pH 6.8, 20% glycerol, 8% SDS, 0.04% 
bromophenol blue. 100 mM DTT was added at time of use. 
- SDS Separating gel: 0.1% SDS, 0.05% ammonium persulfate, desired concentration of 
acrylamide and 375 mM Tris pH 8.8 and made up to 10 ml with distilled H2O. 
- SDS Stacking gel: 0.1% SDS, 0.05% ammonium persulfate, 4% Acrylamide, 125 mM Tris 
pH 6.8 and made up to 5 ml with distilled H2O. 
- Running buffer for western blotting: 25 mM Tris, 250 mM Glycine, 0.1% SDS. 
- Transfer buffer for western blotting: 25 mM Tris, 250 mM Glycine. 
 
Tissue culture reagents and media 
- DMEM -Dulbecco's Modified Eagle Medium (Sigma) supplemented with 10% foetal bovine 
serum (Thermo Scientific) and Penicillin-Streptomycin-Glutamine (Gibco).  
- Foetal bovine serum, heat inactivated (Sigma) used to supplement DMEM medium for 
OHT experiments. 
- DPBS -Dulbecco's Phosphate Buffered Saline 1X without Ca or Mg (Corning). 
- Trypsin-EDTA Solution 10X (Gibco) dissolved in DPBS to 1X working concentration.  
- 4-hydroxytamoxifen, OHT (Sigma) was dissolved in DMSO and administrated at a final 
concentration of 600-780 nM.  
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- Geneticin, G 418 disulfate salt (Sigma) was administrated at a final concentration of 250 
μg/ml.   
- Puromycin (Thermo Scientific) was administrated at a final concentration of 2 μg/ml.   
- Valproic acid (SIGMA) was dissolved in DPBS and administrated at a final concentration 
of 1 mM. 
- Sodium butyrate (Sigma) was dissolved in DPBS and administrated at a final concentration 
of 3 mM.  
- UNC 0638 (Sigma) was dissolved in DMSO and administrated at a final concentration of 
250 nM.  
- Hygromycin B (Thermo Scientific) was administrated at a final concentration of 200 μg/ml.     
 
2.2 Methods 
2.2.1 MEFs derived from mouse embryos and immortalization of cell lines 
Mouse embryonic fibroblasts (MEFs) were derived from E13.5 stage embryos obtained from 
the crosses between heterozygous mice for the Lshoff or Lshon allele and ER-Cre recombinase. 
The Lshon/on MEFs were used for different experiments that were finally not included in this 
thesis. Lsh+/+ MEFs and Lshoff/off MEFs were used for the experiments included in the coming 
chapters of the thesis.  
Pregnant mice were killed by dislocation of the neck according to the manipulation instructions 
and the uterus with the embryos was collected with the help from Christian Belton. Embryos 
were dissected from the uterus without impairment of the amniotic membrane and the 
maternally derived blood tissue was washed 5 times with DPBS. The amniotic membrane was 
punctured and the embryos were placed in the individual dishes containing DPBS for further 
dissection. Then the tissues around the umbilical cord including placenta and foetal 
membranes were removed, the embryos were washed another 3 times with DPBS. These 
13.5 days embryos were used to derive mouse embryonic fibroblasts (MEFs) by disruption of 
the body tissue with trypsin and subsequent culture with DMEM in tissue culture plates to 
select for MEFs.  
Two different methods were used to immortalize these primary MEF cell lines: the ‘3T3 
protocol' (Sharpless 2006) and retroviral transduction of cells with virus containing the SV40 
Large T antigen.  
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2.2.2 Viral packaging and lentiviral transduction 
Phoenix A cells were seeded and cultured for a few days in 10 cm tissue culture dishes before 
adding the plasmid. 15 µg of plasmid was transfected into the Phoenix A cells with the jetPEI 
DNA transfection reagent (PolyPlus).  After 24 hours the medium was replaced and 2 days 
later the medium containing the lentiviral particles was collected and filter through a 0.4 µm 
filter (Minisart). The lentiviruses were aliquoted and frozen at -80°C.  
Viral transduction of MEF cell lines was done in 5 ml of DMEM media (2.5 ml containing virus) 
with Polybrene at a final concentration of 5 µg/ml. Cells were incubated for 24 hours with the 
viral mixture, and then 5 ml extra of medium were added on top to avoid Polybrene toxicity 
and cells were again incubated overnight. Next day, antibiotic selection was started to select 
for stable clones expressing the plasmid.     
 
2.2.3 Mammalian cell culture 
All MEFs were cultured in Dulbecco's Modified Eagle Medium, DMEM (Sigma) containing 10% 
foetal bovine serum (Thermo Scientific) and Penicillin-Streptomycin-Glutamine (Gibco). 
Harvesting of the cells was done by trypsinization using 1 x Trypsin (Gibco). When treating 
MEFs in culture with tamoxifen, 4-hydroxytamoxifen (OHT) (Sigma) was dissolved in DMSO 
and administrated in a final concentration of 600-780 nM.  
Phoenix A cells were cultured in the same conditions as MEFs and using the same reagents.  
 
2.2.4 Molecular cloning  
This method was used for generation of plasmids for transfection of cell lines, as well as for 
the bisulfite DNA sequencing. First, DNA was amplified by the Polymerase Chain Reaction 
(PCR), then restriction enzyme digestion was done when necessary, DNA product was run in 
an agarose gel and the desired bands were extracted to ligate the DNA into an appropriate 
vector. The final plasmids were normally sent for sequencing and purified before use by 
Miniprep or Maxiprep Kit (Quiagen) following the manufacturer’s instructions.  
Polymerase chain reaction (PCR): DNA template was amplified in 1x buffer IV containing 12 
mM MgCl2, 2.5 mM dNTPs, 7% DMSO when needed, 5 µM primers and Taq polymerase (2.5 
units for 50 µl reaction). The different steps of the chain reaction, denaturation, annealing and 
elongation; were carried out in a Biometra thermocycler and were dependent on the specific 
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reaction and application. For bisulfite sequencing, a special PCR buffer was used instead of 
buffer IV. The PCR products were analysed by agarose gel electrophoresis.  
Restriction enzyme digestion: Restriction digests were carried out following the manufacturer’s 
recommendations depending on the enzyme. Incubation times ranged from 1 hour to overnight 
at 37°C. Completion of digestion was assessed by agarose gel electrophoresis.  
Gel extraction: The desired DNA bands were excised from agarose gels and DNA was 
extracted following the manufacturer’s instructions using the GeneJet Gel Extraction Kit 
(Thermo Scientific).  
Ligation: Purified DNA fragments were blunted using the DNA blunting enzyme (Thermo 
Scientific) and ligated into the desired linearized vector using the T4 DNA ligase (Thermo 
Scientific) with incubation times depending on experiment. For bisulfite sequencing the 
CloneJET PCR Cloning Kit (Thermo Scientific) was used. The ligation product was assessed 
by competent cell transformation and selection.          
       
2.2.5 Genomic DNA extraction 
Cell pellets were re-suspended in 1x TE buffer and Proteinase K (Sigma) and SDS were added 
to a final concentration of 200 μg/ml and 0.1%, respectively and incubated at 55°C overnight. 
Digested peptides were removed using phenol:chloroform:isoamyl alcohol extraction followed 
by chloroform extraction. The genomic DNA was precipitated with 1 volume isopropanol and 
1/10 volume of 3 M NaOAc (pH 5.4) solution in a final concentration of 143 mM. Finally, the 
DNA pellet was washed by 70% ethanol and resuspended in desired volume of 1x TE buffer. 
RNA was removed by digestion with RNAse at 37°C for at least 30 minutes. 
 
2.2.6 Extraction of nuclear proteins and protein quantification 
Cell pellets were re-suspended in 1 ml Hypotonic NE1 buffer and disrupted by Dounce 
Homogeniser. The nuclei were pelleted by centrifugation at 4500 rpm for 5 minutes at 4°C and 
re-suspended in NE1 buffer adjusted with 5N NaCl to final NaCl concentration of 500 mM. 
Samples were incubated at 4o C for 1.5 hours under rotation. Nuclear matrix and membranes 
were pelleted by centrifugation at 13000 rpm for 15 minutes at 4°C and supernatant containing 
the nuclear fraction was collected. Protein concentration was measured using the 




2.2.7 Polymerase Chain Reaction –PCR 
Polymerase chain reaction was performed in 1x normal buffer system containing MgCl2, 
dNTPs, 7% DMSO when needed, Taq polymerase (2.5 units in 50 μl), 5 μM primers and 
specific amount of template with the conditions of denature, annealing and elongation 
depending on the specific amplification. The results of PCR were assessed by agarose gel 
electrophoresis. 
 
2.2.8 Western Blotting 
Nuclear extracts (55-60 micrograms of protein) were separated on 8% SDS-PAGE gel for LSH 
and 17% SDS-PAGE gel for histone modifications. The specific amount of protein was 
resuspended in a 1x sample buffer containing 0.1 M DTT and denatured at 95°C for 5 minutes. 
Different sizes of the protein were separated in a suitable concentration SDS-PAGE gel as 
mentioned above at 200 V for 60-75 minutes. Protein separated in the SDS gel was transferred 
onto Nitrocellulose or PDVF membrane (Bio-Rad) for 60-90 minutes in 1x cold transfer buffer 
at 400 mA. Membranes were blocked with 4% skimmed milk in 1x TBS and 0.1% Tween 20 
for 1 hour at RT. Then the membranes were incubated overnight at 4°C in the freshly made 
blocking solution containing the desired concentration of primary antibody (see materials for 
antibody concentrations). After the overnight incubation, the membranes were washed three 
times with 1x PBS with 0.1% Tween 20 and then blocked again for 30 minutes. Secondary 
antibodies were added to a desired concentration (see materials for antibody concentrations) 
and the membrane was incubated for at least 1 hour. The membranes were washed as before 
to remove the unspecific binding of secondary antibodies and scanned on Odyssey 3.0 
Scanner (LI-COR Biosciences). 
 
2.2.9 RNA extraction 
Cell pellets were re-suspended in 1 ml of Trizol reagent (Thermo Scientific) and 0.2 ml of 
chloroform. The samples were vigorously mixed and centrifuged at 12000 g for 15 minutes, 4 
°C to extract the top aqueous phase that was precipitated with 0.5 ml of isopropanol. Then the 
precipitated samples were centrifuged at 12000 g for 10 minutes, 4 °C and RNA pellets were 
washed with cold 75% ethanol. Finally, the RNA pellets were dissolved in RNAse free water 
with 1 μl RiboLock RNAse inhibitor (Thermo Scientific). The trace amount of DNA was 
digested by 10 units of DNAse (Fermentas) at 37°C for 30-60 minutes and the DNAse was 
inactivated at 95°C for 3 min. 
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2.2.10 Quantitative Reverse Transcription PCR (qRT-PCR) 
cDNA synthesis: 1 μg of oligo(dT) primer (0.5μM) was added to 4 μg of total RNA in a final 
volume of 12 μl. Samples were incubated at 65 °C for 5 min and cooled immediately on ice. 8 
μl of mixture solution, including dNTPs (10 mM), 5x FS  cDNA buffer, DTT (0.1 M) and RNAse 
inhibitor (40 U/ul), was added to each sample and incubated together at 42°C for 2 min. Finally, 
1 μl (200 Units) of Superscript II/III Reverse Transcriptase (Invitrogen) was added selectively 
into the positive RT reactions and the reactions incubated at 42 °C for 120 min. 
Quantitative PCR: qPCR was carried out on LightCycler 480 (Roche) with 1x SYBR Green I 
Master-mix (Roche) containing 2.5 μM primers and desired amount of template. The qPCR 
amplification for mRNAs of interest was calculated relative to GAPDH amplification as an 
internal control reference gene to determine differences in expression of the genes of interest.  
  
2.2.11 Bisulfite DNA Sequencing 
Bisulfite conversion of genomic DNA: 2 μg of genomic DNA was resuspended in TE buffer in 
a total volume of 25 μl. DNA was denatured at 110°C for 5 minutes and placed on ice. 2.5 μl 
of freshly made 3 M NaOH (final concentration of 278 mM) was added and the samples were 
incubated at 37°C for 20 minutes. Finally, 270 μl of sodium bisulfite solution (see solutions 
section) was added to each sample. The samples were overlaid with mineral oil and incubated 
overnight for sulfonation at 55°C. The treated genomic DNA was precipitated with 900 μl 
isopropanol and 3 M sodium acetate solution (final concentration 300 mM) with 5 μg glycogen. 
The DNA pellets were resuspended in TE buffer and desulfonated with freshly made 3 M 
NaOH for 15 minutes at 37°C. Samples were then precipitated using 32.5 μl of 5 M ammonium 
acetate pH 7.0 (final concentration 650 mM) and 180 μl 100% ethanol. Finally, DNA pellets 
were dissolved in 25 μl of TE buffer. The sodium bisulfite conversion of genomic DNA when 
sequencing Rhox6/9 and Gm9 loci was achieved using the EpiTect Bisulfite Kit (QIAGEN), 
following the manufacturers’ instructions.  
PCR amplification of regions of interest: Nested PCR primers were designed using Methprimer 
software aiming for amplification regions across CpG-rich region and PCR product length of 
around 300-400 base pairs long. 2 μl of sodium bisulfite treated DNA was used as template 
for the first round PCR reaction. For the nested PCR, 2-4 μl of the first round PCR product 
was used as template.  
Gel extraction and PCR product purification: After running the PCR product in an agarose gel, 
the piece of gel containing the desired size of the DNA fragments was cut and melted at 55°C 
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for 10 min. The PCR product was purified according to the manufacturers’ instructions using 
the Gene JET gel extraction kit (Thermo Scientific). 
Ligation: The concentration of purified DNA fragments was measured using Pico-drop 
spectrophotometry. Ligation was performed according to manufacturer’s instructions by using 
Clone JET PCR Cloning Kit (Thermo Scientific). DNA fragments were blunted and the pJET1.4 
linearized plasmid and T4 DNA ligation enzyme were added.  The ligation reaction was 
performed at 16°C for a minimum of 8 hours.  
Transformation: 10 μl of ligation product was transformed into 50 μl of competent DH5α E. coli 
cells at 42°C for 60 seconds. After recovering at 37°C with gentle shaking for 1 hour, 
transformed E. coli were grown overnight on LB plates under Ampicillin selection.   
Colony PCR: The forward and reverse primers for pJET1.4 plasmid were used for colony 
PCRs, and DNA from colonies of transformed E. coli was used as a template in the PCR 
reactions. For the colony PCR program an annealing temperature of 56°C was used.  
Clean up of the colony PCR product: The PCR products were cleaned using a mixture 
containing 2 μl (40 units) of Exonuclease I (NEB), 20 μl (100 units) of Shrimp Alkaline 
Phosphatase (NEB) and 78 μl of H2O. The mix was incubated at 37°C for 20 minutes and then 
at 80°C for 15 minutes.  
DNA sequencing: Big Dye (Thermo Scientific) Reactions were set up in 10 μl including 4 μl of 
cleaned up colony PCR product. The following program was used for the reactions: 96°C for 
1 minute and 25 cycles of cycling with each cycle at 96°C for 10 seconds, 50°C for 5 seconds 
and 60°C for 4 minutes. Finally, DNA sequencing was carried out by the Genepool Sequencing 
Service at the School of Biological Sciences, University of Edinburgh.  
 
2.2.12 Chromatin-Immunoprecipitation (ChIP) 
Cell pellets from a confluent T175 flask were resuspended in 9 ml of warm DPBS and 1 ml of 
10x crosslinking buffer was added. The final concentration of formaldehyde was adjusted to 
1% and the cell suspension was incubated for 5 minutes at room temperature. The 
crosslinking reaction was stopped by adding 550 μl of 2.5 M freshly made Glycine making a 
final concentration of 125 mM and the cells were collected by spinning at 1400 rpm for 6 
minutes at 4°C and washed twice with cold DPBS containing 0.1 mM PMSF. The crosslinked 
cells were divided to 5 × 106 cells per tube aliquots and stored at -80°C until processed further.  
Cells were thawed on ice and resuspended in 5 ml cold L1 buffer containing 0.1 mM PMSF (5 
ml of buffer were used per 2 × 106 cells) and placed on a spinning wheel for 10 minutes at 
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4°C. Then, the cells were collected by spinning at 3000 rpm for 10 minutes at 4°C and washed 
with cold L2 buffer containing 0.1 mM PMSF and spun down as above. Finally, the cells were 
resuspended with 1850 μl of cold L3 buffer containing 0.5% SDS.  
The cell suspension was sonicated by Biorupter device (Diagenode) at high frequency for 50 
cycles with each cycle of 30 seconds on and 30 seconds off. 50-100μl of the sonicated 
chromatin was spun at 13000 rpm for 10 minutes and the supernatant was moved into a new 
tube. Equal volume of 1x TE buffer with 1% SDS and 5 μl of Proteinase K (Sigma) were added 
to decrosslink and digest the sample overnight at 65 °C. The rest of the sonicated chromatin 
was divided into equal aliquots (in order to have enough chromatin for a couple of IPs 
reactions) and stored at -80°C. After digestion, the DNA was extracted by the 
phenol/chloroform method (see methods for genomic DNA extraction) and the size of the 
sonicated chromatin was assessed by 2% agarose gel electrophoresis. For ChIP, the desired 
size of DNA fragments was around 300 base pairs.  
Immunoprecipitation: The appropriate volume of sonicated chromatin samples, equivalent to 
10 μg of DNA, was diluted in ChIP dilution buffer in order to reduce the SDS concentration to 
0.1%. The volumes of the different samples were adjusted to become equal and appropriate 
antibody was added (4 μg / 500 μl IP reaction). Then the sonicated chromatin samples and 
the antibody were incubated for 2.5 hours on rotating wheel at 4°C. 50 μl of Protein G 
Dynabeads (Thermo Scientific) previously blocked with BSA (250 μg BSA for 100 μl beads) 
were added to each IP tube and incubated together for another 2.5 hours at 4°C. The beads 
were collected by a magnet and washed with Wash buffer 1 and 2 for 4 times and 3 times, 
respectively. The last wash was performed with 1 x TE buffer. The beads were then 
resuspended in 100 μl 1x TE buffer with 1% SDS final concentration and 5 μl of Proteinase K 
(Sigma, 20 mg/ml) was added. The beads were incubated at 65°C overnight. After digestion, 
the DNA fragments were extracted by PureLink Quick PCR Purification Kit (Thermo Scientific) 
and resuspended in 100 μl of distilled water. 
Quantitative PCR (qPCR): the enrichment of DNA fragments corresponding to a genomic 
region of interest after ChIP was detected by qPCR. qPCR was carried out on LightCycler 480 
(Roche) instrument with 1x SYBR Green I Master-mix (Roche) containing 5 μM primers and 2 
μl of purified DNA fragments as template. The percent enrichment of regions of interest was 
calculated relative to input DNA amplification by comparative Ct method, also known as the 





2.2.13 Micrococcal nuclease (MNase) digestion of chromatin 
Collection of cells: 5 × 106 cells were harvested, crosslinked as for ChIP and washed twice 
with ice-cold 1x DPBS and spun down.  At this point, the cell pellets were be kept at -80°C if 
not processed immediately.  
MNase treatment: the cells were resuspended in 500 μl of douncing buffer (10 mM Tris-HCl 
pH 7.5, 4 mM MgCl2, 1 mM CaCl2, and 1x Protease Inhibitors Cocktail from Sigma added 
fresh) and homogenized in a Dounce homogeneizer with 25 strokes. Next, 200 Units of MNase 
(Thermo Scientific) were added and the samples were incubated at 37°C for 15 minutes while 
shaking at 800 rpm. After the incubation, the reaction was quenched by adding EDTA to a 
final concentration of 5 mM and incubation on ice for 5 minutes. Samples were digested 
overnight with 10 μl Proteinase K and 1% SDS at 65°C. Next day, DNA was purified by 
Phenol/Chloroform extraction and incubated with 0.1 μg/μl RNaseA at 37°C for 30 minutes.  
Assessment of MNase digestion: DNA samples were run on 1.5% agarose gel to determine 
the size of nucleosomal DNA bands. Mononucleosomal fragments (100-200 base pairs) were 
excised and DNA purified with GenJet Gel Extraction Kit (Thermo Scientific) when needed.    
 
2.2.14 Nucleosome Occupancy and DNA Methylation (NOMe) 
Collection of cells and crosslinking: exponentially growing cells were harvested, crosslinked 
following the ChIP protocol and washed twice with ice-cold 1x DPBS. Then, cells were spun 
down and resuspended in 1 ml of ice-cold Nuclei Buffer (100 mM Tris-HCl pH 7.4, 100 mM 
NaCl, 30 mM MgCl2, and 1x Protease Inhibitors Cocktail from Sigma added fresh).  
Nuclei Extraction: samples were incubated on ice for 5 min minutes and homogenized with 15 
strokes of a Dounce homogenizer. The homogenized cells were transferred into a tube and 
centrifuged to recover nuclei at 3500 rpm for 3 minutes at 4°C.  Cells were washed in Nuclei 
Buffer and resuspended in 1x M.CviPI reaction buffer (NEB) so that there were 106 cells per 
39.25µl. 
Treatment with M.CviPI: The nuclei previously resuspended was incubated for 15 minutes at 
37°C with 200 Units of M.CviPI enzyme in 1x M.CviPI Buffer containing 160 µM SAM, 300 mM 
Sucrose, and water to achieve 150 µl final volume for the reaction. The reaction was stopped 
by adding an equal volume (150 µl) of Stop Solution (20 mM Tris-HCl pH 7.9, 600 mM NaCl, 
1% SDS, 10 mM disodium EDTA, and Protease Inhibitors Cocktail (Sigma) added fresh) and 
the decrosslinking was done overnight incubating at 65°C with Proteinase K (Sigma). 
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Purification of DNA by Phenol/Chloroform extraction and ethanol precipitation was done next, 
and purified DNA kept at -20°C up to 1 year if not used. 
Bisulfite DNA Conversion was done with the EpiTect Bisulfite Kit (Qiagen) and PCR for specific 
region / promoters of interest as well as cloning for sequencing were performed following the 




















Chapter 3 - LSH can silence active promoters 
3.1 Introduction 
Previous work in the Stancheva laboratory demonstrated that LSH is required for DNA 
methylation at centromeric repeats, repetitive elements and some specific gene promoters 
(Myant et al., 2011). It was previously thought that in the absence of LSH, defects in DNA 
methylation and transcriptional expression were limited to repetitive elements and a few single 
copy sequences (Dennis et al., 2001). In addition, the study carried out in the laboratory 
showed that LSH is required for DNA methylation and appropriate gene expression not only 
at repetitive elements such as centromeric and pericentric satellite repeats, IAP 
retrotransposons, and LINE elements but also at protein coding genes. More recent studies 
have also shown that specific protein coding genes are affected by lack of LSH as well as 
repetitive sequences and large chromosomal domains associated with the nuclear lamina (Yu 
et al., 2014). Furthermore, the study carried out in the lab also compared CpG DNA 
methylation at promoters of protein coding genes in wild-type and Lsh-/- MEFs. It was found 
that 20% of normally methylated promoters had loss of DNA methylation in the absence of 
LSH (Myant et al., 2011). Besides the loss of DNA methylation, many of these genes were 
aberrantly expressed in the Lsh knockout cells. This correlates with the gain of transcription 
observed at repetitive sequences in the absence of LSH. Some of these specific genes 
affected by LSH are the Rhox genes that are part of the reproductive homeobox X-linked gene 
cluster Rhox, Gm9 adjacent to the Rhox cluster, and development and pluripotency associated 
genes such as Dppa2 and Dppa4. The Rhox cluster and the neighbouring Gm9 gene, show a 
big reduction in DNA methylation in Lsh-/- MEFs, being the largest contiguous genomic region 
affected by the lack of LSH in these cells.  
The Rhox cluster encodes a group of reproductive homeobox genes on the X 
chromosome that are expressed in a cell type specific manner. Most of these genes are only 
expressed in germ lines, in both male and female mice (MacLean et al., 2005). The promoters 
of Rhox genes are hypomethylated in the pre-implantation embryo and acquire DNA 
methylation after implantation by the E9.5 embryo stage. This gain of DNA methylation 
happens in the embryonic but not in the extraembryonic tissues (Oda et al., 2006). The de 
novo DNA methylation establishment at the promoters of Rhox genes is dependent on 
DNMT3B and partly on DNMT3A, but is independent of X chromosome inactivation since the 
Rhox genes are methylated and silenced in both male and female somatic cells. The DNA 
methylation status of these genes distinguishes early embryonic lineages (Oda et al., 2006), 
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suggesting that LSH is implicated in de novo DNA methylation and gene expression regulation 
during early development.  
Previous work performed in the lab (Termanis et al., 2016) used wild-type (WT) and  Lsh 
-/-  MEFs that were provided by Kathrin Muegge lab. Lsh knockout mice were obtained crossing 
heterozygous mice for the knockout allele, meaning that wild-type LSH was present during 
germ cell determination in the parents. As a consequence, the DNA methylation abnormalities 
observed in the Lsh-/- MEFs can only be attributed to defects in the maintenance of DNA 
methylation patterns established during maturation of germ cells or de novo methylation 
defects at later stages of embryo development. It is also important to mention that Lsh-/- 
embryos survive until birth without major developmental defects. This might indicate that the 
incomplete DNA methylation establishment in the absence of LSH do not cause substantial 
developmental defects during embryonic development.      
Given the existing knowledge, this study aimed to address two major questions. First, 
whether LSH has an activity in somatic cells where the signalling and transcription factors 
characteristic of early development are largely absent. Second, whether the ATP hydrolysis, 
i.e. the catalytic activity of LSH, is necessary for the role of LSH in DNA methylation and gene 
silencing. In order to answer these questions, stable cell lines expressing different LSH 
plasmids were generated to better understand and potentially rescue the defects in Lsh-/- 
MEFs. Two plasmids, pMSCV-LSH and pMSCV-K237Q were generated by cloning into 
pMSCV vectors, and both plasmids were stably expressed in Lsh-/- MEFs. The pMSCV-LSH 
plasmid contains wildtype LSH. The pMSCV-K237Q plasmid contains a mutation in the 
catalytic site converting a conserved lysine into glutamine in the catalytic domain of LSH 
making this mutant unable to bind and hydrolyse ATP. An additional control cell line was 
generated with the empty pMSCV vector and used as a control knockout cell line, Lsh-/- MSCV 
MEFs. I will refer to this cell line in the text as Lsh-/- MEFs. Experiments using these rescue 
cell lines showed that the gain of expression at specific protein coding genes and repetitive 
elements occurring in the absence of LSH can be rescued to the initial silenced state when 
wild-type LSH is expressed in Lsh-/- MEFs but not the catalytically inactive LSH (K237Q). 
Among these genes are the reproductive homeobox (Rhox) genes and the Gm9. Importantly, 
this gene silencing occurred in somatic cells, Lsh-/- LSH MEFs, in the absence of differentiation 
signals, suggesting that LSH plays a role in a cell autonomous manner. The promoters of 
these unique genes and repetitive elements misregulated in the absence of LSH are 
characterised by overall 40-50% loss of DNA methylation at their promoter region. 
Accordingly, when wild-type LSH was introduced in Lsh-/- MEFs, there was transcriptional 
silencing of these loci and the de novo DNA methylation was re-established at these 
promoters. However, the catalytically inactive LSH was not able to rescue DNA methylation, 
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indicating that ATP hydrolysis by LSH is necessary for both gene silencing and establishment 
of de novo DNA methylation in Lsh-/- MEFs. Bisulfite sequencing analyses for IAPs detected 
almost complete methylation at promoters in some of the sequenced clones and high gain of 
DNA methylation, although not complete, at the promoters of the Rhox genes that were 
silenced such as Rhox2, Rhox6 and Rhox9 genes. On the other hand, some pluripotency 
associated genes such as Dppa2 and Dppa4 were not transcriptionally silenced in Lsh-/- LSH 
MEFs. This indicates that additional signals, not present in MEFs, might be required for 
silencing of pluripotency associated genes in somatic cells.  
 
 
                        
 
Figure 3.1. Schematic diagram showing LSH-dependent gene silencing of specific protein coding 
genes and IAP retrotransposons.  
Representation of bisulfite DNA sequencing in wild-type MEFs, Lsh knockout MEFs, and wild-type LSH or 
mutant LSH rescue cell lines. Each row indicates a DNA strand representing the promoter region of LSH-
dependent loci and each circle is a CpG dinucleotide. Methylated CpGs are shown in black and unmethylated 
CpGs in white. LSH is required for appropriate de novo DNA methylation at these promoters and gene 
silencing. Wild-type LSH is able to rescue the aberrant DNA methylation and active transcriptional state of 




In summary, previous work in the lab has characterised LSH-dependent loci including not 
only repetitive elements that had been already characterised in many studies before but also 
protein coding genes. Extensive DNA methylation and expression defects in Lsh-/- MEFs were 
characterised genome wide. This shows that LSH is directly involved in regulating DNA 
methylation and gene expression throughout the genome at single gene promoters as well as 
clusters of promoters and repetitive sequences (Myant et al., 2011). LSH can overcome these 
defects cell autonomously, when introduced into the Lsh-/- MEFs. However, the catalytic 
activity of LSH is necessary for this restoration of DNA methylation and transcriptional silent 
state (Figure 3.1) (Termanis et al., 2016). It is still unknown how LSH enables this gene 
silencing and DNA methylation to occur at promoters of some genes such as the Rhox cluster 
in somatic cells but not others such as the pluripotency associated genes. It would also be 
interesting to determine whether histone modifications are involved in LSH-dependent gene 
silencing and whether there is a difference in these marks between the loci that respond 
differently to restoration of LSH expression. Answering these questions will be the aim of this 
chapter. The experiments described in this chapter have been published in Nucleic Acids 
Research (Termanis et al., 2016), see appendix 1.   
 
3.2 LSH enables silencing of active promoters marked by H3Ac and H3K4me3 
To better understand how LSH contributed to gene silencing at LSH-dependent loci, it 
was important to analyse whether active transcription of these specific genes in the Lsh-/- MEFs 
was accompanied by histone modifications associated with this transcriptional state. In order 
to determine whether these loci were marked in their promoter region by active histone marks 
such as histone H3 lysine 4 trimethylation (H3K4me3) and histone H3 lysine 9 / lysine14 
acetylation (H3Ac), I carried out ChIP for both marks. Both histone marks, H3K4me3 and 
H3Ac, are normally found in promoters of active genes. H3K4me3 is also found as a mark in 
unmethylated CpG islands in mammalian cells, and this modification does not necessarily 
correlate with its transcriptional activity (Thomson et al., 2010). ChIP experiments were done 
using chromatin extracted from crosslinked cells collected from wild-type MEFs as well as Lsh 
-/- MEFs and both rescued cell lines, Lsh-/- LSH MEFs and the catalytically inactive Lsh-/- K237Q 
MEFs. These ChIP experiments showed that Lsh-/- MEFs were marked by both active histone 
modifications compared to wild-type MEFs where we did not observe these active marks 
(Figure 3.2). However, the enrichment for these marks in Lsh-/- MEFs was different depending 
on the specific locus analysed. The higher enrichment for both active histone marks at some 
genes did not seem to be accompanied by higher transcription (Termanis et al., 2016). The 
transcriptional silencing and DNA methylation at the promoters of Gm9 and Rhox genes in 
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Lsh-/- LSH MEFs was accompanied by loss of both active marks, H3K4me3 and H3Ac marks, 
with the exception of Rhox2 which does not show a rescue in these marks (Figure 3.2). The 
misregulated genes, which were not silenced in the Lsh-/- K237Q MEFs, do not lose H3K4me3 
and H3Ac marks from their promoters. In contrast, these Lsh-/- K237Q MEFs showed an 
increase in both histone marks at the majority of promoters which matched the increase in 
gene expression, although some genes such as Rhox2 and Rhox9 do not show this increase. 
The lack of increase in both histone marks at Rhox2 and Rhox9 in the Lsh-/- K237Q MEFs 
suggests that methylation and histone modifications are not coupled at these loci. There might 












As mentioned earlier, pluripotency-associated genes such as Dppa2 and Dppa4 did not 
follow the same pattern as Rhox genes and were not silenced in Lsh-/- LSH MEFs. Accordingly, 
the ChIP experiments showed that the active histone marks at the promoter region of Dppa2 
did not show a big decrease compared to the Rhox genes or Gm9 when LSH was re-
introduced. However Dppa2 did show an increase in both H3K4me3 and H3Ac in the Lsh-/- 
Figure 3.2. LSH enables silencing of active promoters marked by H3K4me3 and H3Ac. 
The silencing of gene expression by wild-type LSH is accompanied by loss of both marks, H3K4me3 and H3Ac, 
from gene promoters. (A) ChIP for H3K4me3. (B) ChIP for H3Ac. Actin was used as a control since its 
transcriptional state does not change in the cells in study. Tnfsf9 was randomly chosen from a list of promoters 
that acquire DNA methylation in the wild-type LSH rescue cells. A rabbit IgG antibody was used as an additional 
control for H3K4me3 antibody and H3Ac antibody (data not sown). The error bars represent standard deviation 
calculated from 2 biological replicas with 2 technical replicates each.  
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K237Q MEFs, similar to the increase observed at the Rhox gene promoters (Figure 3.2). I also 
analysed two additional loci, Actin and Tnfsf9, which were used as controls for these ChIP 
experiments. Actin is expressed in both wild-type MEFs and Lsh-/- MEFs (Myant et al., 2011) 
and its expression did not change in any of the rescued cell lines, Lsh-/- LSH MEFs or Lsh-/- 
K237Q MEFs. Tnfsf9 was randomly chosen as an additional control since it behaves in the 
same way as Dppa2. Tnfsf9 has no DNA methylation at the promoter and it is expressed in 
the absence of LSH. However, when LSH is reintroduced in the knockout cells, DNA 
methylation is not rescue at Tnfsf9 promoter. We are not aware of its expression state in these 
cells but it seems that Tnfsf9 follows the same trend as pluripotency genes, since we can still 
observe the active marks in Lsh-/- LSH MEFs.   
Taken together, from these ChIP experiments we concluded that LSH when re-expressed 
in LSH-deficient cells is able to silence aberrantly expressed genes that are marked at their 
promoter region by active histone modifications H3K4me3 and H3Ac. These marks decrease 
only when wild-type LSH, but not the catalytically inactive mutant LSH, is expressed in Lsh-/- 
MEFs although there is a variable response of some genes such as Rhox2. The mutant LSH 
does not cause silencing and most of the loci do not lose active chromatin marks from their 
promoters demonstrating that the ability of LSH to hydrolyse ATP is required for these events.   
 
3.3 Lsh-/- MEFs expressing wild-type LSH require additional signals for de novo DNA 
methylation and silencing of pluripotency associated genes  
As mentioned earlier in this chapter, some loci, in contrast to the Rhox genes, do not gain 
silencing when wild-type LSH is re-expressed in the Lsh-/- cells. Following this, it was 
interesting to know whether the de novo DNA methylation was established or not in the 
promoters of Dppa2 and Dppa4 even though the genes were not silenced. In order to study 
this, I designed primers for bisulfite sequencing for both loci and optimized the technique. After 
doing the bisulfite conversion and DNA sequencing using gDNA from wild-type, Lsh-/- MEFs 
and both rescued cell lines, LSH and K237Q; I found that there was no rescue of DNA 
methylation in the promoter region of Dppa2 and Dppa4 (Figure 3.3 A / B). In the Dppa2 gene 
promoter region we observed a decrease in DNA methylation by 59% in Lsh-/- cells compared 
to wild-type MEFs. The percentage of DNA methylation in Lsh-/- LSH and Lsh-/- K237Q MEFs 
was 17% and 18%, respectively, being similar to 21.7% DNA methylation in Lsh-/- cells (Figure 
3.3 A). In the Dppa4 gene promoter region the loss of DNA methylation was higher, observing 
a decrease by 80% in DNA methylation in Lsh-/- cells compared to wildtype MEFs. In a similar 
way to what happens at Dppa2, DNA methylation was not established back at Dppa4 promoter 
in either Lsh-/- LSH or Lsh-/- K237Q MEFs, being the percentages of methylation 25% and 9% 
65 
 
respectively (Figure 3.3 B). This indicates that Dppa2 and Dppa4 might need additional signals 
that are not present in somatic cells to both, silence and re-establish de novo DNA methylation. 
In order to test this hypothesis, we treated Lsh-/- LSH and Lsh-/- K237Q MEFs with retinoic acid, 
since previous studies had shown that retinoic acid regulates pluripotency genes (Maldonado-
Saldivia et al., 2007). Particularly, the expression of Dppa5 has been shown to be 
downregulated during induced differentiation of ES cells with retinoic acid (Kim et al., 2005).  
Lsh-/- MEFs expressing either wild-type or mutant LSH were treated with 300 nM retinoic 
acid for 5 days and this treatment led to silencing of Dppa4 and Dppa2 (data only shown for 
Dppa4) . However, the silencing was stably maintained only by cells expressing the wild-type 
LSH but it could not be maintained by cells expressing the K237Q mutant LSH (Figure 3.3 C). 
5 days after removal of the retinoic acid, Dppa4 expression gradually increased in the Lsh-/- 
K237Q cells and 10 later, the expression of Dppa4 in Lsh-/- K237Q cells reached similar levels 
of expression as in the non-treated cells. In contrast, the silencing was stably maintained even 
10 days after removal of retinoic acid in the Lsh-/- LSH MEFs. We asked whether the gene 
silencing observed when treating these cells with retinoic acid and the difference observed 
between LSH and K237Q rescued cell lines when removing the treatment, were also 
accompanied by a difference in the establishment of the de novo DNA methylation at Dppa4 
promoter. Analysis of DNA methylation by bisulfite DNA sequencing of Dppa4 promoter 
carried out 10 days after removal of retinoic acid from the cell culture, showed that DNA 
methylation was restored only in the Lsh-/- LSH cells (74%) to similar levels as in the wild-type 
MEFs (75.8%) (Figure 3.3 D). However, DNA methylation in the Lsh-/- K237Q MEFs was 9.8%, 
showing no change in comparison with the methylation levels before the retinoic acid 
treatment. These results demonstrate that the ATPase activity of LSH is required for both gene 
silencing and the establishment of de novo DNA methylation. Importantly, DNA methylation at 
the promoter region is necessary for the long-term stable maintenance of silenced state of 
genes. 
In conclusion, pluripotency associated genes in Lsh-/- MEFs require additional signalling, 
when the expression of LSH is restored, to rescue their silent state. Also, the ability of LSH to 
hydrolyse ATP is necessary for this silencing and for the establishment of de novo DNA 
methylation at the promoter region of Dppa4.            
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Figure 3.3. Lsh knockout MEFs expressing wild-type LSH require additional signals for silencing of 
pluripotency associated genes.  
Bisulfite DNA sequencing of Dppa2 (A) and Dppa4 (B) promoters in wild-type MEFs, Lsh knockout MEFs 
carrying an empty MSCV vector and Lsh knockout MEFs expressing either wild-type or mutant LSH. Each row 
of circles represents a single DNA strand, methylated CpGs are shown in black and unmethylated CpGs are 
shown in white. The percentage of methylated CpGs is shown below the diagrams. The numbers below the 
promoter graphs indicate bp upstream (-) or bp downstream (+) from the transcription start site. (C) Treatment 
of wild-type or mutant LSH rescued MEFs with retinoic acid. The graph shows the expression of Dppa4 relative 
to Gapdh measured by qRT-PCR. The error bars represent standard deviation calculated from 2 biological 
replicas with 3 technical replicates carried out for each time point. (D) Bisulfite DNA sequencing of the promoter 
of Dppa4 analysed 10 days after removal of retinoic acid from the culture. Percentage of methylation is shown 




In summary, previous work carried out in the lab has shown that specific genes 
misregulated in the Lsh-/- MEFs can be silenced and DNA methylation restored at their 
promoters when the wild-type LSH but not the catalytically inactive LSH K237Q is introduced 
into these cells. We were surprised to obtain this result since previous studies had been done 
in differentiated ES cells but never in somatic cells. We were asking a different question, 
whether LSH reintroduced in Lsh-/- somatic cells could rescue the inappropriate expression of 
LSH-dependent genes in a cell autonomous manner. We have shown that LSH is able to 
rescue both the appropriate expression and DNA methylation in a cell autonomous manner, 
but the catalytic activity of LSH is required for it. Accordingly, other study showed that 
chromatin remodelling by LSH was necessary for its function in DNA methylation (Ren et al., 
2015). From the ChIP experiments described in this chapter we found that that the aberrant 
expression of specific developmentally-regulated genes in Lsh-/- cells is also accompanied by 
a gain in active histone marks H3K4me3 and H3Ac. This is in agreement with previous 
observations that H3K4me3 was increased in genes showing upregulation in Lsh knockout 
cells but not in genes downregulated in the same condition (Tao et al., 2011). Surprisingly, 
LSH is able to silence genes that are marked in their promoter region by active histone 
modifications such as H3K4me3 and H3Ac. Moreover, these modifications decrease in the 
specific genes where restoration of LSH expression promotes gene silencing but not in the 
control gene Actin or Dppa2 which are not silenced when wild-type LSH is reintroduced into 
the Lsh-/- cells.  It would be interesting to study the expression of Tnfsf9 in these rescue cell 
lines since the histone modifications found at its promoter behave in a similar way as Dppa4. 
This might indicate that Tnfsf9 does not get silenced when wild-type LSH is reintroduced in 
Lsh-/- MEFs as we observed for the development and pluripotency associated genes. To 
summarise, the ChIP experiments show that silencing of the genes in study is accompanied 
by loss of active chromatin marks. In relation to this, it is also important to mention that the 
promoter of Rhox genes has a high number of CpGs, being closer to a CpG island content. 
CpG islands are generally associated with promoters and have a GC percentage greater than 
50%, and an observed-to-expected CpG ratio greater than 60% (Saxonov, Berg, & Brutlag, 2006). 
However, the number of CpGs at the promoters of the pluripotency associated genes Dppa2 
and Dppa4 analysed here is very low. This could explain why the enrichment for H3K4me3 is 
higher for some Rhox genes in Lsh-/- cells since H3K4me3 can be found as a mark of CpG 
islands independently of its transcriptional state (Clouaire et al., 2012; Thomson et al., 2010). 
Moreover, it is not clear why both active histone marks increase in the catalytically inactive 
LSH rescued cell line.  From previous studies it is known that the ATPase activity of LSH is 
not required for its recruitment to chromatin, but it is important for the release of the enzyme 
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from these sites (Lungu, Muegge, Jeltsch, & Jurkowska, 2015). The ATPase-deficient mutant 
has a stronger association with heterochromatin. This stronger association could explain why 
there is no silencing and why gene expression and active marks are higher in Lsh -/- K237Q 
MEFs. The catalytically inactive LSH might still be recruited to these loci in the same way as 
wild-type LSH and more stably associate at these locations of the genome for a longer period. 
This could prevent the access of other enzymes or repressive complexes that might be acting 
in the knockout cells to control the altered gene expression. Another possibility is that the 
mutant LSH, which binds to DNA, might still bind HDACs or DNMT3B through its N-terminal 
domains in the same way as wild-type LSH does. This should be the case since the N-terminal 
region of LSH is sufficient for its interaction with HDACs and DNMT3B. However, the 
interaction of the mutant LSH with these proteins has to be proven since it has never been 
tested before. If this is the case, the mutant LSH could be impairing the activity of these 
enzymes by capturing them together with its inability to release from chromatin. Further 
experiments should be performed in order to clarify whether mutant LSH can still bind HDACs 
and DNMT3B, and to shed more light on the enhanced expression of LSH-dependent genes 
in Lsh-/- cells expressing catalytically inactive LSH.   
It has been established that embryonic development is a highly orchestrated process 
where signalling pathways and transcription factors play an important role in defining the gene 
expression pattern in differentiating cells (Boyer et al., 2006; Loh et al., 2006). We have shown 
that LSH is able to re-establish proper DNA methylation and gene expression patterns at the 
Rhox cluster and Gm9 gene in somatic cells lacking the specific signalling and transcription 
factors characteristic of embryonic development. However, pluripotency associated genes 
required additional signalling for establishment of DNA methylation and gene silencing as I 
showed by qRT-PCR analyses and bisulfite DNA sequencing after retinoic acid treatment. 
Silencing of pluripotency genes during development and differentiation of stem cells involves 
transcriptional regulators and various signalling pathways (Boiani & Schöler, 2005). LSH is 
expressed at high levels in ES cells, before silencing of pluripotency genes occurs. This 
suggests that initiation of the inactivation of pluripotency genes could require exogenous 
signalling factors characteristic of ES cells. These developmental specific signalling pathways 
of stem cells could be a requirement for LSH-dependent gene silencing of specific genes. 
However, exogenous signalling molecules are absent in MEFs. Previous studies have found 
that retinoic acid signalling has a complex function during vertebrate development and 
together with other factors facilitates reprogramming in MEFs (W. Wang et al., 2011). 
Controlled low levels of retinoic acid can modulate Wnt signalling and are required for the 
reprogramming of epiblast stem cells into embryonic stem cell-like cells, highlighting the 
important functions of retinoic acid signalling in reprogramming somatic cells (Yang et al., 
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2015). In summary, silencing of pluripotency associated genes triggered by retinoic acid in 
wild-type LSH rescued cells, indicates that exogenous signalling characteristic of embryo 
development is required for LSH-dependent silencing of some loci. In addition, it reinforces 
the idea mentioned in the introduction of this chapter about the importance of LSH during early 
embryo development as previously reported for the silencing of Hox genes (Xi et al., 2007).     
  
Another aspect which is not yet understood is how LSH is recruited to these specific loci 
in the genome. Unlike other SNF2-like family members involved in transcriptional regulation, 
LSH does not have a characterized chromatin binding domain such as bromodomain or 
chromodomain (T M Geiman et al., 1998).  It should be noted that in the knockout cells, the 
expression of wild-type LSH did not recue all misregulated genes. A possible explanation for 
this is impairment of the recruitment of LSH to some areas of the genome. However, retinoic 
acid treatment triggered the establishment of gene silencing and de novo DNA methylation at 
pluripotency genes. This indicates that the lack of appropriate exogenous signalling in somatic 
cells could be an explanation rather than inaccessibility of specific areas of the genome to 
chromatin remodelling by LSH. It is not clear how LSH is recruited to the specific genes where 
we observe an effect. One hypothesis could be that LSH is recruited to chromatin by DNMTs 
which bind to chromatin through the ADD domain. The ADD domain in the de novo DNMTs 
preferentially binds histone peptides containing unmodified histone H3 lysine 4, H3K4me0 
(Otani et al., 2009). We have shown that appropriate concentration of DNMT3B is necessary 
for rescue of silencing and methylation by wild-type LSH (Termanis et al., 2016). LSH interacts 
through its N-terminal region (coiled-coil domain) with DNMT3B as indicated in a previous 
study (Myant & Stancheva, 2008). DNMTs, specifically de novo DNMTs, have high affinity for 
chromatin (Noh et al., 2015) in contrast to LSH that has a lower affinity for chromatin and 
displays a very dynamic behaviour (Lungu et al., 2015). One possible explanation for the 
recruitment of LSH to specific areas of the genome could be the binding patterns of DNMTs 
in the Lsh -/- MEFs. If DNMTs occupancy in these cells remains unchanged, this will direct LSH 
to the areas where it is needed thus enabling re-establishment of DNA methylation. However, 
the presence of active marks at some of the LSH-targeted genes in Lsh -/- MEFs rules out this 
hypothesis since the binding of DNMT3A and DNMT3B to the N-terminal tails of histone H3 is 
inhibited by the methylation of lysine 4 , both H3K4me2 and H3K4me3 (Otani et al., 2009). 
Further experiments should be performed to address how LSH is recruited to these specific 
loci and understand how LSH is mediating these changes of chromatin modifications in 
somatic cells.  
It is still unknown whether the observed changes in active histone marks are a secondary 
effect of the gene silencing caused by re-establishment of DNA methylation or a direct effect 
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of LSH being restored in these cells. Previous work in the lab, has shown that in reporter-
based assays the interaction of LSH with histone deacetylates (HDACs) is necessary for LSH-
dependent transcriptional repression (Myant & Stancheva, 2008) that does not involve de novo 
DNA methylation. Therefore further studies should be carried out to investigate the order of 
events leading to LSH-dependent gene silencing at endogenous genomic loci since the 
mechanism for this epigenetic repression is yet unclear. It has been suggested in many 
publications that the main role of LSH in epigenetic silencing is to facilitate DNA methylation 
by DNMT3B, but other studies have also shown that the LSH-dependent repression of 
retrotransposons, such as IAPs, does not require the function of DNMT3B (Dunican et al., 
2013). Future work should focus on genome-wide approaches aiming to characterise what 
happens at LSH-dependent loci when LSH is re-expressed. We know that on specific protein 
coding genes, which are affected by the absence of LSH, DNA methylation and gene 
expression can be rescued in a cell autonomous manner when LSH is re-expressed. Genome-
wide analysis would help clarify at which LSH-dependent loci this rescue happens. Once these 
loci that are able to re-establish normal patterns of expression and DNA methylation in LSH-
recued cells are characterised, ChIP-Seq for LSH should be performed to clarify whether it 
binds preferentially to specific regions of the genome. These approaches will help 
understanding the dynamics of LSH-dependent transcriptional silencing in a genome-wide 
context. Also, this study focuses on Lsh-/- MEFs but in order to confirm a potential role of LSH 
in DNA methylation and gene silencing during early development, studies in embryos and 
analyses during different developmental stages should be performed. The use of a conditional 
knockout system that allows the study of embryos with the potential to reactivate LSH at 
different developmental stages would provide a better characterization of the developmental 
timing of LSH-dependent events. However, embryo studies can be difficult to carry out while 
conditional knockout cell lines could provide insight into the order of LSH-dependent events 
leading to gene silencing and de novo DNA methylation. A conditional knockout system for 
LSH needs to be established, validated and characterised before performing the analyses 
suggested above. The establishment of such an in vitro Lsh conditional knockout system will 











The previous chapter raised the need to establish a conditional reversible Lsh knockout 
system in order to better understand the role of LSH in epigenetic gene silencing. Such system 
would help to gain insight into the specific time at which LSH is required during embryo 
development and the order of events leading to LSH-dependent gene silencing and gain of de 
novo DNA methylation. In order to study these aspects and clarify the role of LSH in epigenetic 
gene silencing, a cell system established from mice carrying conditionally reversible Lsh 
alleles and tamoxifen-inducible Cre recombinase had to be optimised.   
Chao Li, a former postdoc in the Stancheva lab, designed and generated a cassette 
flanked by different recombinase target sites (RTs) based on an approach previously used by 
Schnütgen et al (Schnütgen et al., 2005). The cassette contains a splice acceptor (SA), green 
fluorescent protein gene (GFP), neomycin resistance gene (neo), and polyadenylation (pA) 
sequence. I will refer to this cassette as the GFPneo cassette. The design of this cassette was 
based on previously reported gene trap vectors for conditional mutagenesis in embryonic stem 
(ES) cells. These vectors rely on directional site-specific recombination systems that can 
repair and re-induce gene mutations when activated in succession. Once the vectors are 
inserted into the mouse genome, genetic mutations can be produced at a particular time and 
place in somatic cells. The recombinase target sites flanking the cassette designed in the lab 
were the following: frt and F3 (heterotypic target sequences for the FLP recombinase), loxP 
and lox511 (heterotypic target sequences for the Cre recombinase). This cassette was 
introduced by homologous recombination into the intron 3 of the Lsh gene, generating 
heterozygous targeted ES cells from which a strain of mice carrying conditionally reversible 
Lshoff allele was established. The Lshoff/+ mice were then crossed with a strain carrying ER-Cre 
transgene to produce Lshoff/+, ER-Cre+ mice. The Lsh gene is conditionally inactivated by the 
SA and pA in the cassette (Lshoff) since transcripts initiated at the endogenous promoter are 
spliced from the splice donor (SD) of the endogenous exon 3 to the SA of the cassette. Then 
the GFP and neomycin resistance reporter gene are expressed as a fusion with the first three 
exons of Lsh and this hybrid transcript is prematurely terminated at the polyadenylation 
sequence of the cassette. After induction of ER-Cre with tamoxifen, the Cre recombinase 
should invert the SA cassette onto an antisense orientation following recombination between 
loxP and lox511 sites. The SA is not active in the antisense orientation, therefore this inversion 
leads to normal splicing between the endogenous splice sites (exon 3 to exon 4) allowing 
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normal expression of the endogenous Lsh gene (Lshon). FLPo-mediated inversion can further 
be used to invert the cassette back onto the Lshoff orientation (Figure 4.1 A). In this way, a 
mouse model carrying conditionally reversible Lsh alleles (Lshoff) and tamoxifen-inducible ER-
Cre recombinase was generated. Chao Li and Irina Stancheva confirmed the correct 
integration of the cassette and that the LSH protein is undetectable in Lshoff/off ES cells and 
mice. 
Chao Li also designed and optimised a set of primers to detect by PCR the Lshoff and 
Lshon orientation of the GFPneo cassette (Figure 4.1 B). As indicated in Figure 4.1 B, the set 
of primers consist of three primers P1-P2-P3. The annealing of the primers to different regions 
depends on the final orientation of the cassette as shown in the schematic diagram (Figure 
4.1 B). After PCR amplification the position of the cassette can be distinguished since the PCR 
product size is different in each case. The amplification product of the cassette in the Lshon 
position is shorter than the Lshoff allowing to distinguish them when the PCR products are run 





   
   
 
 
Following the establishment of a mouse strain carrying the conditionally reversible Lshoff 
allele and ER-Cre recombinase, I derived mouse embryonic fibroblasts (MEFs) from embryos 
produced by crosses of heterozygous mice for the Lshoff or Lshon allele and ER-Cre 
recombinase. The MEFs were genotyped using two pairs of primers that amplify the wild-type 
(Lsh+) allele and the GFPneo cassette, respectively. The combination of the four primers in a 
PCR reaction allows to detect in the same PCR reaction run on an agarose gel whether the 
cells contain the cassette and whether they are homozygous or heterozygous. Also, primers 
Figure 4.1. Schematic representation of the conditional reversible Lsh allele (Lshoff) and the mechanism 
of activation. 
A) GFPneo cassette containing frt (yellow triangles) and F3 (green triangles), heterotypic target sequences for 
the FLP recombinase; loxP (red triangles) and lox511 (purple triangles), heterotypic target sequences for the 
Cre recombinase; SA, splice acceptor; GFP,green fluorescent protein; neo, neomycin resistance gene; and 
pA, polyadenylation sequence; introduced by homologous recombination in the intron 3 of the Lsh gene. After 
translocation of ER-Cre with OHT, the full length Lsh gene expression is restored (Lshon). FLPo-mediated 
inversion can further be used to invert the cassette back onto the Lshoff orientation. B) Schematic representation 
of the conversion from Lshoff to Lshon. P1, P2 and P3 show the annealing of the three primers used for PCR 
amplification in order to distinguish between the two possible orientations (Lshoff or Lshon) of the GFPneo 
cassette. The amplification product from the cassette in Lshon orientation is shorter than the Lshoff product 
allowing to distinguish them when running the PCR products in an agarose gel. Diagram from Irina Stancheva.      
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to detect ER-Cre were used to select cell lines positive for the presence of the recombinase. 
Finally, another set of primers against the Y chromosome allowed the female or male sex of 
the MEFs to be determined. Figure 4.2 shows an example of genotyping PCRs for sixteen 
MEF cell lines immortalised from 13.5 days embryos.  
 
       
 
 
Male cell lines were used in future experiments since some of the analysed loci, such as 
the Rhox cluster of homeobox genes, are on the X chromosome. It is therefore more 
convenient to use male cell lines because the kinetics of silencing and de novo DNA 
methylation of those genes may differ between the active and the inactive X in female cells. 
Once the MEF cell lines were derived, genotyped and immortalised with the 3T3 protocol 
(Sharpless, 2006), characterization and optimisation of the in vitro system were required 
before undertaking further analyses. The characterization of the Lshoff/off; ER-Cre+ MEFs and 
the optimisation of cassette inversion in the conditionally reversible Lsh knockout cell system 






Figure 4.2. Genotype of sixteen immortalised MEF cell lines derived from 13.5 days embryos. 
gDNA from sixteen different cell lines from two independent dissections was genotyped by PCR for the 
presence of wt Lsh and the GFPneo cassette (Lshoff), as well as the presence of ER-Cre recombinase. Ctrl 
indicates a cell line negative for the presence of ER-Cre recombinase, a negative control for the PCR. The pink 
rectangles show female genotypes and blue rectangles show male genotypes as determined from PCR for the 
male-specific SRY gene.  
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4.2 Expression of LSH-dependent loci in Lshoff/off MEFs 
Previously it has been demonstrated in the lab that specific protein coding genes and 
repetitive elements, such as IAP retrotransposons, gain expression in fibroblasts derived from 
chromatin remodelling ATPase LSH-null mouse embryos (Myant et al., 2011). Previous 
studies have also shown expression of Long Terminal Repeats (LTR) retrotransposons and 
major satellite repeats in the absence of LSH in both MEFs and embryos (Huang et al., 2004).  
In order to validate this cellular system, I first had to test whether LSH-dependent loci 
known to gain expression in the absence of LSH were also misregulated in the Lshoff/off MEFs 
compared to their wild-type Lsh+/+ counterparts. To do so, I performed qRT-PCRs using cDNA 
obtained from three independent RNA extractions from Lshoff/off and Lsh+/+ MEFs. Since most 
of the investigated genes are not expressed in wild-type MEFs, the small variations in noise 
levels produce a large change in the Ct values obtained by qRT-PCR, the average of wild-
type Ct was used as a control reference for the analyses. I determined the expression of 
repetitive elements (Figure 4.3 A / B) and LSH-dependent protein coding genes including 
Gm9, genes from the Rhox cluster, homeobox genes from different clusters, imprinted genes 
and development and pluripotency associated genes (Figure 4.3 C). The IAP retrotransposons 
were upregulated 230-fold in the Lshoff/off MEFs compared to wild-type cells (Figure 4.3 A). 
Other repetitive elements such as SINE B1, SINE B2 and MuLV also showed de-repression 
in Lshoff/off MEFs (Figure 4.3 B). However, their expression in the LSH-deficient cells was not 
as high as the expression of IAPs. The genes of the Rhox cluster, Gm9 gene adjacent to the 
Rhox cluster, Dppa4 and Dppa2, imprinted gene Peg3 and Hoxa5 were also highly 
upregulated in the Lshoff/off MEFs, as expected, while Peg12, Hoxa4 and Hoxc6 genes showed 
a small gain of transcription (Figure 4.3 C). The absence of LSH had a higher impact on the 
expression of pluripotency genes, Dppa4 and Dppa2. Accordingly, previous work had shown 
that LSH is required for the silencing of development and pluripotency associated genes 
during differentiation of embryonic stem cells (Myant, Termanis et al. 2011).  
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I also wanted to determine whether the gain of expression in immortalised Lshoff/off MEFs 
(data shown in previous figure Figure 4.3 A / B / C) was similar to the gain of expression in 
primary cells since there might be a higher misregulation after passaging the cells for a longer 
period in the absence of LSH. I carried out qRT-PCRs to analyse the expression of IAP 
retrotransposons in Lshoff/off MEFs at passage 4 comparing to the expression in immortalised 
Lshoff/off MEFs at passage number 23. As shown in Figure 4.3 D, the expression for IAPs is 
higher in immortalised MEFs than primary Lshoff/off MEFs, although there is a big variation.  
In conclusion, the experiments described above verify the gain of transcription of repetitive 
elements and previously identified LSH-dependent protein coding genes in Lshoff/off MEFs 
compared to Lsh+/+ MEFs. This misregulation of LSH-dependent loci in the Lshoff/off MEFs 
Figure 4.3. Lshoff/off MEFs re-express genes that are normally silenced in the Lsh+/+ MEFs. 
qRT-PCR analyses show re-expression of repetitive elements and single copy genes in Lshoff/off MEFs. The 
graphs represent average expression +/- SD, normalized to GAPDH, from three independent experiments. All 
expression values are displayed relative to Lsh+/+ MEFs. A) Expression of IAP retrotransposons in immortalized 
Lshoff/off MEFs. B) Expression of other repetitive elements in immortalized Lshoff/off MEFs. C) Expression of 
LSH-dependent genes in immortalized Lshoff/off MEFs. D) Expression of IAP retrotransposons in primary and 




mirrors the changes in gene expression observed in previous studies using Lsh knockout cells 
demonstrating that both approaches used to generate LSH-deficient cells and animals result 
in very similar alterations in transcriptional regulation.  
 
4.3 DNA methylation at LSH-dependent loci in Lshoff/off MEFs 
Previous work has demonstrated that in the absence of LSH there is loss of DNA 
methylation from the promoters of genes that are inappropriately expressed in Lsh knockout 
cells as well as other loci that are not upregulated in the knockout cells. LSH is required for 
normal patterns of DNA methylation at non-repeat sequences genome-wide (Myant et al., 
2011; Tao et al., 2011). In addition, other studies have shown that the loci affected by the 
absence of LSH include repetitive elements and single copy genes (Dennis et al., 2001). This 
role of LSH in DNA methylation has been further characterized, showing that LSH promotes 
the establishment of de novo DNA methylation (Termanis et al., 2016; Zhu et al., 2006).  
Therefore additional validation of the conditional Lsh knockout cellular system was to test 
whether the genes that were aberrantly expressed in Lshoff/off MEFs, also lost DNA methylation 
from their promoter region as shown for the previous Lsh knockouts. Bisulfite sequencing 
analyses of IAP retrotransposons and specific protein coding gene promoters from genomic 
DNA of both Lshoff/off MEFs and Lsh+/+ MEFs showed that both types of sequence lost DNA 
methylation in the Lshoff/off MEFs. The LTR-embedded promoter of IAP retrotransposons 
overall lost about 40% of DNA methylation at CpG dinucleotides in Lshoff/off MEFs when 
compared to Lsh+/+ MEFs (Figure 4.4 A). The loss of DNA methylation at IAPs was not the 
same for all the sequenced clones. There was an almost complete loss of DNA methylation at 
half of the clones and no loss of methylation at the rest of clones, which might be explained 
by some of the IAP retrotransposons acquiring gain of expression while others remained 
silenced in Lshoff/off MEFs. The promoters of Rhox genes also showed a significant loss of DNA 
methylation. The loss of methylation at Rhox6 and Rhox9 in Lshoff/off MEFs was 55% and 71%, 
respectively, when compared to Lsh+/+ MEFs (Figure 4.4 B and C). This data is in agreement 
with previous work in the lab showing the loss of DNA methylation by 50% at specific LSH-
dependent loci including IAPs and Rhox genes in cells lacking LSH. A big difference in the 
methylation levels between Lshoff/off and Lsh+/+ MEFs was also observed at development and 
pluripotency associated genes, Dppa2 and Dppa4. Dppa2 promoter lost 84% of methylated 
CpGs (Figure 4.4 D) and Dppa4 68% (Figure 4.4 E) in the Lshoff/off MEFs while both promoters 
were highly methylated in the Lsh+/+ MEFs. It is important to mention that the calculated loss 
of DNA methylation at promoters of single copy genes is an average percentage calculated 
for the analysed clones, but in contrast to IAPs, there is obvious loss in all individual clones. 
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The higher loss of DNA methylation at the promoters of pluripotency associated genes was 
accompanied by high gain of expression as shown earlier (Figure 4.4 C). However, this 
observation is not applicable in all cases since some genes, for example Rhox6, that are also 
highly expressed in Lshoff/off MEFs do not lose DNA methylation at such high levels. In order 
to find a correlation between higher loss of DNA methylation at promoters and higher gene 
expression I analysed previous expression data obtained from microarrays for Lsh-/- MEFs 
and DNA methylation data obtained from MeDIP sequencing. Again, a correlation could not 






Figure 4.4. Lshoff/off MEFs show hypomethylation at promoters of IAPs and single copy genes.  
Sodium bisulfite DNA sequencing for A) IAPs, B) Rhox6, C) Rhox9, D) Dppa2 and E) Dppa4, in MEFs at 
passage 24. The numbers below the promoters graphs indicate bp upstream (-) or downstream (+) from the 
transcription start site. The black bars on the graphs indicate the distribution of CpG sites analysed. Each row 




Following this, I also tested whether this loss of DNA methylation observed at Lshoff/off 
MEFs varied between primary and immortalised cells comparing the same MEF cell line. As 
mentioned earlier, LSH is known to play a role in de novo DNA methylation, but its role in the 
maintenance of DNA methylation is not clear yet. IAPs are retrovirus-like repetitive DNA 
elements that maintain high levels of DNA methylation during development (Rowe & Trono, 
2011). To determine if LSH also plays a role in the maintenance of DNA methylation, I decided 
to analyse whether there was a higher loss of methylation in Lshoff/off MEFs at higher passage 
numbers. Also, we observed that the expression of IAPs was higher in immortalized MEFs 
than in primary Lshoff/off MEFs. This gain of expression could be due to a higher loss of DNA 
methylation at their promoter region potentially due to impaired maintenance of DNA 
methylation in the absence of LSH. To address further this hypothesis, I analysed the CpG 
methylation levels in primary cells at passage 4 and not yet fully immortalised cells at passage 
17-18. To better understand any possible variation in DNA methylation at different passages, 
I also analysed Lsh+/+ cells as an extra control. The bisulfite sequencing data shown previously 
in Figure 4.4 was obtained from immortalised MEFs at passage 24-25. Decrease in DNA 
methylation at the LTR of IAPs could be observed in cells of both genotypes between passage 
4 and passage 17. However, the methylation level of IAPs in Lshoff/off and Lsh+/+ MEFs was 
maintained between cells at passage 17 and immortalised MEFs (Figure 4.5). This could 
indicate that the variation in methylation is partly due to secondary effects of the 
immortalization process rather than the higher passage number since the percentages of DNA 




                
 
            
 
In summary, we observed a loss of DNA methylation from promoters of repetitive IAP 
elements and specific protein coding genes in Lshoff/off MEFs. This alteration in DNA 
methylation at promoters of LSH-dependent loci in Lshoff/off MEFs was comparable to the 
patterns observed in Lsh-/- MEFs and thus verifies the role of LSH in the establishment of de 
novo DNA methylation as shown in previous studies. This implies that the Lshoff/off MEFs from 




Figure 4.5. Hypomethylation of IAPs in Lshoff/off MEFs is maintained in primary and immortalised MEFs.   
Sodium bisulfite DNA sequencing for IAPs in MEFs at passage 4, passage 17-18 and passage 24-25. DNA 
methylation in Lsh+/+ MEFs is shown in the top diagrams and DNA methylation in Lshoff/off MEFs is shown in 
the bottom diagrams. Each row in the diagrams represents a single DNA strand and methylated CpGs are 




4.4 Nucleosome occupancy at LSH-dependent loci in Lshoff/off MEFs 
Recent studies have shown that the role of LSH in the de novo DNA methylation at repeat 
and unique sequences requires intact ATP binding site of the chromatin remodeler (Ren et al., 
2015; Termanis et al., 2016). Ren et al also suggested that ATP binding is required for the re-
establishment of wild-type patterns of nucleosome occupancy at repeat sequences, which are 
lost in the Lsh knockout cells. The analyses of DNA methylation and nucleosome occupancy 
was based on an assay known as Nucleosome Occupancy and DNA Methylation (NOMe) 
sequencing. A NOMe assay carried out to analyse IAPs and Line1 sequences showed that in 
the absence of LSH both nucleosome occupancy and DNA methylation were lower at the 
promoters of these loci. When LSH was re-expressed in differentiating embryonic stem cells, 
it could rescue nucleosome occupancy and DNA methylation at the promoters of repetitive 
elements. It was hypothesized that ATP-dependent nucleosome remodelling is the primary 
molecular function of LSH, and that this nucleosome remodelling could promote de novo DNA 
methylation.  
To obtain preliminary information of a possible difference in nucleosome density between 
wild-type MEFs and Lsh knockout MEFs, I carried out micrococcal nuclease (MNase) 
digestion of chromatin from wild-type and knockout cells. Samples were collected after 5, 10, 
15, and 20 minutes incubation times; and the digestion products were purified and run in an 
agarose gel. There were no clear differences in digestion between wild-type and Lsh-/- MSCV 
MEFs. Both cell lines showed a similar pattern of bands after enzymatic digestion for the 
different incubation times (Figure 4.6 B). The chromatin from Lsh-/- MSCV cells seemed to be 
less accessible to the nuclease as evident from higher molecular weight products at short 
incubation times. This result contradicts the observation of Ren et al since chromatin seems 
to be less accessible in our cells lacking LSH while it was shown lower nucleosome occupancy 
at promoters of cells in the absence of LSH (Ren et al., 2015), which suggests having more 
accessible chromatin. However, the differences in digestion were not obvious since a small 
variation in chromatin concentration or incubation time could cause this effect. An hybridization 
approach, such as Southern Blot, could be used to determine whether the specific loci 
analysed by Ren et al are less accessible or not to enzymatic digestion in the absence of LSH 
in our knockout cells. It was determined that 15 minutes of incubation was sufficient to digest 
the chromatin to mononucleosomal size, around 150 bp digestion product (Figure 4.6 B). The 
chromatin from wild-type and Lsh-/- MSCV MEFs was fully digested in 15 minutes producing a 
unique band of mononucleosomal size in both cell lines (Figure 4.6 C). The same result was 
observed for Lshoff/off and Lsh+/+ MEFs, obtaining a similar digestion pattern in both cell lines 
(Figure 4.6 D). However, small differences in nucleosome density caused by LSH at specific 







In order to gain insight into the nucleosome occupancy in the Lshoff/off MEFs and compare 
them to the Lsh+/+ MEFs as well as study any relationship between DNA methylation and 
nucleosome occupancy, I carried out the NOMe assay for the promoters of Rhox6 and Rhox9 
genes. We observed loss of DNA methylation by 41% in Rhox6 and 51% in Rhox9 (Figure 
4.7). This matches the previous result from the bisulfite sequencing. Surprisingly, we did not 
observe reduced nucleosome occupancy in Lshoff/off MEFs compared to Lsh+/+ MEFs at either 
of the two promoters. This difference with the previously mentioned study could be due to the 
different loci analysed, since their study is focused on repetitive elements. Another explanation 
could be the different cell lines used, since Ren et al worked with differentiating embryonic 
stem cells and my study was carried out in MEF cell lines. 
 
Figure 4.6. Micrococcal Nuclease (MNase) digestion of chromatin from wild-type and Lsh knockout 
MEFs produces a similar pattern.     
A) Schematic diagram of MNase digestion of chromatin and example of the pattern of bands obtained after 
running the products of the digestion in an agarose gel. B) MNase products run in a 2% agarose gel after 5, 
10, 15 and 20 minutes digestion of chromatin from wild-type and Lsh-/- MSCV MEFs with 200 Units of MNase. 
A non-digested chromatin control is shown as 0 minutes digestion. C) MNase digestion product run in a 2% 
agarose gel after 15 minutes digestion of chromatin from wild-type and Lsh-/- MSCV MEFs with 200 Units of 
MNase. D) MNase digestion product run in a 2% agarose gel after 15 minutes digestion of chromatin from 






Finally, it is also important to consider the limitation of the NOMe assay when sequencing 
a small number of colonies and a specific area of a promoter. If a limited number of base pairs 
is sequenced, a hypothetical nucleosome occupancy can only be inferred since information 
from the boundary regions is not available. A NOMe-Seq approach might be useful to clarify 
whether a difference in nucleosome occupancy can also be observed in the Lshoff/off MEFs 
compared to Lsh+/+ MEFs and whether this difference is specific for repetitive elements or a 
general feature of all LSH-dependent loci. 
 
4.5 Time required for the complete conversion of Lshoff allele to Lshon 
Once the Lshoff/off MEFs were characterized, the next step in the establishment of the 
conditionally reversible Lsh knockout cellular system was to test the conversion of the Lshoff 
allele to Lshon upon activation of recombination by ER-Cre. The cells used in this project were 
genotyped as Lshoff/off ER-Cre+ MEFs and Lsh+/+ ER-Cre+ MEFs. Lsh+/+ ER-Cre+ MEFs were 
used as a control for effects that might be caused by the presence of ER-Cre recombinase. 
The treatment of the cells with 4-hydroxytamoxifen (OHT) should translocate the ER-Cre 
Figure 4.7. Nucleosome occupancy and DNA methylation at Rhox6 and Rhox9 promoters in Lshoff/off 
and Lsh+/+ MEFs.    
Nucleosome occupancy and DNA methylation (NOMe) assay for Rhox6 and Rhox9 promoters in Lshoff/off and 
Lsh+/+ MEFs. The data for Lsh+/+ MEFs is shown in the top diagrams and data for Lshoff/off MEFs is shown in 
the bottom diagrams. Each row in a diagram represents a single DNA strand. Nucleosome occupancy diagrams 
are shown on the left for each promoter, methylated GpCs are shown in green and the area of the promoter 
where a nucleosome could be positioned is highlighted in pink. Bisulfite sequencing diagrams are shown on 
the right for each promoter, methylated CpGs are shown in black and the percentage of methylation is indicated 
below the diagram.  
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recombinase to the nucleus allowing the excision of loxP and lox511 recombinase target sites 
and inverting the orientation of the cassette from the Lshoff to the Lshon position.  
Initially, I optimised the concentration of OHT used for treating the cells and the number 
of days of treatment required to maximise the conversion of the cassette to the Lshon position. 
Different OHT concentrations were tested, and 600-800nM of OHT seemed the appropriate 
range of concentration to achieve an optimal conversion of the cassette. The cells were treated 
with OHT during different time points for a maximum of eight days and all samples were 
collected on the same day to minimise variation (Figure 4.8 A). After the cells were collected, 
genomic DNA (gDNA) was extracted and PCR carried out using the primers distinguishing 
between the Lshoff and the Lshon allele (see Figure 4.1 B). In addition, the Lshoff allele was 
analysed by quantitative PCR (q-PCR). I also designed primers to analyse the Lshon allele by 
q-PCR but none of the pairs of primers could be optimised. These experiments showed that 
eight days of OHT treatment was sufficient to convert the cassette in most of the cells to the 
Lshon position (Figure 4.8 B). ImageJ analysis of the PCR (Figure 4.8 C) and the q-PCR 
detecting the Lshoff allele (Figure 4.8 D), showed that eight days of OHT treatment achieved 
around 90% conversion of the cassette. The treatment was also maintained for a longer period 
of time to test whether a higher or complete conversion would be obtained, but the results did 
not indicate further conversion when longer treatments were used (data not shown). Therefore 
we concluded that eight days of OHT treatment is the time required to obtain an optimal 
conversion of the GFPneo cassette from Lshoff to Lshon orientation.         
Once the time required for the conversion of the Lshoff allele to Lshon was determined, I 
analysed whether the protein levels correlated with the 90% efficiency of conversion after eight 
days of OHT treatment. Western blots showed that the LSH protein levels started to be visible 
after four days of OHT treatment and became similar to the wild-type levels after eight days of 
treatment (Figure 4.8 E). However, the LSH expression levels were not completely restored 
after eight days, so I repeated the OHT treatment and Western blot with three additional 
biological replicates to assure that during the eight days of treatment the LSH expression and 
protein levels could be restored to wild-type. We observed that LSH expression levels were 






As mentioned earlier in the introduction, the Lshoff/off MEFs are neomycin-resistant while 
the Lshon/on MEFs lose this resistance. When adding geneticin (resistance to geneticin is 
conferred by the neomycin resistance gene) to the non-treated cells and OHT-treated cells, it 
was apparent that the colony formation by the non-treated cells was higher than by the OHT-
treated MEFs, as expected (Figure 4.9 A and B). This confirms the conversion of the cassette 
previously tested by PCR and Western blotting. Nevertheless, the colony formation in both 
Figure 4.8. Lshoff allele can be converted to Lshon after eight days of OHT treatment restoring LSH 
protein levels to wild-type. 
A) Schematic diagram showing the OHT treatment to convert the Lshoff allele to Lshon. B) PCR analyses 
performed on genomic DNA to monitor the conversion of Lshoff allele to Lshon during the 8 days of OHT 
treatment at final concentration of OHT 600 nM. The conversion efficiency was analysed using a homozygous 
for Lshoff allele cell line. The lower 500 bp band in the gel is the Lshon amplification product while the higher 750 
bp band is the Lshoff amplification product. C) Quantification of the band intensity performed by ImageJ 
software. The percentage of each allele is plotted on the graph according to the number of days under OHT 
treatment. D)  q-PCR analyses of Lshoff allele using gDNA from each treatment day. The sample without OHT 
treatment, 0 days, was used as the control for PCR quantification. E) Western blot detecting LSH protein levels 
from two independent OHT experiments using the same Lshoff homozygous cell line. Protein levels are shown 
at all time points in the first experiment, but only negative control sample, no OHT treatment, and 8 days of 
OHT treatment sample are shown in the second experiment. Protein level from a control Lsh+/+ MEF cell line is 
also shown and HDAC1 nuclear protein is used as a loading control. F) Western blot showing LSH protein 
levels from three independent OHT experiments using the same Lshoff homozygous cell line. Protein levels are 




control plates without geneticin should be the same, but less colonies were formed on the 
plate containing Lshon/on converted MEFs as clearly shown by the quantification (Figure 4.8 B).  
 
     
 
To summarize, eight days of OHT treatment is sufficient to convert the Lshoff allele to Lshon 
in immortalised MEFs. This conversion also restored LSH expression in the Lshon/on MEFs to 
wild-type levels. The conversion of the cassette is also confirmed by the reduced resistance 
to geneticin after eight days of OHT treatment. All these approaches show that the system 
functions as expected and indicate that the reversible Lsh knockout cells can be used for 
further studies.  
 
4.6 Reproducibility of Lshoff to Lshon allele conversion and LSH expression in MEFs  
One of my aims was to determine the order of events leading to gene silencing when LSH 
expression is restored in the Lsh knockout MEFs and the time required for acquisition of gene 
silencing and DNA methylation. In order to study this, time point experiments after OHT 
treatment are required to understand what changes in chromatin come first and how much 
time is needed for the establishment of gene silencing. In the previous section I demonstrated 
that LSH protein levels are restored after eight days of OHT treatment, but the stability of LSH 
expression over time was not tested. This section will focus on the analysis of LSH expression 
Figure 4.9. Lshoff/off MEFs lose their resistance to geneticin after OHT treatment and conversion to 
Lshon/on. 
A) Colony formation assay using Lshoff/off MEFs non-treated and treated with OHT for a period of 8 days. Cells 
were plated in a low density and the medium was supplemented with geneticin to final concentration of 250 
μg/ml. Medium added to plates containing 8 days OHT treated cells was also supplemented with OHT during 
the three weeks of geneticin treatment. The orange square indicates the negative control plates without 
geneticin treatment. B) The graph represents the average number of colonies detected on geneticin treated 
plates in non-treated and OHT-treated cells. The number of colonies in the negative control plates without 




over time after OHT treatment and the reproducibility of the conversion of the cassette to the 
Lshon orientation.    
After eight days of OHT treatment, the converted Lshon/on MEFs were maintained in culture 
for a period of four weeks without renewal of OHT treatment. Surprisingly, LSH protein levels 
in these long-term experiments decreased after four weeks to levels similar to the non-treated 
samples (Figure 4.10 A). When genomic DNA extracted from this experiment was used to 
analyse the cassette orientation during this period we observed that the intensity of the Lshon 
band in the agarose gel decreases as the number of weeks during which the cells were 
cultured increases (Figure 4.10 B). This decrease of the Lshon cassette is accompanied by an 
increase of the Lshoff cassette. Since the Lshon cassette cannot be converted back to Lshoff 
orientation, we hypothesized that the small percentage of non-converted cells after treating 
with OHT (about 10-20% of the cells) could be outgrowing the Lshon/on converted MEFs. This 
could explain the decrease in the LSH protein levels after four weeks. A second hypothesis 
could be that the Lshon/on MEFs are suddenly dying while the Lshoff/off MEFs survive and 
outgrow them. However, there was no visual difference in the number of dead cells between 
the OHT-treated and non-treated plates so this explanation was discarded. To confirm this, I 
carried out growth rate measurement to determine the population doubling time of each cell 
population, the non-treated MEFs and the OHT-treated cells. I tried to study the doubling time 
of the Lshoff/off and Lshon/on MEFs, but it was not possible to select for the Lshon/on cells, so I 
ended up with a mixed cell population and could not determine whether the non-converted 
cells were outgrowing the Lshon/on MEFs. OHT was not added to the medium during the period 
of four weeks when the cells were maintained in culture. Continuous and/or discontinuous 
treatment with OHT during this period could solve the problem of the non-converted cells 
outgrowing the converted population. Therefore the cells converted to the Lshon orientation 
after eight days of OHT treatment were cultured for four weeks either with or without OHT 
renewal. The position of the cassette after four weeks with the different OHT treatments was 
analysed by PCR. However, maintaining the cells for a longer period under OHT treatment did 
not change the outcome. Both, continuous and discontinuous treatment with OHT resulted in 
expansion of Lshoff/off MEF population after four weeks of treatment (Figure 4.10 C). By the 
third week maintaining the cells, the LSH protein was not detectable anymore by Western blot 
(Figure 4.10 D). Nevertheless, discontinuous treatment with OHT kept a higher expression of 
the protein after two weeks (Figure 4.10 D). The only possible explanation at this point, is that 
the initially non-converted MEFs (10-20%), which are either resistant to OHT treatment or may 
have acquired a mutation that prevents conversion of the cassette, outgrow the converted 
Lshon/on MEFs even under continuous OHT treatment.  




           
           
 
Figure 4.10. LSH protein levels are restored to wild-type after tamoxifen treatment but there is loss of 
the protein over a period of four weeks while the Lshoff/off cells outgrow Lshon/on MEFs.    
A) Western blot showing LSH protein levels after OHT treatment in Lshoff homozygous cell line. Protein levels 
are shown for the negative control samples, no OHT treatment, and at 8 days of OHT treatment. 8d + 4weeks, 
represents a triplicate of the 8 day OHT treated cells that were cultured longer, for a period of four extra weeks, 
without renewal of OHT treatment. Lsh+/+ shows a triplicate of the protein levels from a wild-type MEF cell line. 
HDAC1 nuclear protein was used as a loading control. B) PCR analyses performed on genomic DNA monitor 
the conversion of Lshoff allele to Lshon during the 8 days of OHT treatment. The conversion efficiency was 
analysed using a cell line homozygous for the Lshoff allele. The non-treated and 8 day OHT-treated cells were 
cultured longer, for a period of four extra weeks, without renewal of OHT treatment. Samples were collected 
each week to analyse the presence of the converted cassette. The lower 500 bp band in the gel is the Lshon 
amplification product while the higher 750 bp band is the Lshoff amplification product. C) PCR analyses 
performed on genomic DNA monitor the conversion from Lshoff allele to Lshon after 8 days of OHT treatment 
compared to non-treated cells. The 8 day OHT treated cells were cultured longer, for a period of four extra 
weeks, without renewal of OHT (-), with discontinuous renewal of OHT (+/-) and with continuous OHT treatment 
(+). Samples were collected each week to analyse the presence of the converted cassette under the different 
conditions of OHT treatment. D) Western blot showing LSH protein levels after OHT treatment in Lshoff 
homozygous cell line. Protein levels are shown for the negative control samples, no OHT treatment, and at 8 
days of OHT treatment. The 8 day OHT treated cells were cultured for four extra weeks without renewal of 
OHT (-), with discontinuous renewal of OHT (+/-) and with continuous OHT treatment (+). Samples were 
collected each week to analyse the protein levels after the different conditions. Lsh+/+ shows a duplicate of the 




Another issue became apparent when the Lshoff/off MEFs were treated again with OHT to 
reproduce the conversion of the cassette. The conversion obtained after eight days of OHT 
treatment was not as efficient as in earlier experiments. We observed that only about 50% of 
the cassette was converted to the Lshon band (Figure 4.11 A). The initial conversion rate 
obtained in the first experiments was about 90%. To try solving the issue, the concentration of 
OHT was increased to 780 nM and a new batch of OHT was purchased to avoid stability 
problems. Disappointingly, the initial conversion rate could not be reproduce anymore (Figure 
4.11 B). To confirm that there was a problem with the conversion and not with the PCR 
detecting the cassette orientation, Western blots were performed to detect LSH protein levels. 
The protein levels obtained after eight days of OHT treatment were lower than the levels from 
the wild-type cells and the converted Lshon/on MEFs in the initial experiments (Figure 4.11C).  
 
 
                     
 
Figure 4.11. The conversion of Lshoff to Lshon allele and LSH expression are not reproducible in 
immortalised MEFs. 
PCR analyses of gDNA extracted from Lshoff/off MEFs at different time points during the eight days of OHT 
treatment. Negative control sample without OHT treatment (-) is also shown. The cells were treated with OHT 
at final concentration of 600 nM (A) and 780 nM (B). The 500 bp band is the Lshon amplification product while 
the higher 750 bp band is the Lshoff amplification product. C) Western blot showing LSH protein levels from the 
treatment experiment using 780 nM concentration of OHT. Protein levels are shown for all time points and 8 
days of OHT treatment samples from the previous experiments are used as positive controls. Lsh+/+ shows the 
protein level in a wild-type MEF cell line. HDAC1 nuclear protein used as a loading control.  
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The capacity to select for the Lshon/on MEFs would have been very useful even with a very 
low rate of conversion, since it would avoid having a mixed population of cells in the 
experiments and would solve the issue of the unconverted cells outgrowing the Lshon/on MEFs. 
Therefore I designed a cassette containing a puromycin resistance gene in the antisense 
orientation flanked by the recombinase target sites loxP and lox511 (heterotypic target 
sequences for the Cre-recombinase). This design was similar to the design of the GFPneo 
cassette. The cassette was cloned into a pMSCV hygromycin vector, lentivirus containing the 
vector were generated and the Lshoff/off MEFs were transduced. Ideally, when treating the cells 
with OHT to convert from Lshoff to the Lshon orientation, the puromycin cassette should also 
be converted to the right orientation, producing resistance to puromycin in the same cells that 
have converted the GFPneo cassette. The Lshon/on MEFs could now be selected by treating 
the cells with puromycin (see diagram in Figure 4.12 A). I designed different pairs of primers 
to detect the conversion of the puromycin cassette by PCR, but none of the pairs could be 
optimised. In order to test if the puromycin cassette was working, the Lshoff/off MEFs were 
treated again with OHT for a period of eight days and then the cells were treated with 
puromycin to select for the Lshon/on MEFs. This approach was assuming that both cassettes 
were converted in the same cells. However, the cells did not survive the puromycin treatment. 
To test whether the cassettes were converted, I analysed the conversion of the GFPneo 
cassette of two independent experiments after eight days of OHT treatment (Figure 4.12 B). 
The efficiency of conversion to the Lshon orientation was very low. Probably, the efficiency of 
conversion for the puromycin cassette was similar, explaining why the cells were not resistant 
to puromycin treatment. To increase the conversion of both cassettes, a new vector containing 
a more efficient inducible Cre-recombinase, Cre-ERT2, was generated. Cre-ERT2 contains a 
triple mutation of the ligand-binding domain of the estrogen receptor (ER) to decrease the 
nuclear translocation in the absence of the inducer tamoxifen, while increasing the sensitivity 
to tamoxifen and the recombination efficiency (Indra et al., 1999). The vector containing Cre-
ERT2 was introduced into the Lshoff/off MEFs by lentiviral transduction. This newly generated 
cell line was used to repeat the OHT treatment for eight days. The efficiency of conversion 
with the new Cre-ERT2 was very high, producing similar results to the initial OHT treatments 
(Figure 4.12 C). This high efficiency of cassette conversion combined with the possibility to 
select for the converted cells with puromycin could be the solution to the issue of non-
converted cells outgrowing the Lshon/on MEFs. Cre-ERT2 was cloned into a pMSCV hygromycin 
vector, lentivirus were generated and the Lshoff/off MEFs were transduced with lentivirus 
containing Cre-ERT2 and the puromycin cassette. The newly generated cell line was then 
treated with OHT for eight days and then puromycin treatment was applied to select for the 
Lshon/on MEFs (Figure 4.12 D). However, the cells again did not survive the puromycin 
treatment. There must had been a problem in the design of the puromycin cassette that 
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impaired the appropriate expression of puromycin and thus could explain why the converted 
cells did not survive the antibiotic selection treatment.   
 
 
   
 
    
 
 
Figure 4.12. Selection of Lshon/on MEFs by puromycin treatment and the use of Cre-ERT2.  
A) Schematic diagram of the GFPneo and PuroLox cassettes to select for Lshon/on MEFs after eight days of 
OHT treatment. B) PCR analyses of gDNA extracted from Lshoff/off PuroLox MEFs after eight days of OHT 
treatment. Samples are from cells treated for eight days with OHT in two independent experiments. Negative 
control sample without OHT treatment (-). The 500 bp band is the Lshon PCR amplification product while the 
750 bp band is the Lshoff amplification product. C) PCR analyses of gDNA extracted from Lshoff/off Cre-ERT2 
MEFs at different time points during the eight days of OHT treatment. Negative control sample without OHT 
treatment (-) is also shown. The 500 bp band is the Lshon PCR amplification product while the 750 bp band is 
the Lshoff amplification product. D) Schematic diagram showing the approach to select the Lshon/on MEFs with 
puromycin after tamoxifen treatment of Lshoff/off cells transduced with lentivirus containing Cre-ERT2 and 
PuroLox cassette.     
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To understand why the efficiency of conversion was becoming lower in the immortalised 
Lshoff/off MEFs, the same cell line with increasing passage numbers was treated with OHT for 
seven days. Surprisingly, I found that cells with higher passage numbers showed decrease in 
the efficiency of conversion (Figure 4.13 A). There was an almost complete conversion to 
Lshon at passage 3 after seven days of tamoxifen treatment. This efficiency decreased at 
passage 11 and was even lower at passage 23. The use of primary cell lines would circumvent 
the problems with cassette conversion, although it would require more embryo dissections to 
be able to obtain enough material to carry out further experiments. Primary MEF cell lines 
were treated with tamoxifen to test the reproducibility of the conversion of the cassette and 
samples were collected after seven, ten and fourteen days of treatment. The conversion of 
the cassette was almost complete after seven days, and this conversion was stably maintained 
over the fourteen days of treatment (Figure 4.13 B). However, LSH protein levels were not 
detectable by Western blot in any of the collected samples, not even in the Lsh+/+ pMEFs 
(Figure 4.13 C). The Lsh+/+ pMEFs had been maintained in culture without OHT treatment for 
the same period to be collected together with the treated Lshoff/off pMEFs. The cells were not 
dividing when these samples were collected, since primary MEFs stop proliferating after a few 
passages in culture when they enter replicative senescence. Previous studies have shown 
that the expression of LSH is proliferation-associated (Raabe et al., 2001), since LSH is highly 
expressed in proliferating tissues such as thymus and testis (Jarvis et al., 1996; D. W. Lee et 
al., 2000). Moreover, E2F1 has been shown to play a crucial role in transcriptional control of 
the Lsh gene. The decrease in E2F1 expression during senescence leads to lower expression 
of LSH (Niu et al., 2011). This association with proliferation explains why LSH is undetectable 




                   
                       
 
Since the conversion of the GFPneo cassette works better in early passage cells, a new 
approach to immortalise cells quickly after derivation was used. The 3T3 immortalization 
protocol that I used initially, requires up to four months to immortalise the cell lines. A quicker 
and less variable method to immortalise primary cells consist on lentiviral transduction of cells 
with virus containing the Large T antigen (LTag) of SV40 which inactivates p53 transcription 
factor (Sharpless, 2006). Retrovirus containing pBabe Large T antigen vector were kindly 
provided by Sara Buonomo and used to immortalise primary Lshoff/off and Lsh+/+ MEFs. The 
OHT treatment was repeated using these new immortalised cell lines, and gDNA and protein 
Figure 4.13. Lshoff to Lshon conversion works efficiently in primary MEFs but LSH is not express in non-
proliferating cells. 
A) PCR analyses of gDNA extracted from Lshoff/off MEFs after seven days of OHT treatment carried out with 
the same cell line at different passage numbers. Negative control sample without OHT treatment (-). Lshoff/on 
and Lshon/on controls are shown. The 500 bp band is the Lshon PCR amplification product and the 750 bp band 
is the Lshoff amplification product. B) PCR analyses of gDNA extracted from Lshoff/off primary MEFs after 
different days of OHT treatment. Negative control sample without OHT treatment (-). Lsh+/+, Lshoff/off and Lshon/on 
controls are shown. The 500 bp band is the Lshon PCR amplification product and the 750 bp band is the Lshoff 
amplification product. C) Western blot detecting LSH protein levels from the OHT treatment experiment using 
primary Lshoff/off MEFs. Non-treated samples (-). Protein levels are shown for all time points and Lsh+/+ samples 
at the beginning (0d) and end (14d) of the experiment are used as positive controls. HDAC1 nuclear protein 




samples were collected at different time points to analyse the conversion of the cassette and 
the expression of LSH protein. After seven days of OHT treatment, most of the cassette was 
converted to Lshon orientation and this conversion was stably maintained over the fourteen 
days of treatment (Figure 4.14 A). The LSH protein was also detectable by Western blot after 
seven days of treatment and the expression became higher after ten days of treatment, 
reaching similar levels of expression to that in Lsh+/+ MEFs (Figure 4.14 B). However, when 
the OHT treated cells where maintained in culture over fourteen days, with or without 
continuous OHT treatment, the non-converted cells started outgrowing the Lshon/on MEFs (data 
not shown). To maintain the cells with the allele converted to Lshon orientation during the 
fourteen days period, heat inactivated foetal bovine serum was used since Lshon/on MEFs 
seemed to proliferate better when the medium was supplemented with this serum. The gain 
of expression for LSH-dependent loci and loss of DNA methylation at their promoters was 
analysed for the Lshoff/off LTag immortalised MEFs (data not shown). The misregulation of both, 
appropriate gene silencing and DNA methylation, was similar to the changes observed in 
spontaneous immortalised Lshoff/off MEFs, validating the use of these cell lines for future 
experiments.  
 
                          
Figure 4.14. Lshoff to Lshon conversion works efficiently in Large T antigen (LT-ag) immortalised MEFs 
and LSH is expressed at wild-type levels. 
A) PCR analyses of gDNA extracted from Lshoff/off LTag immortalised MEFs after seven, ten and fourteen days 
of OHT treatment. Negative control sample without OHT treatment (-). Lsh+/+, Lshoff/off and Lshon/on controls are 
shown. The Lshon and Lshoff amplification products are indicated. C) Western blot showing LSH protein levels 
in the OHT treated Lshoff/off LTag MEFs. Non-treated samples (-). Protein levels are shown for all time points 




In summary, seven days of OHT treatment is sufficient to convert the Lshoff allele to Lshon 
in SV40 Large T antigen immortalised MEFs. After the conversion of the cassette, the LSH 
expression is detectable in proliferating Lshon/on MEFs and comparable to endogenous wild-
type expression levels. The Lshon/on MEFs population and the expression of LSH protein are 
stably maintained for up to fourteen days of treatment. This time frame might be sufficient to 
determine the time required for acquisition of gene silencing and DNA methylation when LSH 
is reintroduced into the Lsh knockout MEFs and follow the order of events leading to gene 
silencing.   
 
4.7 Discussion 
The characterization of the Lshoff/off MEFs shown in this chapter is in agreement with 
previous studies demonstrating that LSH deficiency affects the expression and DNA 
methylation at promoters of specific single-copy protein coding genes (Myant et al., 2011; Tao 
et al., 2011; Xi et al., 2007) and repetitive elements (Dennis et al., 2001; Huang et al., 2004). 
However, the gain of expression observed at Lshoff/off MEFs is not the same for all LSH-
dependent loci in study. Rhox genes gain expression and lose DNA methylation from their 
promoters in the absence of LSH, demonstrating that LSH contributes to their silent state. 
Pluripotency genes are silenced upon differentiation of stem cells, but they are highly 
expressed in Lshoff/off cells, as well as the imprinted Peg3 gene. The Hox genes are not that 
highly expressed, showing gain of transcription similar to Gm9 and another imprinted gene 
Peg12. The promoters of LSH-dependent genes lose DNA methylation by at least 55% in 
Lshoff/off MEFs compared to Lsh+/+ MEFs. The overall loss of methylation at IAPs is 40%, 
including some sequences which are completely unmethylated and some sequences that 
barely show loss of DNA methylation, which might be explained by some of the IAP 
retrotransposons gaining expression while others remained silenced in Lshoff/off MEFs, as 
mentioned earlier. Importantly, a higher loss of DNA methylation is not always accompanied 
by gain of gene expression. Other factors besides LSH, such as transcription factors which 
may not be present in MEFs, could also play an important role in gene expression. Moreover, 
restoration of LSH expression in Lsh knockout cells is not sufficient to control the expression 
of all misregulated genes since additional exogenous signals are required for silencing of 
development and pluripotency associated genes (Termanis et al., 2016). The difference in the 
loss of DNA methylation at IAPs observed between primary cells and immortalised cells was 
similar in Lshoff/off and Lsh+/+ MEFs. This could indicate that the variation in methylation 
between cells at passage 4 and passage 17-18 is due to secondary effects of the 
immortalization process since the cells need to escape senescence. Culture of primary cells 
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is limited to a certain number of cell divisions before the cells enter replicative senescence, 
which happens around passage 5 in the primary MEFs used in this study. Many studies have 
shown that replicative senescence is associated with changes in DNA methylation at specific 
CpG dinucleotides and the levels of DNA methylation can either increase or decrease over 
subsequent passages (Bork et al., 2010; Koch et al., 2013), although DNA hypomethylation is 
more common (Cruickshanks et al., 2013). Also, these changes in methylation appear to be 
acquired stochastically (Franzen et al., 2017). The percentage of DNA methylation at 
passages 17-18 is very similar to the methylation at passage 24-25 for both Lshoff/off and Lsh+/+ 
cells, indicating that the loss of methylation observed from passage 4 to passage 17-18 is not 
related to higher passage numbers, but to the primary cells entering replicative senescence. 
This suggests that LSH might not play a role in maintaining DNA methylation. Many studies 
have shown the role of LSH in the establishment of DNA methylation but a role in the 
maintenance of DNA methylation has not been clearly determined yet (Briones & Muegge, 
2012). However, some in vivo data (unpublished) generated in the lab suggests that LSH 
might support maintenance as well as de novo DNA methylation. More loci should be analysed 
including single copy genes and other experiments should be carried out in order to clarify 
whether LSH has a role in the maintenance of DNA methylation. The best experiment to 
analyse this would have been to convert the allele in Lshon/on cells to the Lshoff orientation and 
study whether the normal patterns of DNA methylation characteristic of wild-type cells are lost 
in the absence of LSH. This would prove that LSH has a role in the maintenance of DNA 
methylation. I tried to perform this experiment but different issues arose and the conversion 
could not be optimised.  
The conditionally reversible Lsh knockout cellular system seemed to be producing an 
efficient conversion of the Lshoff allele to Lshon orientation, as expected, and resulted in 
appropriate expression of LSH protein with levels similar to those in wild-type cells. However, 
several issues arose when the converted cells were grown for longer periods of time in culture. 
The design of the cassette includes GFP and neomycin resistance as a positive selection for 
the Lshoff/off MEFs, but it is a lacking a selection for the converted Lshon allele. This lack of 
selection for the converted cells would not have been a problem if the Lshoff/off cells were not 
outgrowing the Lshon/on cells in the mixed population in a short period of time. Also, GFP could 
have been used to indirectly select for the Lshon/on cells by cell sorting, but unluckily it is not 
fluorescent when directly coupled with neomycin. The doubling time of the Lshoff/off and Lshon/on 
cells could not be compared since the only way to select for the Lshoff/off MEFs with geneticin 
treatment would have removed the converted cells from the population. However, that is the 
only possible explanation for the increase in the Lshoff allele and decrease in the converted 
allele when the cells are maintained in culture after the initial conversion to the Lshon 
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orientation. We also know from the previous rescue cell lines generated in the lab (Lsh-/- LSH 
MEFs) that Lsh knockout cells tend to become more sensitive and slow down their proliferation 
rate when LSH is re-introduced. This could explain why the Lshoff/off cells outgrow the converted 
cells after they start expressing LSH. Moreover, when the cells were treated with geneticin, a 
lower number of colonies was detected in the non-geneticin control dish for the OHT treated 
cells compared to the non-OHT treated cells. This result reinforces the idea of a lower 
proliferation rate of the Lshon/on cells. The other issue concerned the decrease in the efficiency 
of conversion of the allele with higher passage numbers in the immortalised Lshoff/off MEFs. A 
recent study has shown that MCF7 cells began to lose their sensitivity to tamoxifen from the 
second passage. This is due to a decrease of drug influx via overexpression of the drug efflux 
transporters (Krisnamurti, Louisa, Anggraeni, & Wanandi, 2016). Interestingly, the Lshoff/off 
MEFs became resistant to tamoxifen without previous contact with the drug. Intrinsic 
resistance to tamoxifen could be acquired in the immortalised Lshoff/off MEFs, even without 
previous contact with tamoxifen (Saxena, Stephens, Pathak, & Rangarajan, 2011; Xia & 
Smith, 2012), but it is more likely that the ER-Cre virus is being silenced in the cells. The 
immortalisation of Lshoff/off MEFs using the retrovirus containing Large T antigen managed to 
circumvent the issue of the acquired resistance to tamoxifen. There is a higher percentage of 
cells with the allele in the Lshon orientation until day fourteen of OHT treatment in Large T 
antigen immortalised cells. After this day the non-converted cells expand and outgrow the 
Lshon/on population, generating a time frame of fourteen days to study the changes in chromatin 
produced by LSH that lead to epigenetic gene silencing and establishment of DNA 
methylation.         
Several hypothesis exist for the function of LSH at repetitive genomic regions as well as 
developmentally-programed genes. One hypothesis for the role of LSH in DNA methylation is 
that LSH induces localised accumulation and association of chromatin modification factors 
after binding to a target site in the genome. LSH could play a role as a recruiting factor for 
DNMTs and HDACs to establish transcriptionally repressive chromatin. DNA methylation 
could be involved in either initiating or stabilizing any repressive chromatin state established 
at LSH targeted regions (Myant & Stancheva, 2008). Accordingly, studies analysing LSH 
involvement in pericentromeric heterochromatin formation showed association of LSH with 
repressive epigenetic regulators. LSH can for example associate with HP1, a heterochromatin 
regulator, (Yan, Cho et al. 2003) and this association could involve recruitment of DNMT3A or 
DNMT3B to the LSH target loci in the genome to promote DNA methylation (Zhu et al., 2006). 
Moreover, recent studies have shown that the role of LSH in the establishment of DNA 
methylation requires its ATPase activity (Ren et al., 2015; Termanis et al., 2016), suggesting 
a chromatin remodelling activity in addition to its role as an scaffolding protein (Myant & 
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Stancheva, 2008). As mentioned earlier, different nucleosome occupancy at repetitive 
elements has been shown in knockout ES cells when compared to wild-type ES cells after 
differentiation. This loss of nucleosome occupancy was restored to wild-type levels when wild-
type LSH was re-expressed in the knockout cells but not in the ATP mutant LSH (Ren et al., 
2015). Accordingly, it was suggested that the primary function of LSH was ATP-dependent 
nucleosome remodelling, which may promote de novo methylation in differentiating embryonic 
stem cells. In contrary to these studies, the nucleosome occupancy assay, NOMe assay, 
performed using chromatin from Lshoff/off and Lsh+/+ MEFs did not detect a difference in 
nucleosome occupancy at the promoters of Rhox genes. The use of the conditionally 
reversible Lsh knockout system will allow to study whether LSH restoration involves 
nucleosome remodelling that promotes establishment of DNA methylation and whether this 
occurs at all LSH-dependent loci or only repetitive elements, as shown before (Ren et al., 
2015). Moreover, re-expression of wild-type LSH in somatic knockout cells re-establishes DNA 
methylation and silencing of misregulated genes in a cell autonomous manner (Termanis et 
al., 2016). It would be interesting to know whether the previously suggested difference in 
nucleosome occupancy can also be rescued by LSH in non-differentiating cells. While other 
proteins from the SNF2-like subfamily have nucleosome remodelling activity (Hoffmeister et 
al., 2017; Oppikofer et al., 2017; Stockdale, Flaus, Ferreira, & Owen-hughes, 2006), ATP-
dependent nucleosome remodelling activity by LSH had never been proven in vitro until a 
recent publication has demonstrated that LSH is part of a bipartite nucleosome remodelling 
complex. LSH alone cannot remodel nucleosomes, but the complex that LSH forms with 
CDCA7 possesses nucleosome remodelling activity. Furthermore, they show that CDCA7 is 
essential for binding of LSH to chromatin in cells (Jenness et al., 2018). Mutations in CDCA7, 
LSH, or DNMT3B cause immunodeficiency–centromeric instability–facial anomalies (ICF) 
syndrome (Thijssen et al., 2015). ICF syndrome is thought to be caused by defective DNA 
methylation although the molecular basis of the syndrome is unknown (G.-L. Xu et al., 1999). 
Importantly, the study concerning the LSH-CDCA7 complex also mentions that DNMT3A or 
DNMT3B were not detected on chromatin, suggesting a role for the nucleosome remodelling 
complex prior to and perhaps beyond DNA methylation.  
To summarise, the results described and discussed in this chapter confirm that our 
conditionally reversible Lsh knockout cellular system is suitable for further experiments. This 
conditional knockout will allow us to re-express LSH in the Lshoff/off MEFs and study the time 
required for establishment of gene silencing and DNA methylation at LSH-dependent loci. 
Once this is determined, the understanding of the order of events and changes in chromatin 
modifications leading to gene silencing, will help to gain some insight into the specific role of 
LSH. The study of LSH-dependent mechanisms in gene silencing will be the aim of chapter 5.  
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Chapter 5 - Mechanism of LSH dependent gene silencing 
 
5.1 Introduction 
The previous chapter validated the conditionally reversible Lsh knockout cellular system, 
making it suitable for further experiments. This conditional knockout allows us to re-express 
LSH in a controlled manner in the Lshoff/off MEFs and study the time required for acquisition of 
gene silencing and DNA methylation at LSH-dependent loci. Once the time required to rescue 
gene silencing in this Lsh knockout system is determined, the understanding of the order of 
events and changes in chromatin modifications leading to this silencing will help to gain further 
insight into the specific role of LSH. 
Previous work carried out in the lab has shown that specific genes misregulated in Lsh-/- 
MEFs can be silenced and DNA methylation restored at their promoters when the wild-type 
LSH, but not the catalytically inactive mutant LSH, is introduced into these cells. LSH was able 
to silence genes that are marked at their promoter regions by active histone modifications 
such as H3K4me3 and H3Ac, and this silencing was accompanied by loss of the active 
chromatin marks. Importantly, LSH-dependent gene silencing occurred in somatic cells, in the 
absence of differentiation signals, suggesting that LSH functions in a cell autonomous manner 
(Termanis et al., 2016). It is not yet understood whether the changes in active histone marks 
are a secondary effect of the gene silencing or directly caused by the restoration of LSH 
expression in these cells. Other alterations in histone modifications have been reported in the 
absence of LSH, such as an increase of the histone modification H3K27me3 at promoter 
regions, suggesting potential redundancy of epigenetic silencing mechanisms (Yu et al., 
2014). Moreover, LTR retrotransposons were shown to gain H3K4me3 in Lsh knockout cells 
and lose H3K9me3 at misregulated IAPs (Dunican et al., 2013). Interestingly, in reporter-
based assays an indirect interaction of LSH with histone deacetylases (HDACs) via DNMT3B 
was shown to be necessary for LSH-dependent transcriptional repression, but this repression 
did not involve de novo DNA methylation (Myant & Stancheva, 2008). Another study has 
shown that the LSH-dependent repression of retrotransposons, such as IAPs, does not require 
the function of DNMT3B (Dunican et al., 2013). However, it has been suggested in many 
publications that the main role of LSH in epigenetic gene silencing is to facilitate DNA 
methylation by DNMT3B, and that chromatin remodelling by LSH is necessary for this function 
in DNA methylation (Ren et al., 2015). Accordingly, the homolog DDM1 in Arabidopsis thaliana 
promotes nucleosome repositioning in an ATP-dependent manner (Brzeski & Jerzmanowski, 
2003) and is required for gene silencing and normal patterns of DNA methylation (J. Jeddeloh 
& Bender, 1998). The ATPase chromatin remodeling activity of LSH has been suggested 
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many times and a recent publication has shown that LSH, together with CDCA7, forms part of 
a nucleosome remodeling complex (Jenness et al., 2018).  
In summary, the mechanism of LSH-dependent gene silencing is yet unclear. The use of 
the conditionally reversible Lsh knockout system allows the changes in chromatin 
modifications leading to gene silencing to be examined in more detail. Therefore such studies 
will help to determine the order of events leading to gene silencing after restoration of LSH 
expression and gain clearer insights into the role of LSH in epigenetic gene silencing. 
 
5.2 LSH expression leads to silencing of misregulated genes in Lshoff/off MEFs 
 As mentioned earlier, when wild-type LSH is re-expressed in Lsh knockout MEFs, the 
gain of transcription of specific protein coding genes and repetitive elements in the absence 
of LSH can be rescued to the initial silenced state in a cell autonomous manner (Termanis et 
al., 2016). The Lshoff/off MEFs used in this study also show gain of expression at specific genes 
and repetitive elements as shown in the previous chapter. To determine whether re-expression 
of LSH in Lshoff/off MEFs can also rescue the silenced state of these misregulated genes, 
Lshoff/off cells were treated with OHT and gene expression analysed by qRT-PCR. Specific 
protein coding genes including Gm9, Rhox2, Rhox6 and Tnfsf9 were studied, as well as IAP 
retrotransposons. Gm9, Rhox2 and Rhox6 genes were chosen from all the LSH-dependent 
loci since we knew that they were re-silenced when LSH was reintroduced in Lsh knockout 
MEFs. Tnfsf9 was chosen because LSH re-expression in knockout cells did not rescue DNA 
methylation at Tnfsf9 promoter but we were not aware of its expression state in these cells. It 
was interesting to know whether the gain of expression of Tnfsf9 was re-silenced after LSH 
expression even though DNA methylation was not rescued at its promoter. 
 The Lshoff/off MEFs were treated with OHT and samples collected after LSH re-expression 
(see Figure 4.14), at day seven and day fourteen of treatment, to study whether there was 
gene silencing in these cells. The protein coding genes Gm9, Rhox2 and Rhox6 showed gain 
of transcription in the absence of LSH and they were silenced after fourteen days of OHT 
treatment (Figure 5.1 A). Surprisingly, Tnfsf9 did not gain transcription in Lshoff/off cells 
compared to Lsh+/+ MEFs, and acquired higher expression after seven and fourteen days of 
OHT treatment. Interestingly, some experiments showed gain of transcription of Tnfsf9 in the 
Lshoff/off MEFs, but Tnfsf9 was never silenced after OHT treatment. The gain of expression of 
IAP retrotransposons in Lshoff/off cells was also rescued to a silent state after OHT treatment. 
LSH expression was restored to wild-type level after seven days of OHT treatment as shown 
in the previous chapter. Accordingly, at day seven of OHT treatment there was a detectable 
decrease in the expression of all examined loci that are susceptible to re-silencing in the 
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presence of LSH, except Rhox6, which showed a transient increase in the expression. At day 
fourteen of OHT treatment all these loci were silenced although they showed different degrees 
of downregulation. It is important to mention that there was a lot variation between experiments 
since the non-converted Lshoff/off cells were outgrowing at different rates the Lshon/on MEFs. 
This caused big differences in the gene expression after OHT treatment, depending on the 
number of cells with the allele in the non-converted or converted Lshon orientation. The same 
experiment was performed, but the cells were treated with DMSO as a control. This control 
was done to confirm that silencing of misregulated genes in Lshoff/off MEFs was caused by the 
conversion of the allele to Lshon orientation and LSH expression upon OHT treatment, and 
was not a secondary effect of the treatment or DMSO used as a solvent. The control 
experiment demonstrated that DMSO treatment did not cause silencing of any of the loci in 
study (Figure 5.1 B). In conclusion, LSH expression after OHT treatment of Lshoff/off MEFs 
leads to silencing of misregulated genes such as Gm9, Rhox2, Rhox6, and IAP 






Figure 5.1. LSH expression after OHT treatment leads to silencing of misregulated genes in Lshoff/off 
MEFs. 
Expression of IAP retrotransposons and LSH-dependent genes in Lsh+/+ MEFs, Lshoff/off MEFs and Lshoff/off 
MEFs after OHT (A) and DMSO (B) treatment for a period of seven and fourteen days. The graphs show the 
change in expression relative to Lshoff/off MEFs as assessed by quantitative RT-PCR. The housekeeping Gapdh 
gene was used for normalisation. The error bars represent the standard deviation.       
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5.3  Silencing of LSH-dependent genes occurs without gain of DNA methylation 
 Specific genes and repetitive elements that are misregulated in Lsh-/- MEFs, also lose 
DNA methylation from their promoters (Myant et al., 2011). We have shown in the previous 
chapter that the misregulation of LSH-dependent loci in Lshoff/off MEFs is also accompanied by 
loss of DNA methylation (see Figure 4.4). The previous section of this chapter has 
demonstrated that LSH re-expression in Lshoff/off MEFs can silence these loci. Since LSH can 
restore DNA methylation when expressed in long-term in the null MEFs (Termanis et al., 
2016), I next examined whether or not DNA methylation was re-established simultaneously 
with gene silencing. I also wanted to determine the time required to restore DNA methylation 
at the promoters of protein coding genes and IAP retrotransposons in Lshoff/off MEFs, to better 
understand the order of events leading to gene silencing after OHT treatment.   
 Lshoff/off MEFs were treated with OHT and samples collected after LSH is expressed to 
determine whether DNA methylation was rescued simultaneously with or after gene silencing. 
As previously, the expression of Gm9 gene and IAP retrotransposons was examined at days 
seven and day fourteen of OHT treatment in Lshoff/off primary MEFs. DNA methylation at the 
promoter of Gm9 and LTR-embedded promoter of IAPs was examined at the same time 
points, day seven and fourteen, by bisulfite sequencing. As expected, the gain of expression 
observed for Gm9 gene in Lshoff/off MEFs was downregulated after seven days of OHT 
treatment and the gene was completely silenced after fourteen days (Figure 5.2 A). IAPs 
expression started to be downregulated after seven days of OHT treatment and was 
completely repressed at day fourteen (Figure 5.2 B). The silencing of both loci in primary MEFs 
at day fourteen of treatment is in agreement with the previously obtained results from 
immortalised MEFs (Figure 5.1 A). There was an overall loss of DNA methylation by 36% from 
promoter of Gm9 and 34% from LTR of IAPs in Lshoff/off MEFs compared to Lsh+/+ MEFs (Figure 
5.2 C and D, respectively). Surprisingly, the percentage of DNA methylation at the two time 
points after OHT treatment was similar to the Lshoff/off MEFs, showing no rescue of DNA 
methylation at these promoters when LSH was expressed in the cells and genes silenced 
(Figure 5.2). DNA methylation at the promoter of Gm9 decreased after seven days of 
treatment and then slightly increased at day fourteen compared to Lshoff/off MEFs (Figure 5.2 
C). On the contrary, DNA methylation at IAPs decreased after fourteen days of treatment 
compared to Lshoff/off cells (Figure 5.2 D). However, the variation in the percentages of DNA 
methylation was small and could be due to the limited number of sequenced clones for each 
time point. Taken together, these results show that LSH-dependent loci are silenced after 
fourteen days of OHT treatment and this happens without significant gain of DNA methylation 











Figure 5.2. Silencing of Gm9 and IAPs upon LSH restoration occurs without rescue of DNA methylation 
at their promoters in primary MEFs. 
Expression of Gm9 (A) and IAPs (B) in Lsh+/+ MEFs, Lshoff/off MEFs and Lshoff/off MEFs after OHT treatment for 
a period of seven and fourteen days. The graphs show the change in expression relative to Lshoff/off MEFs as 
assessed by quantitative RT-PCR. The housekeeping Gapdh gene was used for normalisation. The error bars 
represent the standard error of the mean calculated from three technical replicates. Sodium bisulfite DNA 
sequencing for Gm9 (C) and IAPs (D) promoters in Lsh+/+ MEFs, Lshoff/off MEFs and Lshoff/off MEFs after OHT 
treatment. Each row in the diagrams represents a single DNA strand and methylated CpGs are shown as black 
circles. The percentage of methylation is indicated below the diagrams.  
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 This analysis was done in primary MEFs, but since we observed differences in DNA 
methylation between primary and immortalised cells, I wanted to determine whether there was 
a difference in the rescue of DNA methylation in immortalised cells undergoing OHT treatment 
and gene silencing. DNA methylation at LTR-embedded promoter of IAPs was analysed by 
bisulfite sequencing using gDNA from LTag immortalised MEFs. There was an overall 62% 
loss of DNA methylation in Lshoff/off MEFs compared to Lsh+/+ MEFs (Figure 5.3). The loss of 
DNA methylation was higher than the 34% observed in primary cells (Figure 5.2 D), which was 
in agreement with the observation mentioned in chapter 4. The DNA methylation at IAPs at 
day fourteen of OHT treatment was 50% in LTag immortalised MEFs (Figure 5.3). This result 
indicated a mild increase in the methylation after OHT treatment at immortalised cells although 
the overall percentage of DNA methylation was similar to the 56% value obtained for primary 
MEFs. This increase in DNA methylation was similar to the increase observed at Gm9 
promoter in primary MEFs and could be also due to the limited number of sequenced clones. 
There was still a 46% difference in DNA methylation at IAPs between Lsh+/+ cells and fourteen 
days OHT-treated MEFs, which was similar to previous values obtained for Lsh knockout cells.  
 
                                   
 
 In conclusion, silencing of LSH-dependent loci after OHT treatment occurs without rescue 
of DNA methylation at their promoters in primary and immortalised MEFs. Therefore this 
indicates that promoting DNA methylation might not be the primary function of LSH in 
epigenetic gene-silencing as previously hypothesized.  
   
Figure 5.3. There is no rescue of DNA methylation at IAPs upon LSH restoration in LTag immortalised 
MEFs. 
Sodium bisulfite DNA sequencing for IAPs (5’ LTR) in Lsh+/+ MEFs, Lshoff/off MEFs and Lshoff/off MEFs after 
fourteen days of OHT treatment. Each row in the diagrams represents a single DNA strand and methylated 




5.4    LSH expression leads to changes in histone modifications and histone density 
 Previously we have shown that histone modifications, such as H3K4me3 and H3Ac, 
associated with active transcription and found at genes that are misregulated in Lsh knockout 
cells are loss when LSH is reintroduced in these cells and genes re-silenced. This re-silencing 
of misregulated genes is accompanied by gain of DNA methylation at the promoters of the 
genes (Termanis et al., 2016) upon sustained expression of LSH. Surprisingly, when Lshoff/off 
MEFs are treated with OHT and LSH expression is restored in these cells, there is silencing 
of LSH-dependent loci after fourteen days of treatment but not gain of DNA methylation during 
this period. To better understand the role of LSH in gene silencing, I analysed whether 
changes in histone modifications that may lead to silencing occur after OHT treatment. 
Moreover, other studies have shown that LSH, when re-expressed in differentiating Lsh 
knockout ES cells, can rescue normal patterns of nucleosome density at repetitive sequences 
(Ren et al., 2015). Therefore, I also analysed histone density at the promoters of misregulated 
genes after OHT treatment of the Lshoff/off cells to determine whether LSH plays a role as a 
chromatin remodeler in the conditionally reversible Lsh knockout system. 
 Before attributing the possible changes in chromatin structure and modifications to LSH, 
I first determined whether LSH localises at the loci of interest that were silenced after OHT 
treatment in Lshoff/off MEFs. Previously, the lack of appropriate commercial antibodies against 
LSH that could be used in ChIP experiments had made it difficult to study the localization of 
LSH to specific loci, but luckily a new commercially available polyclonal antibody enabled me 
to perform such ChIP experiments. As mentioned earlier, LSH was detected after treating the 
Lshoff/off MEFs for four days with OHT but its expression was not restored to wild-type level 
until day seven of OHT treatment when assessed by Western blot. ChIP experiments for LSH 
were carried out using crosslinked chromatin from Lsh+/+ MEFs, Lshoff/off MEFs and Lshoff/off 
cells treated for seven and fourteen days with tamoxifen. The amount of LSH detected in 
Lshoff/off MEFs was considered as a background signal produced by the antibody at each locus. 
The ChIP experiments showed that LSH binds at LSH-dependent loci in Lsh+/+ MEFs, which 
was somewhat unexpected given that LSH displays a very dynamic chromatin binding 
behaviour (Lungu et al., 2015). Interestingly, I detected LSH at most examined loci, including 
the control promoters of Actin and Tnfsf9 genes, after seven days of OHT treatment (Figure 
5.4 A). However, LSH was not detected at Rhox2 gene after OHT treatment. The location of 
LSH at the promoters of these loci matched the time required for the protein levels of LSH to 
be restored to wild-type levels after OHT treatment. After fourteen days of OHT treatment 
there was a loss of LSH from all examined loci with the exception of Rhox2 (Figure 5.4 A). 
This observation could be explained by the dynamic association of LSH with chromatin, as 
mentioned earlier. Once I detected LSH at the loci of interest, I examined whether or not 
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changes in histone density occur after LSH restoration in the Lshoff/off MEFs. ChIP for histone 
H3 was performed using the control cell lines and the same time points of OHT treatment in 
Lshoff/off MEFs (Figure 5.4 B). The occupancy of H3 at the promoters of Actin, Gm9 and Rhox6 
was higher in Lshoff/off cells than Lsh+/+ MEFs. However, Rhox2, Tnfsf9 and IAPs showed 
similar H3 occupancy in both cell lines. There was a general decrease in H3 occupancy after 
seven days of tamoxifen treatment at the promoters of most studied loci, which was in 
agreement with the presence of LSH at these promoters at the same time point. However, 
after fourteen days of OHT treatment the examined loci did not follow a similar trend. Some 
promoters maintained a lower histone occupancy while others showed an increase in H3 
occupancy. Moreover, there was no correlation between the loci that showed presence of LSH 
at their promoters at day fourteen of treatment and the loci maintaining a lower H3 occupancy 
at the same time point. Taken together, these results demonstrate that LSH localises to LSH-
dependent loci as well as the control loci Actin and Tnfsf9, and leads to a mild decrease in H3 
occupancy after seven days of tamoxifen treatment. However, the change in histone density 
is not maintained in all the studied loci after fourteen days of treatment.                
 
      
 
Figure 5.4. LSH localises at LSH-dependent loci and leads to a mild decrease in H3 occupancy after 7 
days of tamoxifen treatment at the promoter region of specific protein coding genes and IAPs. 
ChIP for LSH (A) and histone H3 (B) in Lsh+/+ MEFs, Lshoff/off MEFs and Lshoff/off MEFs after OHT treatment. 
Actin was used as a control since its transcriptional state is not expected to change in the cells in the study. 
Tnfsf9 was used as a negative control since it is not silenced after OHT treatment when LSH is expressed in 




     To determine whether LSH restoration in Lshoff/off MEFs, which leads to a decrease in H3 
occupancy at the promoters of LSH-dependent loci, also facilitates changes in histone 
modifications, I carried out ChIP experiments to examine H3Ac and H3K9me2 modifications. 
As expected, the Lsh+/+ cells were marked by H3Ac at the promoter of the control gene Actin 
compared to the non-expressed LSH-dependent loci where we barely observed this mark 
(Figure 5.5 A). There was enrichment for the H3Ac modification at the promoters of all the loci 
in study in Lshoff/off cells compared to Lsh+/+ MEFs. The enrichment was higher for the loci that 
gained transcription in the Lshoff/off MEFs, as expected since H3Ac mark is associated with 
active transcription. After seven days of OHT treatment there was loss of H3Ac mark from the 
promoters of LSH-dependent genes as well as the controls Actin and Tnfsf9, reaching similar 
to wild-type levels of these modifications for each locus. The loss of H3Ac mark occurred at 
simultaneously with LSH binding at these promoters and the decrease in H3 occupancy. 
However, this loss of H3Ac mark was not maintained in LSH-dependent loci at day fourteen 
of treatment, showing a mild increase that did not reach the levels in Lshoff/off MEFs. Contrary 
to this, the level of H3Ac mark at the controls Actin and Tnfsf9 was restored to the Lshoff/off 
MEFs levels (Figure 5.5 A). The expression of both control genes did not change in Lshoff/off 
MEFs and cells treated for fourteen days with OHT, which might explain the similar levels of 
H3Ac mark at their promoters. The gain of H3Ac at LSH-dependent loci at day fourteen of 
OHT treatment could be explained by the expansion of non-converted cells which at this point 




              
  
 Once I detected loss of H3Ac mark from LSH-dependent loci after seven days of OHT 
treatment, I decided to determine whether histone modification H3K9me2 has a role in LSH-
dependent gene silencing in the absence of DNA methylation. I decided to study this histone 
mark since LSH has been previously shown to cooperate with the G9a/GLP complex, that 
catalyses mono and di-methylation of H3K9, to generate normal DNA methylation patterns 
and stable gene silencing at specific promoters (Myant et al., 2011). I performed ChIP for 
H3K9me2 with the same cell lines and time points used in previous ChIP experiments. The 
level of H3K9me2 mark was similar in Lshoff/off and Lsh+/+ MEFs at all examined loci, although 
some of the specific genes and IAPs were only expressed in the knockout cells (Figure 5.5 
B). After seven days of OHT treatment there was a small increase of H3K9me2 mark at the 
promoters of the controls Actin and Tnfsf9, but not at LSH-dependent loci. Interestingly, at day 
fourteen of the treatment there was a substantial gain of H3K9me2 mark at the promoters of 
all LSH-dependent loci, including Tnfsf9 gene. However, the gain of H3K9me2 mark at day 
fourteen was higher at LSH-dependent loci than at the control genes Actin and Tnfsf9. This 
indicates that the G9a/GLP complex might be facilitating gene silencing upon LSH restoration. 
The differential H3 occupancy (Figure 5.4 B) has potential implications on the results shown 
here since the ChIP data has not been normalized to H3 occupancy. The loss of H3Ac after 
Figure 5.5. There is loss of H3Ac and gain of H3K9me2 modification at the promoters of LSH-dependent 
loci upon LSH expression after OHT treatment. 
ChIP for H3Ac modification (A) and histone H3K9me2 modification (B) in Lsh+/+ MEFs, Lshoff/off MEFs and 
Lshoff/off MEFs after seven and fourteen days of OHT treatment. Actin was used as a control since its 
transcriptional state does not change in the cells in study. Tnfsf9 was used as a negative control since it is not 
silenced after OHT treatment when expressed in Lshoff/off MEFs. The error bars represent the standard error of 
the mean calculated from two independent experiments. 
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seven days of treatment would be less obvious due to the lower occupancy of H3 at this time 
point. However, the gain of H3K9me2 mark at day fourteen of treatment would increase if the 
data was normalised to H3.      
 In conclusion, LSH localises to the promoters of LSH-dependent loci upon restoration of 
its expression following the OHT treatment, and leads to a decrease in H3 occupancy at the 
promoters of specific genes. The transcriptional silencing of these genes and repetitive 
elements is accompanied by loss of H3Ac and subsequent gain of H3K9me2 at their promoter 
region. 
 
5.5   The role of HDACs and G9a/GLP in LSH-dependent gene silencing  
Since the first changes in histone modifications observed upon restoration of LSH 
expression in the conditionally reversible Lsh knockout cells are the loss of H3Ac and 
subsequent gain of H3K9me2 at the promoters of LSH-dependent loci, I decided to investigate 
the role of HDACs and the G9a/GLP complex in LSH-dependent gene silencing. More 
specifically, I wanted to determine whether the activity of HDACs and G9a/GLP enzymes is 
required for the transcriptional repression induced by LSH. I used two drugs for this purpose, 
valproic acid (VPA) and UNC 0638 (UNC), which are potent inhibitors of HDACs and 
G9a/GLP, respectively. Valproic acid was used since it has been shown that cells tolerate 
better this drug than any other HDAC inhibitor (Gottlicher et al., 2001).  
 To clarify whether removal of H3Ac by HDACs is necessary for LSH-dependent gene 
silencing, Lshoff/off MEFs were treated with OHT to convert the cassette to the Lshon orientation 
and then VPA was added to the cell culture medium after four days of OHT treatment when 
LSH is starting to be expressed (Figure 5.6 A). Samples were collected at the beginning of the 
experiment and after seven and fourteen days of treatment. The efficiency of the HDACs 
inhibitor was assessed by Western blot using antibodies against histone H3 acetylated at K9 
and K14 and histone H4 as a control. Samples from Lshoff/off MEFs treated with OHT and UNC 
were also included in this experiment as an extra control since we were not expecting changes 
in the levels of H3Ac in these samples. An increase in H3Ac mark was expected for the 
samples treated with OHT and VPA compared to the control samples, only OHT and OHT 
plus UNC treatment. However, there was no detectable increase in H3Ac mark in the samples 
treated with VPA, especially when comparing to the OHT-treated samples (Figure 5.6 B).This 
suggests that the drug was not working or that the converted OHT-treated cells were dying 
under VPA treatment. To verify that the VPA treatment was not working in the OHT-treated 
MEFs and it was not an issue with the concentration or the drug itself, a control experiment 
was carried out. Lsh+/+ and Lshoff/off MEFs were treated with VPA and sodium butyrate (NaB), 
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which is another widely used inhibitor of HDACs. The concentration of VPA in the control 
experiment was the same as the one used previously and as described by others (Gottlicher 
et al., 2001). The treatment of Lsh+/+ and Lshoff/off MEFs with both inhibitors, VPA and NaB, 
caused an increase in H3Ac compared to the non-treated control samples as assessed by 
Western blot (Figure 5.6 C). The quantification of the Western blot showed the fold change in 
H3Ac after VPA and NaB treatment. The fold change increase in H3Ac relative to H4 was 
higher for NaB than VPA treatment in both cell lines, which indicates that the treatment with 
NaB was more efficient than the VPA treatment (Figure 5.6 D). The difference in the treatment 
of Lshoff/off MEFs with only VPA and VPA plus OHT could indicate a higher sensitivity of the 
OHT-converted cells to VPA. This would explain why there is no increase in H3Ac mark when 
the cells are treated at the same time with OHT and VPA, since the converted cells might not 
tolerate the inhibition of HDACs. The inefficient VPA treatment combined with OHT treatment 








 I also treated the Lshoff/off MEFs with OHT and UNC to determine whether deposition of 
H3K9me2 at promoters of LSH-dependent loci by G9a/GLP is required for gene silencing. The 
sequential treatment with OHT and UNC (Figure 5.7 A) was performed as the VPA treatment 
described earlier. A decrease in the global levels of H3K9me2 modification was expected after 
UNC treatment. This was initially assessed by Western blot, including non-treated Lsh+/+ and 
Lshoff/off MEFs as controls together with samples from Lshoff/off MEFs treated only with OHT 
and with OHT plus UNC for seven and fourteen days. The OHT and VPA treated samples 
were also included as an additional control. There was no clear difference in the global levels 
of H3K9me2 after seven days of treatment (Figure 5.7 B). However, after fourteen days of 
combined OHT with UNC treatment there was a decrease in the global levels of H3K9me2 
Figure 5.6. There is no change in the levels of H3Ac in Lshoff/off MEFs after treatment with OHT and VPA, 
although VPA treatment leads to an increase in H3Ac in Lsh+/+ MEFs and Lshoff/off MEFs.  
A) Schematic diagram of the sequential treatment of Lshoff/off MEFs with OHT and VPA. B) Western blot for 
H3Ac modification with an antibody to detecting acetylation of H3 at K9/K14. Lshoff/off MEFs were treated with 
OHT and VPA in addition to OHT (+VPA). Samples were collected after seven days and fourteen days of 
treatment to analyse the histone modifications. Lsh+/+ and Lshoff/off 0d were used as controls for the initial H3Ac 
levels. +UNC samples are used as an additional control. H4 is a loading control. C) Western blot detecting 
H3Ac levels in Lsh+/+ and Lshoff/off MEFs treated with VPA and NaB for a period of three days. Samples from 
untreated Lsh+/+ and Lshoff/off MEFs were used to detect the initial H3Ac levels. H4 is a loading control. D) 
Quantification of H3Ac in the Western blot shown in (C). H3Ac intensity relative to H4 for Lsh+/+ and Lshoff/off 
MEFs was normalised to the control non-treated samples.     
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compared to the control samples. To verify this globally observed difference in a locus specific 
manner, ChIP for H3K9me2 was carried out for LSH-dependent loci. The ChIP was performed 
with non-treated control samples from Lsh+/+ and Lshoff/off MEFs, and samples from Lshoff/off 
MEFs treated only with OHT and OHT with UNC for seven and fourteen days. H3K9me2 mark 
was barely detectable at the promoters of the control genes, Actin and Tnfsf9, which is in 
agreement with their unaltered expression during the OHT treatment (Figure 5.7 C). There 
were no clear differences in H3K9me2 mark between the OHT-treated and OHT with UNC-
treated samples after seven days of treatment, as observed earlier in the Western blot. 
However, at day fourteen of OHT treatment there was a big gain of H3K9me2 mark at the 
OHT-treated samples but no gain of H3K9me2 was observed at the OHT with UNC-treated 
samples. This demonstrates that the UNC inhibitor produces the expected effect when applied 
to the OHT-converted Lshoff/off MEFs for a period of fourteen days. It also demonstrates that 
either G9a or GLP are involved in the LSH-dependent deposition of H3K9me2.  
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Figure 5.7. There is no deposition of H3K9me2 mark at LSH-dependent loci after treatment of Lshoff/off 
MEFs with OHT and UNC, an inhibitor of G9a/GLP.  
A) Schematic diagram of the sequential treatment of Lshoff/off MEFs with OHT and UNC. B) Western blot for 
H3K9me2 modification in Lshoff/off MEFs treated with OHT and UNC in addition to OHT (+UNC). Samples were 
collected after seven days and fourteen days of treatment to analyse the histone modification after the different 
conditions. Lsh+/+ and Lshoff/off 0d were used as controls for the initial H3K9me2 levels. +VPA samples are used 
as an additional control. H4 is a loading control. C) ChIP for H3K9me2 in Lsh+/+ MEFs, Lshoff/off MEFs and 
Lshoff/off MEFs after OHT and OHT +UNC treatment. Actin was used as a control since its transcription does 
not change in the cells under study. Tnfsf9 was used as a negative control since it is not silenced after OHT 




  To determine further whether the inhibition of G9a/GLP activity has an effect on LSH-
dependent gene silencing, I analysed the expression of specific protein coding genes and IAP 
retrotransposons by quantitative RT-PCR. Rhox2 and Rhox6 genes were silenced after 
fourteen days of OHT treatment, as expected, but this silencing was not observed when the 
cells were treated with OHT together with UNC for the same period (Figure 5.8 A). However, 
there were no clear differences in the expression of Rhox genes at day seven between the 
OHT and OHT plus UNC treated samples, which correlates with the effect of the inhibitor on 
H3K9me2 at day seven. In this experiment Gm9 gene was not highly expressed in the Lshoff/off 
MEFs compared to Lsh+/+ MEFs and this weak gain of expression was not affected by either 
the OHT or the OHT with UNC treatment. Similarly, there was no gain of expression of Tnfsf9 
in the Lshoff/off MEFs and therefore there were no changes observed after the different 
treatments. Surprisingly, the expression of IAPs in the Lshoff/off MEFs was reduced in both 
cases, in the OHT and the OHT plus UNC treated samples. After seven days of treatment we 
observed the same decrease in IAPs expression for both conditions (Figure 5.8 B) and at day 
fourteen of treatment IAPs were silenced in both samples. It seems that, in contrast to the 
Rhox genes, IAPs do not require deposition of H3K9me2 by the G9a/GLP complex for 
silencing upon LSH expression. To understand the silencing of IAPs after inhibition of 
G9a/GLP activity, I performed ChIP for H3K27me3 since this histone modification has been 
shown to play a role in IAPs silencing in the absence of DNA methylation (Walter, Teissandier, 
Pérez-Palacios, & Bourc’his, 2016). The changes in this histone mark were also analysed for 
the control gene Actin and IAPs in the control cell lines and Lshoff/off MEFs after seven and 
fourteen days after different treatments, OHT and OHT with UNC. Lshoff/off MEFs were marked 
by H3K27me3 at promoters of IAPs compared to Lsh+/+ MEFs where we did not observe this 
mark (Figure 5.8 C). This gain of H3K27me3 in Lshoff/off cells could be responsible for the 
silencing of some IAPs in the absence of LSH. After seven days of OHT treatment, there was 
further gain of H3K27me3 which could be responsible for the silencing of IAPs when LSH 
expression was restored. The gain of H3K27me3 was higher in the OHT with UNC treated 
cells, which could be compensating for the lack of H3K9me2 deposition when the action of 
G9a/GLP enzymes is impaired. However, at day fourteen of treatment, there was loss of 
H3K27me3 in both samples, the OHT and OHT with UNC treated cells. This indicates that the 
role of H3K27me3 mark in the silencing of IAPs is transient in the absence of G9a/GLP activity 
when LSH is restored and suggests that another mechanism must be playing a role to maintain 
IAPs repressed after fourteen days of treatment. The gain of H3K27me3 between Lshoff/off cells 
and seven days of OHT and UNC treated cells can justify the level of repression of IAPs. The 
limited gain of the repressive mark H3K27me3 could be explained by limiting Polycomb 
Complex. However, this mark could be triggering other mechanisms to continue the silenced 




      
Figure 5.8. H3K9me2 deposition by G9a/GLP is required for LSH-dependent gene silencing of Rhox 
genes while H3K27me3 seems to be playing a transitory role in the silencing of IAP retrotransposons 
in the absence of G9a/GLP activity.   
Expression of specific protein coding genes (A) and IAP retrotransposons (B) in Lsh+/+, Lshoff/off and Lshoff/off 
MEFs after OHT and OHT with UNC (+UNC) treatment for a period of seven and fourteen days. The graphs 
show the change in expression relative to Lshoff/off MEFs assessed by quantitative RT-PCR. The housekeeping 
Gapdh gene was used for normalisation. The error bars represent standard error of the mean from two 
independent experiments. C) ChIP for H3K27me3 at IAPs in Lsh+/+, Lshoff/off and Lshoff/off MEFs after OHT and 
OHT with UNC treatment. Actin was used as a control since its transcriptional state is not expected to change 




 To summarise, the inhibition of G9a/GLP impairs the silencing of Rhox genes upon 
restoration of LSH. However, in the absence of H3K9me2 deposition by the G9a/GLP 
complex, the IAP retrotransposons are silenced and H3K27me3 seems to play a transient role 
in this silencing. To investigate whether there are other changes in histone modifications in 
the absence of G9a/GLP activity that could contribute to gene silencing, I performed ChIP for 
H3K9me3. At day fourteen of OHT treatment there was gain of H3K9me3 at the promoters of 
the protein coding genes, Gm9, Rhox2 and Rhox6, which accompanied the silencing of Rhox 
genes mentioned earlier (Figure 5.9 A). However, this gain of H3K9me3 was not observed 
when the cells were treated with OHT and UNC. Accordingly, IAPs only gained H3K9me3 
mark at their promoters after fourteen days of OHT treatment. Importantly, the gain of 
expression of IAPs in Lshoff/off MEFs was accompanied by reduction of H3K9me3 at their 
promoter regions compared to Lsh+/+ MEFs. In conclusion, specific protein coding genes and 
IAP retrotransposons gain H3K9me3 at day fourteen of OHT treatment, but not after OHT with 
UNC treatment. This indicates that the H3K9me3 mark observed is a result of H3K9me2 
modification initially deposited by the G9a/GLP complex.    
 I also analysed nucleosome density to determine whether UNC treatment was affecting 
the changes in H3 occupancy observed upon LSH restoration. ChIP for H3 was carried out 
using the same cell lines after OHT and OHT with UNC treatment. We observed no clear 
differences between the OHT and OHT with UNC treated samples (Figure 5.9 B). In general, 
Lshoff/off MEFs followed the same trend under both treatments. We observed a delay in the 
recovery of H3 occupancy at promoters of Gm9 and IAPs after fourteen days of OHT with 
UNC treatment compared to the OHT only treated samples. However, more biological 
replicates should be done to confirm this observation.    
 Taken together, these results demonstrate that H3K9me2 deposition by the G9a/GLP 
complex is required for LSH-dependent gene silencing of Rhox genes while H3K27me3 seems 
to be playing a transitory role in the silencing of IAP retrotransposons in the absence of 
G9a/GLP activity. However, more experiments should performed to determine the role of 
HDACs in LSH-dependent gene silencing since the inefficient VPA treatment combined with 
OHT did not permit us to study whether HDACs are strictly required before H3K9me2 






Figure 5.9. Inhibition of G9a/GLP impairs the gain of H3K9me3 mark at LSH-dependent loci upon 
restoration of LSH but it does not affect H3 occupancy at promoters of specific genes and IAP 
retrotransposons.   
ChIP for H3K9me3 (A) and histone H3 (B) at specific protein coding genes and IAPs in Lsh+/+, Lshoff/off and 
Lshoff/off MEFs after OHT and OHT with UNC treatment. Actin and Tnfsf9 were used as controls since their 
transcriptional state does not change. The error bars represent standard error of the mean calculated from 
three technical replicates. 
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5.6   Discussion  
 To understand the role of LSH in epigenetic gene silencing it is important to consider the 
order of events taking place upon LSH restoration in the Lshoff/off MEFs. We have shown that 
after seven days of OHT treatment, when LSH protein levels are restored to wild-type, LSH 
localises at LSH-dependent loci leading to a mild decrease in H3 occupancy. This is 
accompanied by loss of H3Ac mark from these promoters at day seven of treatment, which 
happens at the same time the genes start to get silenced. At day fourteen of OHT treatment, 
LSH-dependent loci are silenced and we observe gain of H3K9me2 at their promoters. 
Surprisingly, all these events happen without gain of DNA methylation at the promoters of 
LSH-dependent genes and retrotransposons. This order of events occurring after expression 
of LSH in the knockout cells could indicate a primary role of LSH as a chromatin remodeling 
protein that also leads to removal of H3Ac mark, to establish a suitable substrate for G9a/GLP 
activity since these enzymes do not methylate acetylated histones. The subsequent 
methylation of H3K9 by G9a/GLP leads to a transcriptionally repressive chromatin state and 
DNA methylation could be involved in stabilizing this repressive state already established at 
LSH targeted regions. 
 LSH localises at all the studied loci after seven days of tamoxifen treatment, including 
control genes and LSH-dependent loci. This could indicate that after LSH restoration, LSH 
performs a genome-wide scanning but it only stays longer at specific places in the genome. 
The recently shown interaction of LSH with CDCA7 could target LSH to specific regions in the 
genome since CDCA7 is required for LSH recruitment to chromatin and contains a highly 
conserved zinc finger domain, which may facilitate their chromatin recruitment in a sequence 
specific manner (Jenness et al., 2018). The binding of LSH at these loci is accompanied by a 
mild decrease in H3 occupancy, which might indicate that LSH is acting as a chromatin 
remodeler either sliding nucleosomes or evicting the histone octamer. The sliding of 
nucleosomes by LSH could enable access to other proteins or protein complexes required for 
the generation of the transcriptionally repressive state, such as proteins that recruit HDACs to 
these target regions or histone demethylases that remove the H3K4me3 mark observed in the 
absence of LSH at LSH-dependent loci that gain transcription (Termanis et al., 2016). This 
nucleosome sliding could also facilitate binding of CDCA7 to specific sequences through its 
zinc finger domain and stabilise LSH recruitment. In addition to the nucleosome repositioning 
activity, LSH could be acting as a scaffolding protein to facilitate HDACs recruitment to these 
loci and removal of the acetylation mark (Myant & Stancheva, 2008), which is necessary for 
the subsequent deposition of H3K9me2 by the G9a/GLP complex. Another possibility for the 
chromatin remodeling activity of LSH could be the eviction of nucleosomes with active 
chromatin marks, which would allow the incorporation of non-acetylated histones to facilitate 
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the establishment of a repressive chromatin state by G9a/GLP activity. LSH has been recently 
shown to slide nucleosomes in vitro but free DNA was not generated during the course of the 
remodeling, indicating that the LSH-CDCA7 complex could not evict the nucleosome (Jenness 
et al., 2018). The optimisation of the HDACs inhibitor treatment will help clarify whether 
HDACs activity is essential for LSH-dependent gene silencing. This would rule out the 
hypothesis of LSH evicting nucleosomes with acetylated histones and reinforce the role of 
LSH as a chromatin remodeler that slides nucleosomes to facilitate the access of chromatin 
modifying enzymes that lead to LSH-dependent gene silencing.    
 We have also shown that DNA methylation is not necessary for the initial silencing of 
misregulated genes. In contrast to these findings, recent studies have shown that the role of 
LSH in gene silencing is accompanied by establishment of DNA methylation and this requires 
the ATPase activity of LSH (Ren et al., 2015; Termanis et al., 2016). Interestingly, these 
studies hypothesized a role for LSH as a chromatin remodeler in addition to its previously 
suggested role as a scaffolding protein (Myant & Stancheva, 2008). It has been previously 
shown in the lab that LSH cooperates with DNMT1, DNMT3B and the histone deacetylases 
HDAC1 and HDAC2 to silence transcription when LSH is targeted to the promoter of a reporter 
gene. This transcriptional repression by LSH and the interaction with HDACs are lost in 
DNMT1 and DNMT3B knockout cells. Histone deacetylation is required for silencing of the 
reporter gene, although the enzymatic activities of DNMTs are not required for this silencing 
mediated by LSH (Myant & Stancheva, 2008). Another publication also shows that p16 
repression mediated by LSH requires HDACs activity, but it does not required DNMTs activity. 
Moreover, they also show that LSH associates with HDAC1 and HDAC2 (Zhou, Han, Li, & 
Tong, 2009). Accordingly, in our cellular system LSH could be sliding nucleosomes and also 
recruiting HDACs to promote the establishment of transcriptionally repressive state that might 
be further stabilized by DNA methylation at the targeted loci. It is not clear yet whether DNA 
methylation is rescued at some point after gene silencing is established in this conditionally 
reversible Lsh knockout cellular system. We would need to be able to select for the Lshon/on 
cells in order to maintain the converted cells for a longer period in culture without the Lshoff/off 
cells outgrowing them. This would allow to study if DNA methylation is restored upon LSH 
expression and the specific time when it happens. It would also be interesting to know how 
long can this repressive state be maintained in the absence of DNA methylation.  
 After the removal of H3Ac upon LSH restoration, the next change in chromatin 
modifications observed is the deposition of H3K9me2 by G9a/GLP at LSH-dependent loci. 
The results from this chapter show that H3K9me2 deposition by G9a/GLP is required for LSH-
dependent gene silencing of Rhox genes, but not of IAP retrotransposons. The histone 
modification H3K27me3 seems to play a transitory role in the silencing of IAP retrotransposons 
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in the absence of G9a/GLP activity. The gain of H3K27me3 after seven days of OHT treatment 
is not maintained during the fourteen days period of treatment although IAPs remained 
silenced at day fourteen of OHT treatment. Interestingly, PRC2-mediated histone methylation 
has been suggested to be necessary for PRC1 recruitment (Kuzmichev, Nishioka, Edrjument-
Bromage, Tempst, & Reinberg, 2002). This transitory gain of H3K27me3 mark could be 
recruiting components of the PRC1 complex to stabilise this silencing through ubiquitylation 
of histone H2A (Boyer et al., 2006) and later promote DNA methylation to stably maintain 
silencing of IAPs. Reinforcing this hypothesis, LSH can associate with PRC1 components and 
influence PRC-mediated histone modifications such H2A ubiquitylation (Xi et al., 2007). Taken 
together, in the absence of G9a/GLP activity IAPs silencing mediated by PRC complexes 
could be facilitated by LSH-dependent nucleosome sliding and the interaction of LSH with 
different components of the complexes, promoting the association of PRC complexes with the 
target regions. As mentioned earlier, in contrast to the silencing of IAPs, Rhox genes require 
deposition of H3K9me2 by G9a/GLP for silencing upon LSH restoration. Previously it has been 
shown in the lab that cooperation between LSH and theG9a/GLP complex facilitates 
establishment of normal patterns of DNA methylation and gene silencing at specific promoters 
during differentiation of ES cells. Also, G9a/GLP recruitment is compromised when LSH is 
absent suggesting that LSH promotes the association of G9a/GLP with specific promoters 
although interaction between LSH and the G9a/GLP complex in coimmunoprecipitation 
experiments was not detected. This study suggested that LSH promotes G9a/GLP recruitment 
by bringing HDACs to remove acetylation that inhibits the activity of the G9a/GLP complex 
(Myant et al., 2011). The previous study carried out in the lab used differentiating ES cells with 
retinoic acid treatment (Myant et al., 2011). However, retinoic acid could be silencing these 
pluripotency genes in differentiating cells rather than LSH due to the stronger action of retinoic 
acid receptor. Here, we have shown that restoration of LSH expression in somatic cells leads 
to changes in chromatin structure and histone modifications that create a silence chromatin 
state without establishment of DNA methylation. We can hypothesize that removal of acetyl 
groups from H3 by LSH-associated histone deacetylases (Myant & Stancheva, 2008; Zhou et 
al., 2009) generates a suitable substrate for mono- and di-methylation of H3K9 and we 
observe subsequent gain of H3K9me2 at fourteen days of treatment after LSH localises at its 
targeted loci. In relation to this, mass spectrometry analysis carried out in the lab found LSH 
as an interacting partner of the G9a/GLP complex (T. Zhang et al., 2016). Therefore, binding 
of G9a/GLP to these loci could be facilitated by this suitable substrate generated and a 
possible interaction of LSH with the G9a/GLP complex.  
 In summary, we have demonstrated that LSH localises at LSH-dependent loci upon its 
restoration in our conditionally reversible Lsh knockout cellular system. We observe a mild 
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decrease in the occupancy of H3 at the promoters of these loci at the same moment that LSH 
localises there, reinforcing the previously shown role of LSH as a chromatin remodeler 
(Jenness et al., 2018). The activity of LSH as a remodeler sliding nucleosomes that could 
promote binding of other factors and the previously shown interaction of LSH with HDACs 
(Myant & Stancheva, 2008), facilitate the removal of acetyl groups from H3 tails observed at 
the same time point that LSH localises at these loci. Then, the suitable substrate created for 
G9a/GLP activity promotes deposition of H3K9me2 modification at the same time that 
misregulated genes are silenced. Taken together, our results suggest that the primary role of 
LSH is to promote changes in chromatin structure and modifications that lead to gene silencing 





Chapter 6 - Conclusion and future outlook 
 
Previous work has shown that specific genes misregulated in the Lsh-/- MEFs can be 
silenced and DNA methylation restored at their promoters in a cell autonomous manner when 
wild-type LSH is reintroduced into the knockout cells (Termanis et al., 2016). However, neither 
gene expression nor DNA methylation are rescued when the ATP mutant LSH is reintroduced. 
The silencing of these LSH-dependent genes is accompanied by loss of active chromatin 
marks, H3Ac and H3K4me3 (Termanis et al., 2016) from their promoter region. ATP hydrolysis 
by LSH is essential for its function in gene silencing and de novo DNA methylation (Ren et al., 
2015; Termanis et al., 2016), which suggests that chromatin remodeling by LSH is necessary 
for these functions. From the previous study carried out in the laboratory we also know that 
the defects in gene expression and DNA methylation that occur in the absence of LSH in MEFs 
can be rescued autonomously (Termanis et al., 2016). Moreover, we have shown using the 
previous Lsh knockout system that an appropriate concentration of DNMT3B is necessary for 
the final rescue of gene repression and DNA methylation by wild-type LSH (Termanis et al., 
2016). However, it is not clear the molecular mechanism of LSH-dependent gene silencing 
and de novo DNA methylation. We do not understand how LSH re-expression leads to the 
final repressive state, in which misregulated genes are silenced and de novo methylation 
established at their promoters. The principal aim of this work was to determine how LSH-
dependent changes in chromatin structure and modifications facilitate epigenetic gene 
silencing and de novo DNA methylation. The use of the conditional knockout cellular system 
enabled us to express LSH in the Lshoff/off MEFs and study the order of events leading to the 
establishment of gene silencing and DNA methylation at LSH-dependent loci.  
The characterization of the Lshoff/off MEFs is in agreement with previous studies 
demonstrating that LSH deficiency affects the expression and DNA methylation at promoters 
of specific single-copy protein coding genes (Myant et al., 2011; Tao et al., 2011; Xi et al., 
2007) and repetitive elements (Dennis et al., 2001; Huang et al., 2004).  Treatment with OHT 
for seven days is sufficient to convert the Lshoff allele to the Lshon orientation in immortalised 
MEFs and the allele conversion restores LSH expression in the Lshon/on MEFs to wild-type 
levels. Therefore, the conditionally reversible Lsh knockout cellular system functions as 
expected and allows us to study the order of events occurring immediately after LSH 
restoration in MEF cell lines in order to understand the molecular mechanism of LSH-
dependent gene silencing. This was not possible to achieve in the earlier studies. However, 
since the non-converted cells outgrow the Lshon/on MEFs, the changes in chromatin produced 
by LSH that lead to gene silencing and establishment of DNA methylation could only be 
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investigated in a narrow window of fourteen days. During the first seven days of OHT 
treatment, when LSH is restored, it localises at the promoters of LSH-dependent loci leading 
to a mild decrease in the occupancy of H3 and removal of acetyl groups from H3 tails. As 
these events occur at the same time that LSH binds to these loci, this reinforces the role of 
LSH as a chromatin remodeler (Jenness et al., 2018) and a scaffolding protein, since LSH has 
been previously shown to interact with HDACs (Myant & Stancheva, 2008; Zhou et al., 2009). 
Jenness et al have shown that CDCA7 is required to stimulate the ATPase-dependent 
nucleosome remodeling activity of LSH, which leads to nucleosome sliding. This nucleosome 
sliding could facilitate the recruitment of chromatin modifying enzymes such as histone 
demethylases to remove the H3K4me3 observed in Lsh knockout cells (Termanis et al., 2016). 
Then, the suitable substrate created after removal of H3Ac mark by HDACs interacting with 
LSH, facilitates the deposition of H3K9me2 by G9a/GLP histone methylases at the same time 
point when misregulated genes are completely silenced. This order of events suggests that 
LSH plays a role as a chromatin remodeler and also as a scaffolding protein leading to 
changes in chromatin structure and modifications that facilitate epigenetic gene silencing 
without rescue of DNA methylation in the initial period when LSH is restored in MEF cell lines 
(Figure 6.1). This supports earlier findings showing that transcriptional repression of the Oct-
4 gene during early embryogenesis is followed by an increase in H3K9me2 mediated by the 
G9a/GLP complex. The methylation of H3K9 promotes local heterochromatinization through 
binding of HP1 protein which is needed for subsequent de novo DNA methylation by 
DNMT3A/3B (Feldman et al., 2006). The G9a/GLP complex has also been shown to direct 
DNA methylation in mouse embryos. The silencing of germline genes mediated by G9a/GLP 
is incomplete without the establishment of DNA methylation by DNMT3B (Auclair et al., 2016). 
Moreover, H3K9me3 mediated by Suv39h has been shown to direct de novo DNA methylation 
via HP1 to pericentric repeats (Lehnertz et al., 2003). In relation to this, HP1 has been shown 
to bind both H3K9me2 and H3K9me3 marks via its chromodomains (Fischle et al., 2003). 
Therefore, a possible hypothesis for the establishment of DNA methylation in LSH-dependent 
loci might be the recruitment of DNMT3A/B through LSH, G9a or HP1 that binds to the already 
established methylation at lysine 9 of histone 3. However, de novo DNA methylation is not 
necessary for the establishment of the initial transcriptionally repressive chromatin state upon 
LSH restoration in somatic cells.  
Further work is required to determine whether DNA methylation occurs in the reversible 
knockout cellular system to provide long term stability of the initial silent state created upon 
LSH restoration. The capacity to select for the Lshon/on MEFs is needed in order to maintain 
these cells for a longer period without the non-converted cells outgrowing them after fourteen 
days in culture. This would allow to study the possible establishment of DNA methylation later 
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on time. It would be very interesting to know whether de novo DNA methylation follows the 
repressive state mediated by LSH restoration in these cells. In case there is rescue of DNA 
methylation following the repression, the next question to ask would be when it happens and 
how long can this repressive state be maintained in the absence of DNA methylation. A 
possible approach to select for the converted Lshon/on MEFs would be to cross the mice 
containing the conditionally reversible Lsh cassette with mice containing a Cre-dependent 
fluorescent reporter. This would enable to distinguish the cells were recombination of the 
cassette occurred since the cells converting the GFPneo cassette to the Lshon orientation will 
also express the fluorescent reporter, allowing us to select for the Lshon/on MEFs by cell sorting. 
After selection of the Lshon/on MEFs we could study whether DNA methylation is established 
following LSH-mediated repression at these loci. Once we have determine the time when DNA 
methylation occurs, we could perform ChIP experiments for G9a, HP1 and DNMT3B at 
different time points to clarify whether they play a role in the establishment of DNA methylation 
at these repressed loci.           
 
Figure 6.1. Schematic diagram of the mechanism of LSH-dependent gene silencing in MEF cell lines. 
Model explaining the mechanism of LSH-dependent gene silencing upon LSH restoration in Lshoff/off MEFs. 
The model shows nucleosomes over the active misregulated genes in Lshoff/off MEFs. The promoters initially 
contain H3K9/K14Ac. When LSH is restored after OHT treatment of the Lshoff/off MEFs, it localises to these 
promoters potentially leading to sliding of nucleosomes, manifested by a decrease in H3 occupancy, and 
removal of H3Ac mark by HDACs interacting with LSH. Once deacetylated, H3K9 becomes a substrate for 
methylation by G9a leading to H3K9me2 deposition. However, it is not clear whether or not LSH interacts with 
G9a to facilitate its recruitment to these loci. H3K9me2 deposition is accompanied by silencing of misregulated 
genes creating a repressive chromatin state. Then, the protein HP1 could be recruited via H3K9me2 
modification and promote de novo DNA methylation by DNMT3B enzyme, which could be recruited to the 
promoter through HP1, G9a or LSH. The establishment of appropriate patterns of DNA methylation following 




 Furthermore, the use of mass spectrometry to identify which proteins or protein 
complexes can be pulled down with LSH could provide more insight into the recruitment of 
G9a/GLP and DNMT3 enzymes by LSH to these LSH-dependent loci. This would improve our 
understanding of the role of LSH in gene silencing and establishment of de novo DNA 
methylation. To determine which LSH-dependent loci are able to re-establish normal patterns 
of expression upon LSH restoration, genome-wide analysis should be performed. To know 
which loci are silenced we should performed RNA-Seq followed by ChIP-Seq for LSH to 
attribute this silencing to the action of LSH. ChIP-Seq for LSH would also clarify whether it 
binds preferentially to specific regions of the genome, since it was shown that LSH is important 
for DNA methylation at the nuclear compartment that is in part defined by lamin B1 attachment 
sites (Yu et al., 2014). These approaches will help understand the dynamics of LSH-
dependent transcriptional silencing in a genome-wide context. We have shown that LSH 
localises at the loci in study at day seven of OHT treatment when its protein expression levels 
are restored to wild-type. At the same time point there is a mild decrease in H3 occupancy at 
these promoters, but it is not clear how LSH remodels nucleosomes to enable changes in 
histone modifications. LSH could be repositioning nucleosomes or evicting the nucleosomes, 
which would also remove the acetylation mark and create a suitable substrate for G9a/GLP to 
methylate H3K9. The optimization of the HDACs inhibitor treatment would clarify whether 
HDACs activity is essential for this initial gene silencing or whether the acetylation mark is 
removed by nucleosome eviction. However, it is more probable that LSH acts sliding 
nucleosomes since it has been shown in in vitro assays that LSH can slide nucleosomes but 
not evict them (Jenness et al., 2018). The use of the NOMe-Seq assay at different time points 
after LSH restoration would clarify the dynamics of chromatin genome wide and its correlation 
with the de novo DNA methylation mediated by LSH. As mentioned earlier, recently it was 
demonstrated that LSH forms part of a bipartite nucleosome remodelling complex with CDCA7 
(Jenness et al., 2018). The complex that LSH forms with CDCA7 possesses nucleosome 
repositioning activity although LSH alone cannot slide nucleosomes. Jenness et al have also 
shown that CDCA7 is essential for binding of LSH to chromatin in cells. It would be interesting 
to determine whether CDCA7 is necessary for recruitment of LSH to chromatin in our cellular 
system. CDCA7 could be knocked out in the Lshoff/off MEFs to study whether or not gene 
silencing occurs in the converted cells when LSH is restored in the absence of CDCA7. This 
could also help gain some insight into the requirement of ATP-dependent nucleosome 
remodeling by LSH in the initial repression of genes before acquisition of DNA methylation. It 
has been shown that the ATP binding by LSH is necessary for its function in de novo DNA 
methylation (Ren et al., 2015; Termanis et al., 2016), but it might not be required for the initial 
changes in chromatin modifications that lead to LSH-dependent gene silencing.     
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Several studies have shown that LSH plays a role in the establishment of de novo DNA 
methylation, but its role in the maintenance of DNA methylation has never been clarified. The 
sodium bisulfite DNA sequencing of IAPs from primary Lshoff/off MEFs and immortalised cells 
at different passage numbers did not show progressive loss of DNA methylation at higher 
passages. This preliminary analysis could indicate that LSH might not have a role in the 
maintenance of DNA methylation, although we have some in vivo data from mouse embryos 
(unpublished data) suggesting that LSH might support maintenance as well as de novo DNA 
methylation. The best experiment to analyse this would have been to convert the allele in the 
Lshon/on MEFs to Lshoff orientation and study whether the normal patterns of DNA methylation 
characteristic of wild-type cells are lost in the absence of LSH. This would prove that LSH has 
a role in the maintenance of DNA methylation. I tried to perform this experiment using different 
cell lines but several issues arose with the cells and the conversion of the allele could not be 
optimised. Therefore the conversion of the allele to the Lshoff orientation needs to be optimised 
in order to study the possible role of LSH in maintenance of DNA methylation. The use of the 
conditional knockout system also allows the study in mouse embryos with the potential to 
reactivate LSH at different developmental stages which would provide a better 
characterization of the developmental timing of LSH-dependent events. 
In conclusion, this work has demonstrated that changes in chromatin modifications 
leading to a repressive chromatin state can be established in somatic cells by the chromatin 
remodeler LSH to facilitate LSH-dependent gene silencing without acquisition of DNA 
methylation. This suggests that the primary role of LSH is to promote changes in chromatin 
structure and modifications that lead to gene silencing and not DNA methylation, which most 
likely occurs as a consequence of transcriptional silencing. This is an important aspect of LSH 
function since mutations in LSH and CDCA7 have recently been found to cause ICF syndrome 
(Thijssen et al., 2015), which is commonly associated with mutations in DNMT3B. The 
evidence from this study showing that the changes in chromatin required to silence 
misregulated genes can occur without gain of DNA methylation when LSH expression is 
restored in somatic cells, could lead to further research into new therapeutic options for 
patients with ICF syndrome.  
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